Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3010156	s-hcrp	mg/l (mg/l)	5106	6489	0.00%
3010156	s-hcrp	— (—)	4773	6005	100.00%	Distribution not available
3010156	s-hs-crp	mg/l (mg/l)	3606	7574	0.04%
3010156	s-ucrp	mg/l (mg/l)	1937	3244	0.00%
3010156	p-hs-crp	mg/l (mg/l)	492	1302	0.00%
3010156	s-hs-crp	— (—)	355	479	100.00%	Distribution not available
3010156	s-ucrp	— (—)	351	410	100.00%	Distribution not available
3010156	s-hscrp	mg/l (mg/l)	287	344	0.00%
3010156	s-c-reaktiivinenproteiini,herkkä	mg/l (—)	117	120	100.00%	Distribution not available
3010156	c-reaktiivinenproteiini,herkkä	mg/l (—)	107	148	100.00%	Distribution not available
3010156	c-reaktiivinenproteiini,vieritutkimus	mg/l (—)	80	85	100.00%	Distribution not available
3010156	c-reaktiivinenproteiini,vieritutkimusnordlab	mg/l (—)	74	82	100.00%	Distribution not available
3010156	c-reaktiivinenproteiini,pika	mg/l (—)	71	81	100.00%	Distribution not available
3010156	s-c-reaktiivinenproteiini,pika	mg/l (—)	66	77	100.00%	Distribution not available
3010156	p-hs-crp	— (—)	52	65	100.00%	Distribution not available
3010156	s-hscrp	— (—)	14	15	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Obesity, other/unspecified

1241

5719

2.27

146.50

2.2

1.6

4.99

3.18

mg/l

4.31

1145

3791

Other nutritional deficiencies

2060

11303

1.83

135.68

2.0

1.6

4.96

3.25

mg/l

7.91

1857

7480

Obesity

1948

10939

1.81

124.44

2.0

1.6

5.06

3.25

mg/l

8.19

1780

7252

Obesity and other hyperalimentation

1952

10972

1.81

123.96

2.0

1.6

5.07

3.25

mg/l

8.26

1782

7274

Obesity due to excess calories

1501

7943

1.95

120.52

2.1

1.6

5.06

3.19

mg/l

6.42

1377

5262

Depression

2919

12608

1.62

119.10

1.7

1.6

3.56

3.45

mg/l

0.30

2343

8378

Mood [affective] disorders

3037

12740

1.60

114.48

1.7

1.6

3.62

3.45

mg/l

0.48

2427

8485

Sleep disorders (combined)

2750

11224

1.64

114.39

1.8

1.6

4.40

3.24

mg/l

4.63

2276

7532

Mood disorders

3040

12747

1.59

114.08

1.6

3.64

3.45

mg/l

0.60

2428

8491

Myocarditis

285

672

4.74

113.03

11.5

1.4

3.07

3.61

mg/l

0.39

272

437

Recurrent or chronic depression

1536

5970

1.91

110.46

1.7

1.6

3.25

3.40

mg/l

0.30

1235

3814

Sleep apnoea, including avohilmo

2507

10486

1.58

90.05

1.8

1.6

4.56

3.19

mg/l

5.39

2072

7139

Sleep apnoea

2328

10051

1.60

89.05

1.9

1.6

4.62

3.23

mg/l

5.00

1950

6860

Mood disorders, excluding more controls

2747

11040

1.54

87.37

1.7

1.6

3.65

3.38

mg/l

0.82

2190

7281

Anxiety (asthma-related co-morbidities)

2003

9937

1.62

83.38

1.6

3.63

3.44

mg/l

0.48

1552

6500

Neurotic, stress-related and somatoform disorders

2641

12559

1.52

81.63

1.7

1.6

3.82

3.40

mg/l

1.37

2048

8441

All anxiety disorders

2037

10434

1.61

81.14

1.6

3.62

3.42

mg/l

0.54

1575

6909

Anxiety disorders

2647

12592

1.51

80.42

1.7

1.6

3.83

3.40

mg/l

1.49

2052

8465

Nonorganic sleeping disorders, excluding more controls

641

2948

2.27

76.46

1.6

3.21

3.40

mg/l

0.23

526

1891

Sarcoidosis

430

1672

2.70

74.94

8.0

1.5

3.85

3.78

mg/l

0.04

387

1192

Anxiety disorders, excluding more controls

2422

10754

1.52

73.55

1.7

1.6

3.86

3.32

mg/l

1.84

1884

7066

Special screening examination for infectious and parasitic diseases

1091

4513

1.87

72.91

1.5

1.6

3.20

3.24

mg/l

0.05

719

2861

Other antidepressants

2800

10037

1.47

71.06

1.6

3.60

3.58

mg/l

0.04

2167

6575

Behavioural syndromes associated with physiological disturbances and physical factors

1068

6036

1.82

69.69

1.6

3.18

3.59

mg/l

1.13

856

4018

Generalized anxiety disorder

610

2876

2.22

68.75

1.6

3.24

3.67

mg/l

0.64

479

1852

Sleep disorders

702

3529

2.06

66.18

1.6

1.7

3.18

3.76

mg/l

1.18

579

2388

Selective serotonin reuptake inhibitors

2740

10053

1.45

64.68

1.6

3.46

3.58

mg/l

0.28

2090

6587

Nonorganic sleeping disorders

641

3156

2.11

64.17

1.6

3.21

3.69

mg/l

0.82

526

2154

Insomnia

550

2595

2.21

61.81

1.6

1.7

2.91

3.84

mg/l

2.01

456

1772

Other anxiety disorders

1477

8373

1.60

58.88

1.6

3.56

3.43

mg/l

0.26

1150

5444

Certain disorders involving the immune mechanism

514

2515

2.11

52.16

6.9

1.5

4.00

3.82

mg/l

0.15

451

1763

Depression or dysthymia

1879

7191

1.48

49.85

1.7

1.6

3.33

3.39

mg/l

0.10

1458

4681

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

175

4180

0.36

41.68

1.6

1.7

5.56

3.68

mg/l

1.59

142

2946

Continuous positive airway pressure

515

2367

1.93

39.85

2.2

1.4

4.77

2.68

mg/l

4.55

453

1500

Chronic diseases of tonsils and adenoids

2217

10351

1.37

39.42

1.6

3.36

3.44

mg/l

0.17

1552

7052

Triptan medication for migraine, single purchase ok

2239

11250

1.36

38.82

1.7

1.6

3.30

3.56

mg/l

0.62

1577

7727

Migraine, single triptan purchase ok & required. ICD-code if available is included

2239

11250

1.36

38.82

1.7

1.6

3.30

3.56

mg/l

0.62

1577

7727

Diagnoses used for exclusion with ILD

508

2754

1.88

37.98

7.0

1.5

5.25

3.75

mg/l

1.41

458

1956

Depression medications

1243

4171

1.53

37.09

1.6

1.3

3.69

2.73

mg/l

4.19

948

2376

Episodal and paroxysmal disorders

2919

11541

1.31

36.42

1.7

1.6

3.94

3.31

mg/l

1.78

2241

7634

Hyperkinetic disorders, excluding more controls

363

1788

2.05

33.86

1.4

1.6

3.17

3.42

mg/l

0.28

279

1039

Other diseases of upper respiratory tract

2670

10834

1.30

31.38

1.7

1.6

3.62

3.51

mg/l

0.19

1888

7429

Adjustment and management of implanted device

286

1368

2.13

30.74

8.9

1.5

4.00

3.42

mg/l

0.39

260

957

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

2303

0.24

29.60

1.7

5.85

3.72

mg/l

0.77

1625

KRA_PSY_EATING, excluding more controls

322

1660

2.01

28.57

1.6

1.5

3.50

3.77

mg/l

0.19

237

980

Symptoms and signs involving the circulatory and respiratory systems

2801

11143

1.27

28.04

1.8

1.5

4.23

3.19

mg/l

3.45

2044

7480

Diabetes, insulin treatment (Kela reimbursement)

1402

11660

0.73

27.77

1.9

1.6

4.75

3.35

mg/l

5.30

1222

8060

Restless leg syndrome

281

1396

2.08

27.68

1.8

1.7

3.40

3.78

mg/l

0.25

245

998

Benzodiazepine use

2355

13195

1.28

26.75

1.7

1.6

3.87

3.44

mg/l

1.34

1873

8995

Stroke, including SAH

428

5396

0.58

26.64

1.6

1.7

3.49

3.66

mg/l

0.13

322

3885

Sleep disorders, other/unspecified

140

533

2.82

26.25

1.7

1.8

3.33

3.63

mg/l

0.19

126

357

Disorders of the thyroid gland

2259

11621

1.28

25.45

1.8

1.6

3.88

3.46

mg/l

1.42

1729

7910

Stroke, excluding SAH

376

4852

0.57

25.24

1.6

1.7

3.25

3.72

mg/l

0.45

290

3491

Medical observation and evaluation for suspected diseases and conditions

1789

6971

1.33

25.01

1.8

1.6

3.90

3.30

mg/l

1.39

1332

4624

Persistent mood disorders

471

2830

1.70

25.01

1.7

1.6

3.79

3.57

mg/l

0.21

400

1894

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1436

13423

0.75

24.97

1.9

1.6

5.79

3.22

mg/l

8.21

1146

9231

Hypothyroidism, other/unspecified

2124

11005

1.28

24.55

1.8

1.6

4.04

3.40

mg/l

2.42

1639

7495

Obesity related asthma

727

4855

1.52

24.46

2.0

1.7

5.79

3.18

mg/l

3.11

638

3384

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1377

11210

0.74

23.94

1.9

1.6

4.73

3.26

mg/l

5.71

1203

7645

Personality disorders, excluding more controls

742

5009

1.51

23.84

1.6

3.64

3.34

mg/l

0.49

603

3179

Headache

1706

10982

1.31

23.77

1.7

1.6

3.55

3.29

mg/l

0.67

1260

7377

Chronic sinusitis

983

6999

1.42

23.47

1.8

1.6

3.79

3.49

mg/l

0.48

745

4863

Abnormalities of heart beat

750

5039

1.49

23.33

2.1

1.6

4.11

3.17

mg/l

1.45

558

3406

Hard cardiovascular diseases

811

7486

0.69

22.87

2.0

1.7

4.29

3.53

mg/l

0.95

630

5351

Hypothyreosis and Thyroxine purchase for inclusion criteria

2168

11360

1.27

22.85

1.8

1.6

4.01

3.39

mg/l

2.36

1671

7760

Pneumonias (Asthma/COPD co-morbidities)

1519

13720

0.76

22.81

1.9

1.6

5.65

3.22

mg/l

8.02

1196

9436

Other chronic obstructive pulmonary disease, including avohilmo

323

4698

0.57

22.51

1.7

8.50

3.53

mg/l

4.40

272

3355

Chronic rhinitis, nasopharyngitis and pharyngitis

734

5005

1.49

22.32

1.6

1.7

3.47

3.34

mg/l

0.11

536

3463

All pneumoniae

1542

13792

0.77

22.12

1.9

1.6

5.69

3.22

mg/l

8.25

1213

9478

Ischaemic Stroke, excluding all haemorrhages

339

4399

0.58

21.88

1.6

1.7

3.28

3.70

mg/l

0.35

263

3186

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1129

8149

1.37

21.80

1.7

1.6

3.30

3.52

mg/l

0.37

829

5659

Other sleep disorders

259

1362

1.95

21.75

1.8

1.7

2.96

3.52

mg/l

0.78

225

903

Hypothyroidism (congenital or acquired)

963

3929

1.43

21.67

1.9

1.3

4.04

2.75

mg/l

4.53

740

2272

Triptan medication for migraine, min. 3 purchases

1635

10010

1.30

21.65

1.7

1.6

3.07

3.54

mg/l

1.53

1152

6889

Disorder of the sleep-wake schedule

240

3.55

21.49

1.7

3.54

3.46

mg/l

0.03

167

Pneumonia, organism unspecified

1283

12244

0.75

21.20

1.9

1.6

6.06

3.21

mg/l

7.91

1031

8438

Cerebrovascular diseases

638

6758

0.67

21.11

1.7

3.65

3.58

mg/l

0.06

483

4841

Hyperkinetic disorders

363

2115

1.75

20.97

1.4

1.6

3.17

3.75

mg/l

0.88

279

1365

Phobic anxiety disorders

410

2498

1.68

20.89

1.5

1.6

4.04

3.72

mg/l

0.26

325

1589

Coronary revascularization (ANGIO or CABG)

273

3420

0.55

20.76

1.7

1.6

4.53

3.58

mg/l

0.53

202

2446

Hypothyroidism, levothyroxine purchases

953

3919

1.42

20.68

1.9

1.3

4.01

2.74

mg/l

4.33

731

2265

Hypothyroidism and >3 levothyroxin purchases

953

3919

1.42

20.68

1.9

1.3

4.01

2.74

mg/l

4.33

731

2265

Postmenopausal atrophic vaginitis

506

1919

1.61

20.39

1.7

2.58

3.65

mg/l

2.35

365

1404

Parodontitis or operation codes

1189

11606

0.75

20.34

1.7

5.90

3.29

mg/l

4.15

923

8158

Parodontitis

1189

11601

0.75

20.17

1.7

5.90

3.29

mg/l

4.15

923

8156

Migraine

1354

8809

1.32

20.13

1.7

1.6

3.15

3.31

mg/l

0.41

973

5776

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

1718

0.28

19.86

1.5

1.7

9.66

3.67

mg/l

1.83

1220

Chronic periodontitis, including avohilmo

1187

11590

0.75

19.72

1.8

1.7

5.89

3.28

mg/l

4.11

921

8152

Pain in joint

1492

7633

1.31

19.70

1.7

1.6

4.03

3.24

mg/l

1.88

1114

5032

Disturbance of activity and attention

340

1983

1.75

19.61

1.5

1.6

3.20

3.61

mg/l

0.53

260

1276

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

273

3745

0.56

19.48

1.4

1.7

4.16

3.67

mg/l

0.37

223

2659

Polyarthropathies

946

8589

0.73

19.41

2.0

1.6

4.97

3.42

mg/l

3.65

753

5873

Influenza and pneumonia

1720

14237

0.79

19.40

1.9

1.6

5.57

3.21

mg/l

8.25

1333

9746

Panic disorder

445

2822

1.61

19.31

1.6

4.06

3.73

mg/l

0.30

349

1809

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

1716

0.35

19.16

2.3

1.6

4.96

3.84

mg/l

0.36

1214

COPD

252

3714

0.55

19.10

1.8

1.6

10.78

3.15

mg/l

5.11

210

2625

Hypothyroidism, strict autoimmune

1839

9695

1.27

19.07

1.8

1.6

4.02

3.28

mg/l

2.67

1420

6534

Cardiomyopathy, other and unspecified

166

781

2.19

19.04

6.9

1.4

4.91

4.32

mg/l

0.19

148

540

Major coronary heart disease event

590

5782

0.68

18.82

2.1

1.7

4.53

3.63

mg/l

0.89

464

4158

Disorders of conjunctiva

1941

13091

1.25

18.80

1.7

1.6

3.52

3.46

mg/l

0.13

1370

9015

COPD, early/later onset

239

3634

0.55

18.67

1.7

9.89

3.60

mg/l

4.01

199

2614

COPD, hospital admissions

237

3609

0.55

18.46

1.7

9.97

3.58

mg/l

4.05

197

2594

Bipolar affective disorders

511

3375

1.54

18.43

1.7

1.6

4.18

3.57

mg/l

0.67

416

2193

Diseases of arteries, arterioles and capillaries

533

5905

0.67

18.19

1.7

4.25

3.71

mg/l

0.54

409

4203

Conjunctivitis

1813

12692

1.26

18.14

1.6

3.47

3.46

mg/l

0.02

1280

8731

Glucagon-like peptide-1 (GLP-1) analogues

427

5437

0.64

18.06

2.2

1.7

5.67

3.54

mg/l

2.52

359

3818

Emergency coronary revascularization (for ACS)

303

3657

0.59

17.99

1.7

4.89

3.85

mg/l

0.52

226

2646

Other chronic obstructive pulmonary disease

238

3527

0.56

17.93

1.7

1.6

9.94

3.21

mg/l

4.50

198

2500

Cystitis

2003

9914

1.24

17.69

1.7

1.6

3.52

3.50

mg/l

0.04

1450

6819

Allergic conjunctivitis

1414

10921

1.29

17.63

1.7

1.6

3.32

3.43

mg/l

0.25

989

7517

Examination and observation for other reasons

1458

6929

1.29

17.42

1.9

1.6

3.58

3.31

mg/l

0.48

1112

4605

COPD (mode)

171

2646

0.51

17.41

1.8

1.4

10.15

2.86

mg/l

4.44

140

1822

Female infertility, cervigal, vaginal, other or unspecified origin

832

4032

1.40

17.40

1.6

3.57

3.64

mg/l

0.09

552

2737

Other bacterial diseases

1273

11318

0.77

17.29

1.9

1.6

5.28

3.31

mg/l

5.68

1021

7889

Propionic acid derivatives

710

2484

1.45

17.26

1.7

1.6

3.82

3.69

mg/l

0.11

506

1487

Eating disorder

322

1946

1.71

17.18

1.6

3.50

4.00

mg/l

0.49

237

1275

Reimbursement for rheumatic diseases

673

9406

0.71

17.12

1.9

1.7

6.33

3.29

mg/l

4.38

521

6586

Peripheral artery disease

207

3047

0.54

17.03

1.6

1.7

5.20

3.95

mg/l

0.81

174

2205

AV-block

234

1165

1.85

16.87

8.0

1.4

3.52

3.92

mg/l

0.20

217

811

Vasomotor and allergic rhinitis

969

7168

1.35

16.87

1.6

3.48

3.40

mg/l

0.11

677

4845

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1358

10485

1.29

16.85

1.7

1.6

3.30

3.41

mg/l

0.25

948

7205

Social phobias

267

1542

1.79

16.83

1.5

1.6

4.24

3.94

mg/l

0.16

207

974

Personality disorders

742

5354

1.41

16.80

1.6

1.7

3.64

3.51

mg/l

0.19

603

3616

Other extrapyramidal and movement disorders in other diseases

392

2489

1.60

16.79

1.7

3.32

3.70

mg/l

0.38

325

1765

Specific personality disorders

654

4623

1.44

16.72

1.7

3.84

3.56

mg/l

0.39

533

3116

Atherosclerosis, excluding cerebral and coronary sclerosis

169

2611

0.51

16.71

1.8

1.6

5.15

3.92

mg/l

0.61

139

1881

Autoimmune diseases excluding thyroid diseases, strict definition

1733

11966

0.80

16.67

1.7

1.6

4.15

3.32

mg/l

2.30

1297

8008

Lung cancer and mesothelioma

1440

0.33

16.55

2.6

1.5

4.70

2.97

mg/l

0.60

1003

Irritable bowel syndrome

643

4538

1.44

16.47

1.6

3.84

3.46

mg/l

0.38

476

3100

Cardiomyopathy

293

1737

1.71

16.47

5.6

1.4

6.51

3.92

mg/l

2.32

262

1221

Parodontitis and operation codes

1132

11389

0.77

16.44

1.7

6.01

3.29

mg/l

4.06

875

8029

Deviated nasal septum

643

4536

1.43

16.36

1.6

1.7

3.79

3.59

mg/l

0.14

469

3177

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1436

11338

0.79

16.34

1.9

1.6

5.59

3.09

mg/l

8.07

1123

7667

1436

11338

0.79

16.34

1.9

1.6

5.59

3.09

mg/l

8.07

1123

7667

Major coronary heart disease event excluding revascularizations

516

5216

0.68

16.34

2.3

1.7

4.69

3.67

mg/l

0.90

407

3747

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

1409

0.34

16.33

2.6

1.6

4.62

3.47

mg/l

0.34

1007

Female infertility

910

4163

1.37

16.29

1.6

3.74

3.67

mg/l

0.08

614

2827

Autoimmune diseases excluding thyroid diseases

1784

12198

0.81

16.24

1.7

1.6

4.20

3.33

mg/l

2.59

1339

8183

Disorders of adult personality and behaviour

781

5728

1.38

16.02

1.6

3.71

3.48

mg/l

0.35

633

3857

Hypothyroidism, strict autoimmune, 3 medication purchases required

1930

10754

1.23

15.99

1.8

1.6

3.91

3.39

mg/l

1.65

1487

7344

Genitourinary diseases

1580

6301

1.27

15.84

1.7

1.6

4.49

3.36

mg/l

1.52

1099

4197

STROKE

699

6693

0.72

15.80

1.7

1.6

3.53

3.25

mg/l

0.31

506

4722

Use of hypnotics and sedatives

2406

11616

1.20

15.52

1.7

3.64

3.50

mg/l

0.29

1857

8059

Iron deficiency

393

2.61

15.33

1.6

1.7

2.71

2.53

mg/l

0.14

250

Sulfonylureas

154

2378

0.51

15.33

2.0

1.6

4.74

3.97

mg/l

0.32

131

1700

Pacemaker

344

2097

1.61

15.33

6.2

1.5

5.21

3.71

mg/l

1.34

308

1513

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

600

3863

1.44

15.18

1.5

3.56

3.73

mg/l

0.22

451

2420

Dental caries 2 and operation codes, only avohilmo

1556

7747

1.26

15.12

1.8

1.6

4.26

3.75

mg/l

0.55

1074

5442

Emotionally unstable personality disorder

384

2504

1.57

14.96

1.6

4.20

3.96

mg/l

0.23

311

1678

Endocrine, nutritional and metabolic diseases

2311

9809

1.21

14.80

1.9

1.5

4.34

2.97

mg/l

5.14

1838

6155

COPD, hospital admissions 1, only main diagnosis

153

2480

0.52

14.55

1.7

12.66

3.63

mg/l

3.77

128

1779

Later onset COPD

1148

0.33

14.45

1.4

1.5

10.20

3.09

mg/l

0.93

856

Any mental disorder

2623

11100

1.19

14.43

1.7

1.6

3.98

3.38

mg/l

2.03

2028

7325

Malignant neoplasm

1375

10184

0.80

14.42

1.6

1.7

3.35

3.57

mg/l

0.41

1022

7215

Biguanides

1389

10671

0.80

14.41

1.9

1.6

4.80

3.36

mg/l

5.64

1188

7413

Other medical care

308

4732

0.63

14.36

1.4

1.5

5.56

3.49

mg/l

1.49

221

3304

Psychiatric diseases

2605

11032

1.19

14.24

1.7

1.6

3.95

3.38

mg/l

1.82

2018

7271

Rheumatoid arthritis

293

4226

0.62

14.18

1.9

1.6

5.70

3.23

mg/l

1.86

218

2922

Acute upper respiratory infections

2358

12431

1.19

14.17

1.8

1.6

4.08

3.34

mg/l

2.75

1733

8499

Oxycodone

249

3962

0.60

14.09

1.8

1.7

9.00

3.06

mg/l

4.41

215

2716

Schizophrenia

138

2659

0.51

14.03

1.7

5.26

3.60

mg/l

1.34

113

1835

Eating disorders

342

2205

1.59

14.01

1.6

3.38

3.87

mg/l

0.54

255

1463

COPD, hospital admission 2, with asthma infections

139

2294

0.51

13.97

1.8

1.7

9.83

3.60

mg/l

3.25

126

1665

Coronary angioplasty

214

2806

0.58

13.82

1.8

1.6

5.64

3.66

mg/l

0.81

159

2023

Other (not insulin) diabetes medications

1465

10897

0.81

13.79

2.0

1.6

4.94

3.34

mg/l

6.71

1258

7511

Pain and other conditions associated with female genital organs and menstrual cycle

583

4010

1.42

13.75

1.6

3.08

3.60

mg/l

1.47

419

2709

Fenamates

356

1545

1.58

13.63

1.5

1.7

3.38

3.35

mg/l

0.03

256

955

General examination and investigation of persons without complaint and reported diagnosis

1612

6971

1.24

13.62

1.7

1.6

4.12

3.30

mg/l

1.76

1243

4624

Coxibs

625

2374

1.41

13.57

1.5

1.6

3.36

3.69

mg/l

0.51

467

1433

Bacterial pneumoniae

371

4913

0.66

13.55

1.9

1.6

6.03

3.33

mg/l

2.98

298

3395

Acetic acid derivatives and related substances

626

2329

1.41

13.46

1.7

1.6

3.27

3.71

mg/l

0.49

457

1404

Second line medication for Crohn's disease

733

9745

0.75

13.45

3.5

1.6

6.79

3.32

mg/l

4.54

579

6790

Neurological diseases

2333

9895

1.19

13.42

1.7

1.5

4.04

3.23

mg/l

1.94

1739

6457

COPD related to multimorbidity

189

2781

0.57

13.41

1.8

1.7

9.88

3.61

mg/l

3.15

160

2015

COPD, hospital admissions 3, with asthma pneumonia sepsis

1675

0.45

13.25

1.8

1.6

11.23

3.60

mg/l

2.79

1215

Anti-inflammatory and antirheumatic products, non-steroids

681

2484

1.39

13.23

1.7

1.6

3.44

3.69

mg/l

0.29

490

1487

Malignant neoplasm of respiratory system and intrathoracic organs

1281

0.35

13.23

2.4

1.6

4.68

3.64

mg/l

0.32

936

Myocardial infarction, strict

340

3767

0.65

13.16

2.4

1.6

4.71

3.64

mg/l

0.73

270

2702

Myocardial infarction

381

4061

0.67

13.16

2.4

1.6

5.25

3.56

mg/l

1.31

305

2914

Cerebrovascular diseases (FINNGEN)

415

4321

0.68

13.02

1.7

1.4

3.74

3.15

mg/l

0.56

311

2883

Later onset COPD, excluding more controls

1066

0.35

12.96

1.4

10.44

2.97

mg/l

0.96

775

Bacterial pneumonia, not elsewhere classified

341

4546

0.66

12.93

1.9

1.6

6.04

3.37

mg/l

2.68

274

3140

Noninflammatory disorders of female genital tract

1182

4693

1.28

12.90

1.6

3.89

3.65

mg/l

0.19

820

3178

Insulin medication

693

7905

0.74

12.84

1.9

1.6

5.16

3.45

mg/l

3.71

624

5376

Other menopausal disorders

583

2403

1.42

12.83

1.5

1.7

2.52

3.58

mg/l

4.54

395

1725

Chronic laryngitis and laryngotracheitis

267

1657

1.64

12.77

1.8

1.7

3.87

3.90

mg/l

0.02

188

1167

Malignant neoplasm of digestive organs

186

3162

0.57

12.77

1.4

1.7

4.46

3.72

mg/l

0.43

147

2280

Post-traumatic stress disorder

254

1569

1.66

12.59

1.5

1.6

3.84

4.12

mg/l

0.15

199

1007

Rheumatoid arthritis, including avohilmo

338

5062

0.66

12.58

1.9

1.7

5.73

3.41

mg/l

1.86

253

3596

Diabetes medication

1735

12648

0.83

12.30

1.9

1.6

4.74

3.30

mg/l

7.78

1508

8576

L04AX Other immunosuppressants

715

9387

0.76

12.05

3.5

1.6

6.87

3.33

mg/l

4.49

563

6549

Tonsillectomy and adenotomy

1636

9450

1.22

12.00

1.6

3.64

3.49

mg/l

0.31

1114

6409

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1453

10448

0.82

11.96

1.6

1.7

3.42

3.55

mg/l

0.21

1083

7365

781

9074

0.77

11.88

1.6

1.7

4.95

3.53

mg/l

2.85

645

6245

Malignant neoplasm, wide definition for exclusion

1455

10453

0.82

11.88

1.6

1.7

3.42

3.55

mg/l

0.21

1084

7370

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1455

10452

0.82

11.87

1.6

1.7

3.42

3.55

mg/l

0.21

1084

7369

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

193

3221

0.59

11.75

1.7

6.14

3.33

mg/l

1.25

141

2296

Other/unspecified seropositive rheumatoid arthritis

195

3243

0.59

11.70

1.7

6.42

3.33

mg/l

1.43

142

2313

726

8702

0.76

11.63

1.6

1.7

4.84

3.57

mg/l

2.32

600

5998

Endometriosis

883

4076

1.30

11.46

1.5

1.6

3.17

3.59

mg/l

1.05

615

2795

Bulimia nervosa (incl. atypical)

137

734

1.96

11.43

1.7

1.6

3.17

3.44

mg/l

0.23

102

475

Renal tubulo-interstitial diseases

1230

11572

0.81

11.39

2.0

1.6

4.98

3.43

mg/l

4.47

974

7989

Pain in throat and chest

1974

10202

1.19

11.33

2.0

1.6

4.18

3.18

mg/l

2.06

1478

6922

Neurological diseases, wide definition

1057

4200

1.28

11.32

1.7

1.4

4.40

2.73

mg/l

2.45

787

2472

Abnormalities of breathing

2185

11076

1.18

11.24

1.8

1.5

4.56

3.19

mg/l

6.57

1680

7443

Any event in cancer register

1598

11355

0.83

11.23

1.6

1.7

3.17

3.58

mg/l

1.24

1169

7959

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1154

4631

1.26

11.23

1.7

1.5

4.39

2.89

mg/l

1.90

836

2894

Diseases of arteries, arterioles and capillaries (FINNGEN)

256

2770

0.64

11.05

1.8

1.4

5.24

3.33

mg/l

1.38

200

1826

Exposure to other specified factors

1638

12877

1.20

11.05

1.6

3.60

3.49

mg/l

0.17

1196

8831

Other eating disorders

178

1041

1.77

11.02

1.6

3.93

3.85

mg/l

0.05

135

675

Bleeding

989

9008

0.79

11.01

1.7

4.59

3.47

mg/l

1.11

754

6359

Dermatitis and eczema

2436

13790

1.16

10.89

1.7

1.6

4.22

3.38

mg/l

2.03

1769

9488

Organic, including symptomatic, mental disorders

263

2914

0.65

10.80

1.6

3.99

3.79

mg/l

0.09

211

2106

Allergic rhinitis

794

6132

1.30

10.74

1.6

3.48

3.47

mg/l

0.01

553

4150

Gastro-oesophageal reflux disease

1315

9584

1.22

10.74

1.7

4.79

3.32

mg/l

2.15

1010

6715

Other degenerative diseases of the nervous system

195

2414

0.61

10.67

1.6

3.53

3.50

mg/l

0.02

141

1620

Bacterial pneumonia (organism specified)

396

5087

0.70

10.64

1.9

1.7

6.50

3.46

mg/l

3.08

314

3544

Lyme disease

451

3240

1.41

10.64

1.6

1.7

2.88

3.65

mg/l

1.24

321

2286

Conduction disorders

427

2511

1.43

10.64

5.7

1.4

3.69

3.71

mg/l

0.01

367

1761

Any dementia

107

1455

0.52

10.63

1.6

3.35

3.46

mg/l

0.03

1081

Elevated blood glucose level

166

958

1.77

10.61

2.2

1.7

4.91

4.24

mg/l

0.31

146

667

Coronary atherosclerosis

678

5708

0.76

10.55

1.9

1.6

5.55

3.44

mg/l

2.46

524

4100

Acute alcohol intoxication

228

3562

0.63

10.53

1.5

1.7

5.35

3.71

mg/l

1.17

193

2430

Migraine without aura

549

4084

1.36

10.52

1.8

1.6

3.08

3.32

mg/l

0.39

398

2658

Seropositive rheumatoid arthritis, wide

207

3288

0.62

10.30

2.1

1.7

6.22

3.32

mg/l

1.45

153

2342

Other spirochaetal diseases

455

3299

1.40

10.18

1.6

1.7

2.96

3.62

mg/l

0.98

323

2326

Diseases of pulp and periapical tissues, including avohilmo

2017

12220

0.85

10.12

1.7

1.6

4.42

3.21

mg/l

3.04

1549

8188

Seropositive rheumatoid arthritis

207

3266

0.63

10.12

2.1

1.7

6.22

3.14

mg/l

1.59

153

2215

Biological medication for rheuma

164

2730

0.59

10.09

1.4

1.7

5.38

3.73

mg/l

0.63

121

1876

Use of pramipexole

330

2263

1.48

10.07

1.7

3.57

3.64

mg/l

0.04

282

1618

Dental pulpitis 1

2021

12234

0.85

10.02

1.7

1.6

4.42

3.21

mg/l

3.01

1550

8200

Hypertrophy of breast

410

2935

1.42

10.01

1.7

3.19

3.35

mg/l

0.19

336

2042

Angina pectoris

540

4872

0.74

10.01

2.0

1.6

5.08

3.45

mg/l

1.37

417

3487

Dental pulpitis 1, only avohilmo

2053

12473

0.86

10.00

1.7

1.6

3.92

3.31

mg/l

1.22

1563

8399

Dental pulpitis 4

2021

12228

0.85

9.99

1.7

1.6

4.42

3.21

mg/l

3.03

1550

8195

Other reaction to severe stress, and adjustment disorders

914

7319

1.26

9.95

1.9

1.6

4.28

3.48

mg/l

1.28

725

4831

Ischemic heart diseases

924

7225

0.80

9.94

2.2

1.6

5.42

3.42

mg/l

3.08

721

5183

Mental and behavioural disorders due to alcohol

643

8109

0.77

9.87

1.6

1.7

4.78

3.48

mg/l

2.28

538

5575

Dental pulpitis 4, only avohilmo

2051

12434

0.86

9.74

1.7

1.6

3.97

3.30

mg/l

1.38

1566

8367

Any dementia, excluding more controls

106

1383

0.53

9.72

1.6

1.5

3.39

3.46

mg/l

0.02

1005

Diseases of the eye and adnexa

2298

9956

1.16

9.71

1.7

1.6

3.72

3.43

mg/l

0.44

1634

6704

Other headache syndromes

918

7380

1.25

9.63

1.7

1.6

3.02

3.25

mg/l

0.47

678

4922

Other disorders of breast

286

1931

1.51

9.59

1.5

1.7

2.82

3.55

mg/l

1.04

186

1347

Type 2 diabetes, strict (exclude DM1)

1504

10658

0.84

9.59

2.2

1.6

4.93

3.31

mg/l

7.38

1286

7328

Paracetamol of NSAID medication

488

1788

1.39

9.55

1.7

1.5

3.67

3.61

mg/l

0.04

339

1017

Extrapyramidal and movement disorders

521

3898

1.35

9.50

1.7

3.18

3.57

mg/l

0.54

412

2750

Functional dyspepsia

513

3837

1.35

9.45

1.8

1.7

5.13

3.18

mg/l

1.76

375

2668

Psychotic depression

145

836

1.78

9.37

1.9

1.7

3.08

3.48

mg/l

0.34

124

537

Hypertrophy of breast in women and men

443

3250

1.38

9.33

1.7

3.08

3.38

mg/l

0.45

363

2264

Dental caries 2

1866

12594

1.17

9.32

1.8

1.6

4.17

3.44

mg/l

1.19

1286

8687

Somatoform disorder

353

2495

1.44

9.27

1.8

1.7

4.32

3.54

mg/l

0.59

279

1696

Alcohol use disorder, Swedish definition

695

8213

0.78

9.26

1.6

1.7

5.09

3.56

mg/l

2.73

580

5692

Type 2 diabetes, definitions combined

1507

10635

0.84

9.22

2.2

1.6

4.93

3.29

mg/l

7.60

1290

7307

Persons encountering health services for examination and investigation

1644

6971

1.19

9.22

1.7

1.6

4.42

3.30

mg/l

2.57

1171

4624

Tumor necrosis factor alpha inhibitors

148

2467

0.59

9.22

1.4

1.7

5.57

3.82

mg/l

0.59

109

1696

Psoriasis

285

4128

0.68

9.11

1.7

3.77

3.56

mg/l

0.20

223

2893

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2520

12588

1.15

9.08

1.7

1.6

4.41

3.29

mg/l

3.34

1915

8541

Dementia, including avohilmo

167

1879

0.61

9.06

1.5

1.6

3.25

3.51

mg/l

0.10

129

1381

Acute alcohol intoxication, ICD10

190

2974

0.63

8.99

1.5

1.7

4.64

3.95

mg/l

0.44

157

2063

Dental caries 2 and operation codes

1834

12540

1.17

8.96

1.7

1.6

4.17

3.45

mg/l

1.14

1257

8652

Migraine without aura and triptan purchases

446

3303

1.37

8.93

1.8

1.6

2.80

3.72

mg/l

2.29

318

2228

Type 2 diabetes, wide definition

1040

8252

0.82

8.88

2.1

1.6

5.02

3.33

mg/l

4.62

931

5729

Any gastric operation

2188

9528

1.16

8.88

1.8

1.5

4.47

2.93

mg/l

4.77

1610

6169

GASTRO-related operations

2188

9528

1.16

8.88

1.8

1.5

4.47

2.93

mg/l

4.77

1610

6169

Disturbances of skin sensation

609

4714

1.31

8.85

1.8

1.7

3.27

3.54

mg/l

0.34

453

3261

Antihypertensive medication - note that there are other indications

1898

8935

1.17

8.85

2.0

1.4

4.31

3.00

mg/l

3.63

1466

5630

Insulin, combination of fast acting with intermediate-acting or long-acting

693

8090

0.78

8.83

1.9

1.7

5.16

3.60

mg/l

3.18

624

5613

Other or ill-defined heart diseases

112

609

1.88

8.81

8.9

1.4

2.37

4.80

mg/l

1.53

105

426

Methotrexate

117

2050

0.56

8.78

1.6

1.5

5.74

3.34

mg/l

1.00

1435

Seropositive rheumatoid arthritis, strict definition

110

1959

0.55

8.77

1.5

1.7

6.35

3.45

mg/l

0.80

1403

Alcohol dependence

256

3754

0.68

8.76

1.6

1.7

4.86

3.68

mg/l

0.89

230

2602

Coronary artery bypass grafting

126

1659

0.57

8.76

1.5

1.6

3.20

3.78

mg/l

0.37

1208

Transplanted organ and tissue status

187

1174

1.62

8.74

2.7

1.5

20.51

3.43

mg/l

9.05

175

814

Exposure to unspecified factor

2097

14161

1.15

8.74

1.6

3.68

3.49

mg/l

0.40

1562

9720

Type 2 diabetes

1650

11442

0.85

8.68

2.1

1.6

4.91

3.28

mg/l

8.38

1432

7808

Diseases of male genital organs

939

3828

1.25

8.66

1.6

1.7

3.92

3.70

mg/l

0.18

672

2629

Other specific joint derangements/joint disorders

1833

10596

1.17

8.58

1.7

1.6

4.10

3.38

mg/l

1.86

1375

7081

Type 2 diabetes, definitions combined, including avohilmo

1549

10751

0.85

8.57

2.1

1.6

4.94

3.30

mg/l

7.82

1325

7371

Tinnitus

412

3033

1.37

8.48

1.5

1.7

3.63

3.49

mg/l

0.08

283

2147

Peripheral arterial reconstruction

977

0.39

8.47

1.7

1.6

9.58

3.45

mg/l

0.94

720

Ischaemic heart disease, wide definition

912

7007

0.81

8.46

2.2

1.6

5.47

3.40

mg/l

3.18

712

5036

Dental caries 2, only avohilmo

1831

12495

1.16

8.37

1.7

1.6

4.09

3.46

mg/l

0.95

1258

8624

Dental caries 3

1461

8793

0.85

8.36

1.7

1.6

4.34

3.07

mg/l

1.99

1072

5940

Thyroiditis, ILD-related definition

268

1842

1.48

8.29

1.8

1.7

3.41

3.54

mg/l

0.11

207

1276

Acute upper respiratory infections of multiple and unspecified sites

1720

11107

1.17

8.22

1.7

1.6

4.63

3.34

mg/l

4.43

1260

7508

Asthma (mode)

1869

8871

1.16

8.21

1.7

1.4

4.72

2.87

mg/l

5.30

1396

5925

Dislocation, sprain and strain of joints and ligaments of knee

1425

11271

1.18

8.19

1.6

3.37

3.50

mg/l

0.26

1029

7742

Symptoms and signs involving the skin and subcutaneous tissue

1344

11341

1.19

8.16

1.7

4.17

3.47

mg/l

1.26

983

7920

Pollen allergy

494

3727

1.33

8.11

1.6

3.33

3.73

mg/l

0.59

343

2490

Primary_lymphoid and hematopoietic malignant neoplasms

148

2393

0.61

8.09

1.4

1.7

5.30

3.80

mg/l

0.77

108

1672

Dementia

156

1735

0.62

8.08

1.5

1.6

3.27

3.38

mg/l

0.04

120

1277

Non-rheumatic valve diseases

440

4268

0.75

8.05

2.0

1.4

4.20

3.52

mg/l

0.53

305

2964

Dental caries, including avohilmo

1354

8167

0.84

7.97

1.7

1.6

4.31

3.10

mg/l

1.63

984

5538

Sulfasalazine

340

4664

0.72

7.96

1.6

1.5

4.06

3.18

mg/l

1.69

258

3190

Dental caries 3, only avohilmo

1486

8898

0.85

7.96

1.7

1.6

4.16

3.22

mg/l

1.30

1085

6022

Diabetes mellitus

1835

12596

0.87

7.91

2.0

1.6

4.80

3.26

mg/l

8.78

1598

8499

Dental caries 1

1356

8170

0.84

7.90

1.7

1.6

4.30

3.10

mg/l

1.62

985

5541

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

1541

0.53

7.89

1.3

1.7

4.30

3.87

mg/l

0.18

1092

Schizophrenia or delusion

427

5650

0.75

7.85

1.6

1.7

4.50

3.51

mg/l

1.89

337

3874

Nightmares

6.22

7.82

1.3

1.4

4.30

3.52

mg/l

0.12

Cough

758

5862

1.25

7.81

1.9

1.6

4.00

3.18

mg/l

1.08

540

4034

Asthma, including avohilmo

2633

13584

1.13

7.81

1.6

4.72

3.27

mg/l

5.21

1945

9301

Valvular heart disease excluding rheumatic fever

446

4301

0.75

7.79

2.0

1.4

4.20

3.51

mg/l

0.55

311

2986

Adenomyosis (Endometriosis of uterus)

246

1683

1.48

7.77

1.5

1.7

3.18

3.35

mg/l

0.12

180

1172

Diabetes, varying definitions

1819

12492

0.87

7.77

2.0

1.6

4.84

3.26

mg/l

9.02

1583

8439

Other (seronegative) rheumatoid arthritis, wide

141

2278

0.61

7.72

1.6

1.7

7.42

3.42

mg/l

1.40

105

1621

Polyuria

322

2315

1.40

7.69

1.8

1.7

4.46

3.59

mg/l

0.44

230

1637

Subjective visual disturbances

444

3362

1.33

7.64

2.0

1.7

3.31

3.65

mg/l

0.38

332

2344

Asthma and allergy, excluding more controls

365

2656

1.38

7.60

1.5

1.4

3.72

2.95

mg/l

1.02

249

1678

Schizophrenia, schizotypal and delusional disorders

430

5653

0.75

7.57

1.6

1.7

4.49

3.51

mg/l

1.85

338

3875

Asthma and allergy

365

2661

1.37

7.51

1.5

1.4

3.72

2.99

mg/l

0.94

249

1684

Other disorders of veins

695

5575

1.26

7.50

1.7

2.81

3.45

mg/l

2.12

523

3979

Allergic asthma (mode), excluding more controls

618

4811

1.27

7.45

1.6

1.4

3.86

2.86

mg/l

2.21

430

3068

ILD medications: immunosuppressive drugs

938

10814

0.83

7.41

3.4

1.4

7.71

2.97

mg/l

9.91

760

7342

Other arrhythmias

1316

8584

1.18

7.38

2.5

1.4

3.66

3.37

mg/l

0.46

976

5949

Oter anti-inflammatory and antirheumatic agents, non-steroids

332

1319

1.41

7.37

1.7

2.97

3.84

mg/l

1.11

253

879

Allergic asthma (mode)

618

4823

1.27

7.31

1.6

1.4

3.86

2.88

mg/l

2.13

430

3086

Fentanyl

853

0.39

7.28

1.6

1.7

5.48

3.08

mg/l

0.69

595

Other disorders of lacrimal gland

594

4703

1.27

7.26

2.0

1.7

3.67

3.51

mg/l

0.15

448

3299

Mental and behavioural disorders due to alcohol, excluding acute intoxication

547

6932

0.78

7.25

1.7

4.91

3.61

mg/l

1.87

465

4830

Disorders of breast

1048

8159

1.20

7.17

1.6

1.7

3.21

3.39

mg/l

0.33

768

5713

Spirochaetal infections, other/unspecified

149

935

1.62

7.09

1.8

1.7

3.86

3.78

mg/l

0.03

104

673

Dental caries 1, only avohilmo

1389

8277

0.85

7.06

1.7

1.6

4.14

3.24

mg/l

1.10

1004

5622

Cardiac arrhythmias

1585

9077

1.16

7.05

2.7

1.5

3.93

3.05

mg/l

2.34

1182

6043

Autism spe, excluding more controls

306

2.13

7.03

1.4

1.8

2.83

2.78

mg/l

0.02

181

Parodontitis or/and operation codes

938

6697

0.83

7.02

1.8

1.7

6.09

3.48

mg/l

3.09

732

4722

Spondylopathies

1154

8269

0.84

7.01

1.8

1.7

4.16

3.50

mg/l

0.93

871

5801

Dental caries 3 and operation codes

1630

9626

0.86

7.01

1.8

1.6

4.39

3.12

mg/l

2.17

1177

6552

Monoamine oxidase A inhibitors

210

1423

1.50

7.01

1.8

1.7

2.93

3.90

mg/l

0.97

169

948

Cholecystectomy

1254

9465

1.18

6.99

1.8

1.7

4.52

3.40

mg/l

1.71

1019

6693

Cardiomyopathies, Primary/intrinsic

174

1135

1.55

6.94

4.8

1.5

8.14

3.98

mg/l

2.68

155

799

Excessive, frequent and irregular menstruation

986

4567

1.21

6.94

1.7

1.6

3.96

3.65

mg/l

0.21

727

3102

Codeine or tramadol medication

2591

12823

1.12

6.92

1.8

1.6

4.14

3.38

mg/l

2.77

2029

8674

Unspecified/other endometriosis

251

1770

1.44

6.89

1.6

1.7

3.52

3.56

mg/l

0.05

172

1189

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

987

8276

1.20

6.88

1.8

1.7

4.20

3.44

mg/l

1.51

770

5837

Other heart diseases, wide

2153

11824

1.13

6.86

2.7

1.4

3.93

3.38

mg/l

1.42

1632

8123

Disorders of lacrimal system

717

5837

1.24

6.85

1.9

1.6

3.60

3.47

mg/l

0.14

542

4116

Fracture of femur

119

1778

0.61

6.84

1.7

1.6

3.28

3.71

mg/l

0.29

100

1265

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1407

0.54

6.81

1.7

5.76

3.89

mg/l

1.28

997

Senile cataract

674

5167

0.80

6.79

1.9

1.7

3.89

3.43

mg/l

0.52

514

3706

Mouth breathing

730

5956

1.23

6.78

1.7

3.34

3.61

mg/l

0.38

547

4200

Seronegative rheumatoid arthritis

1518

0.56

6.76

1.8

1.7

5.69

3.43

mg/l

0.89

1030

Inflammatory bowel disease, strict (require KELA)

304

4119

0.73

6.70

1.5

1.7

3.26

3.61

mg/l

0.53

213

2832

Other disorders of fluid, electrolyte and acid-base balance

210

2921

0.69

6.66

2.3

1.6

3.87

3.53

mg/l

0.24

168

2047

Primary_lymphoid and hematopoietic malignant neoplasms

148

2283

0.64

6.63

1.4

1.7

5.30

3.69

mg/l

0.84

108

1634

Alcohol abuse, main dg

152

2323

0.65

6.59

1.6

1.7

4.46

4.07

mg/l

0.18

131

1606

Dental pulpitis 2

1249

7464

0.85

6.53

1.7

1.6

4.44

3.05

mg/l

1.87

914

5015

Soft tissue disorders

2480

11521

1.12

6.49

1.7

1.6

3.69

3.48

mg/l

0.45

1861

7696

Endometriosis of pelvic peritoneum

393

2963

1.33

6.47

1.6

1.7

3.40

3.63

mg/l

0.35

278

2038

All-cause Heart Failure

409

3829

0.77

6.41

3.5

1.6

6.61

3.58

mg/l

3.54

376

2743

Asthma, excluding more controls

1852

8685

1.14

6.40

1.7

1.4

5.08

2.82

mg/l

6.91

1385

5761

Persons encountering health services in circumstances related to reproduction

1374

8054

1.16

6.35

1.6

1.7

3.74

3.60

mg/l

0.16

932

5650

Infections with a predominantly sexual mode of transmission

792

6568

1.22

6.35

1.6

3.14

3.48

mg/l

0.75

591

4415

IBD patients in KELA-register

304

4083

0.74

6.34

1.5

1.7

3.26

3.60

mg/l

0.51

213

2804

Asthma

1869

8835

1.14

6.30

1.7

1.4

5.08

2.87

mg/l

6.72

1398

5896

Dental pulpitis 2, only avohilmo

1273

7569

0.86

6.29

1.7

1.6

4.34

3.10

mg/l

1.64

933

5103

Inflammatory diseases of prostate (prostatitis)

174

1162

1.51

6.26

1.5

1.7

2.87

3.71

mg/l

0.67

122

813

Adalimumab

1504

0.58

6.24

1.5

1.7

5.23

4.01

mg/l

0.37

1049

Enthesopathies of lower limb, excluding foot

448

3499

1.29

6.23

1.7

3.14

3.61

mg/l

0.78

334

2432

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

131

2006

0.64

6.22

1.6

5.41

3.21

mg/l

1.01

1422

Asthma (only as main-diagnosis), excluding more controls

1663

8685

1.15

6.20

1.7

1.4

4.86

2.82

mg/l

8.76

1218

5761

Cardiovascular diseases

1896

9129

1.14

6.19

2.0

1.4

4.01

3.17

mg/l

1.56

1384

5893

Preparation and fitting of bite rail to mouth

305

2265

1.37

6.16

1.6

1.7

3.99

3.75

mg/l

0.15

231

1572

Atopic dermatitis

1393

10343

1.16

6.12

1.6

3.98

3.31

mg/l

1.56

980

7018

Migraine with aura

576

4647

1.25

6.11

1.7

1.6

3.05

3.24

mg/l

0.31

407

3016

Asthma (only as main-diagnosis)

1668

8835

1.14

6.10

1.7

1.4

4.85

2.87

mg/l

8.36

1223

5896

Arthropathic psoriasis

1572

0.59

6.10

1.5

1.7

3.88

mg/l

0.00

1112

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1058

8994

1.18

6.10

1.8

1.7

4.19

3.45

mg/l

1.59

825

6324

Papulosquamous disorders

445

5656

0.78

6.09

1.8

1.7

4.19

3.46

mg/l

0.78

340

3977

Anxious personality disorder

346

1.99

6.09

1.5

1.9

3.07

3.21

mg/l

0.08

231

Retinal breaks without detachment

244

1750

1.41

6.06

2.0

1.7

2.96

3.78

mg/l

0.96

172

1248

Other and unspecified disorders of skin and subcutaneous tissue

118

730

1.65

6.02

1.5

1.7

4.67

3.93

mg/l

0.22

520

Psoriatic and enteropathic arthropathies

111

1778

0.62

6.02

1.8

1.7

3.60

3.52

mg/l

0.05

1196

Diaphragmatic hernia

507

4033

1.27

6.02

1.8

1.7

4.89

3.26

mg/l

1.61

392

2876

Haemorrhoids and perianal venous thrombosis

416

3228

1.30

6.01

1.6

1.7

3.68

3.42

mg/l

0.17

304

2260

Other diseases of pleura

327

3832

0.75

6.01

2.2

1.7

12.64

3.54

mg/l

6.99

266

2757

Mental and behavioural disorders due to psychoactive substance use

857

9604

0.84

6.01

1.6

4.97

3.46

mg/l

3.53

719

6574

Seborrhoeic keratosis

288

2124

1.37

6.00

1.5

1.7

3.20

3.60

mg/l

0.22

195

1527

Pleural effusion

1131

0.53

5.92

2.6

1.6

8.54

3.26

mg/l

0.96

794

Unstable angina pectoris

243

2779

0.72

5.91

2.0

1.7

3.90

3.81

mg/l

0.03

184

2029

Presbyopia

135

868

1.59

5.91

1.8

1.7

4.94

3.86

mg/l

0.25

621

Myalgia

483

3836

1.27

5.89

1.9

1.6

3.62

3.55

mg/l

0.06

372

2582

Heart failure and coronary heart disease

140

1594

0.65

5.89

2.7

1.6

7.42

4.01

mg/l

1.38

123

1172

Postviral fatigue syndrome

145

2.60

5.88

2.5

1.9

3.73

2.86

mg/l

0.39

Etanercept

976

0.49

5.88

1.4

1.8

4.24

4.14

mg/l

0.03

680

Dementia in Alzheimer disease

521

0.36

5.88

1.4

1.5

3.73

3.19

mg/l

0.14

407

Other diseases of urinary system

2240

11286

1.12

5.86

1.7

1.6

3.74

3.50

mg/l

0.52

1641

7778

Erosion of teeth, including avohilmo

421

3177

1.29

5.86

1.7

1.6

3.91

3.10

mg/l

0.67

305

2139

General symptoms and signs

2640

11946

1.11

5.82

1.8

1.5

4.15

3.26

mg/l

3.89

1979

8027

Procreative management

760

5339

1.21

5.78

1.7

1.6

4.06

3.66

mg/l

0.33

491

3715

Excessive attrition of teeth

830

3758

1.21

5.78

1.8

1.6

4.11

3.13

mg/l

1.46

590

2531

Bacterial infection, other or unspecified

519

5815

0.80

5.77

1.9

1.6

6.33

3.39

mg/l

4.12

422

4062

Anaemias

641

3481

1.23

5.76

2.0

1.3

5.86

2.73

mg/l

5.10

490

2061

Sequelae of cerebrovascular disease

212

2611

0.71

5.76

1.7

1.6

3.49

3.82

mg/l

0.15

154

1879

Cardiomyopathy (excluding other)

175

1192

1.48

5.76

4.7

1.5

8.20

3.95

mg/l

2.82

156

840

Other and unspecified mood [affective] disorders

182

1254

1.48

5.75

1.6

1.7

4.39

4.12

mg/l

0.13

135

791

Inflammatory diseases of female pelvic organs

1428

9418

1.15

5.74

1.6

3.34

3.41

mg/l

0.15

1055

6470

Persons encountering health services in other circumstances, wide

2686

12615

1.11

5.69

1.8

1.6

4.41

3.29

mg/l

3.54

2028

8553

TMD related operations

362

2790

1.31

5.67

1.5

1.7

4.28

3.67

mg/l

0.41

276

1933

Other neurological diseases

824

7862

0.84

5.65

1.8

1.7

3.76

3.57

mg/l

0.19

601

5574

Other disorders starting during childhood or adolecense, excluding more controls

118

716

1.62

5.64

1.4

1.5

4.31

3.22

mg/l

0.86

413

Acute sinusitis

1201

9710

1.16

5.63

1.8

1.6

4.02

3.31

mg/l

1.55

907

6560

Oxicams

402

1766

1.30

5.60

1.6

1.7

3.83

3.75

mg/l

0.04

296

1109

Injuries to the knee and lower leg

2609

13523

1.11

5.58

1.6

3.64

3.50

mg/l

0.33

1896

9282

Excluding asthma or asthma-COPD overlap

1996

8914

1.13

5.57

2.0

1.4

4.56

2.87

mg/l

4.66

1474

5947

Obsessive-compulsive disorder

173

1189

1.48

5.56

1.6

3.29

4.04

mg/l

0.38

140

747

Psoriatic arthropathies

1484

0.60

5.56

1.5

1.7

3.90

3.47

mg/l

0.28

995

Arthropod-borne viral fevers and viral haemorrhagic fevers

1181

0.55

5.55

1.2

1.7

3.68

4.25

mg/l

0.12

837

Alcohol use disorder, ICD-based

517

6388

0.80

5.55

1.6

1.7

4.76

3.65

mg/l

1.46

442

4442

Heart failure, not strict

897

7280

0.85

5.52

3.2

1.6

6.23

3.22

mg/l

4.95

794

5130

Codeine

2309

11423

1.11

5.51

1.7

1.6

4.08

3.10

mg/l

4.22

1811

7581

Invasive ventilation

768

0.45

5.51

2.3

1.7

6.80

4.12

mg/l

0.44

542

L04AD Calcineurin inhibitors

207

1471

1.43

5.51

4.6

1.7

15.54

3.56

mg/l

6.94

193

1023

Psoriatic arthropathies, ICD10

1467

0.60

5.50

1.5

1.7

3.90

4.09

mg/l

0.11

1037

ILD differential diagnosis

1985

8871

1.12

5.48

2.0

1.4

4.50

2.87

mg/l

4.39

1466

5925

Pain (limb, back, neck, head abdominally)

1752

7775

1.13

5.46

1.7

1.6

3.97

3.29

mg/l

1.64

1268

5110

Substance abuse

832

9380

0.84

5.44

1.6

4.98

3.46

mg/l

3.49

704

6427

Dental caries 1 and operation codes

1557

9053

0.88

5.44

1.8

1.6

4.39

3.15

mg/l

1.94

1120

6188

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

625

0.40

5.43

1.5

1.7

7.11

3.91

mg/l

0.46

446

Psoriasis vulgaris

181

2571

0.70

5.43

1.6

1.7

4.37

3.80

mg/l

0.40

140

1803

Amiodarone users

118

749

1.59

5.41

7.9

1.6

6.94

3.49

mg/l

1.55

111

544

Agoraphobia

560

1.71

5.40

1.5

1.7

4.28

3.55

mg/l

0.47

348

Insulin, intermediate and long-acting

627

7432

0.82

5.40

1.8

1.7

4.99

3.56

mg/l

2.59

566

5166

Unspecified urinary incontinence

137

902

1.54

5.37

1.5

1.7

4.20

3.67

mg/l

0.28

112

649

COPD differential diagnosis

1983

8874

1.12

5.36

2.0

1.4

4.50

2.87

mg/l

4.35

1465

5926

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

1117

0.55

5.21

1.3

1.7

3.51

4.32

mg/l

0.46

756

Abnormal results of function studies

158

1081

1.48

5.18

2.0

1.7

3.06

3.87

mg/l

0.59

121

760

Other diseases of intestines

2434

12827

1.11

5.14

1.7

1.6

4.07

3.46

mg/l

1.79

1798

8789

Endometriosis of ovary

364

2838

1.29

5.13

1.6

1.7

3.44

3.52

mg/l

0.06

242

1957

Melanocytic naevi

573

4712

1.23

5.13

1.6

1.7

2.94

3.63

mg/l

1.65

380

3280

285

2157

1.34

5.13

2.7

1.6

4.48

3.39

mg/l

1.07

230

1455

Polyp of the female genital tract

638

3063

1.22

5.11

1.9

1.7

3.75

3.54

mg/l

0.26

469

2158

Follow-up examination after treatment for conditions other than malignant neoplasms

1011

5697

1.17

5.09

1.6

3.07

3.23

mg/l

0.33

751

3792

Heart failure,strict

430

3884

0.80

5.08

3.7

1.5

6.92

3.30

mg/l

5.20

396

2763

Other Crohn's disease

1147

0.57

5.08

1.3

1.7

3.72

4.17

mg/l

0.21

779

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

245

2017

0.74

5.07

1.5

1.8

3.88

4.24

mg/l

0.15

178

1425

Colorectal cancer, excluding all cancers (controls excluding all cancers)

179

2437

0.71

5.07

1.3

1.6

3.33

3.86

mg/l

0.42

148

1725

Gastrointestinal diseases

1708

7611

1.13

5.05

1.7

1.6

4.22

2.98

mg/l

2.48

1246

4931

Visual disturbances

801

6802

1.18

5.02

1.9

1.6

3.37

3.49

mg/l

0.15

593

4704

Other psoriatic arthropathies

1432

0.61

5.01

1.5

1.7

3.90

4.02

mg/l

0.07

1015

Testicular dysfunction

413

1.79

4.97

2.0

1.8

4.43

4.30

mg/l

0.02

296

Retinal detachments and breaks

455

3662

1.25

4.97

1.9

1.7

2.74

3.88

mg/l

3.18

330

2610

Irregular menses

1225

8711

1.15

4.95

1.7

1.6

3.98

3.30

mg/l

0.84

922

5935

Crohn disease (strict definition, require KELA)

1049

0.55

4.95

1.3

1.7

3.65

4.37

mg/l

0.37

715

Crohn disease (strict definition, require KELA, min 2 HDR)

1036

0.55

4.95

1.3

1.7

3.73

4.40

mg/l

0.33

704

Ascites

680

0.45

4.91

1.5

1.7

5.24

4.17

mg/l

0.34

496

Mixed and other personality disorders

200

1447

1.41

4.89

1.6

1.7

3.58

3.94

mg/l

0.25

166

988

Nontraumatic intracranial haemmorrhage

110

1680

0.65

4.84

1.7

4.97

3.73

mg/l

0.31

1216

Unspecified dementia

351

0.28

4.84

1.1

1.5

3.63

3.22

mg/l

—

283

Ulcerative colitis, NAS

151

2161

0.69

4.80

1.7

3.13

3.84

mg/l

0.83

113

1493

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

399

3185

1.27

4.80

1.8

1.6

3.70

3.51

mg/l

0.17

285

2147

Convalescence

109

703

1.58

4.78

1.4

1.6

2.43

3.69

mg/l

0.74

485

Diseases of the ear and mastoid process

2766

12803

1.10

4.78

1.6

3.67

3.47

mg/l

0.47

1952

8844

malignant neoplasm of female genital organs

1479

0.63

4.78

1.5

1.7

5.48

3.36

mg/l

0.68

1074

Heart failure, strict

441

3930

0.80

4.74

3.7

1.6

6.82

3.54

mg/l

4.42

405

2817

Other specified and unspecified personality disorders

216

1591

1.38

4.73

1.8

1.7

4.56

4.03

mg/l

0.30

187

1090

Failed induction of labour

177

1265

1.43

4.73

1.7

3.29

4.34

mg/l

1.04

146

843

Hypertensive heart and/or renal disease

172

1870

0.71

4.72

1.7

1.6

3.65

3.43

mg/l

0.08

142

1284

Presence of other functional implants

527

4535

0.82

4.71

1.6

1.5

3.87

3.23

mg/l

0.73

408

3219

Other condition

140

2022

0.68

4.70

1.6

1.7

5.10

3.98

mg/l

0.60

1406

Fibromyalgia

206

1508

1.39

4.70

1.5

1.6

4.01

3.63

mg/l

0.28

175

1003

Degenerative diseases of the nervous system

110

1263

0.65

4.69

1.6

2.80

3.48

mg/l

0.43

936

Melanocytic naevi

573

4760

1.21

4.67

1.6

1.7

2.94

3.66

mg/l

1.76

380

3272

Undefined dementia

350

0.29

4.66

1.1

1.5

3.63

3.07

mg/l

—

284

Polycystic ovarian syndrome

175

1252

1.43

4.65

1.6

4.35

3.56

mg/l

0.92

131

818

Other heart diseases

1238

7191

1.14

4.65

3.5

1.4

4.23

3.12

mg/l

2.79

963

4763

Crohn's disease of large intestine

822

0.51

4.64

1.5

1.7

3.09

4.22

mg/l

0.46

569

Wide developmental disorders, excluding more controls

410

1.76

4.64

1.4

1.7

2.81

3.43

mg/l

0.39

245

Visual disturbances and blindness

841

7221

1.17

4.63

1.9

1.6

3.51

3.47

mg/l

0.05

625

5006

Other soft tissue disorders, not elsewhere classified

2025

11313

1.11

4.60

1.7

1.6

3.66

3.49

mg/l

0.38

1544

7573

Unspecific neurodegenerative disorder

141

1409

0.69

4.60

1.5

1.6

2.51

3.51

mg/l

0.82

108

1051

Disorders of refraction and accommodation

551

4554

1.21

4.57

1.6

3.86

3.62

mg/l

0.19

399

3109

Early onset COPD

190

2592

0.73

4.52

1.8

1.7

9.81

3.55

mg/l

3.75

158

1850

Condition for Implicit Sepsis (Organ dysfunction codes)

1272

10435

0.88

4.48

2.2

1.6

6.09

3.24

mg/l

7.68

1001

7259

Other sexually transmitted chlamydial diseases

195

1429

1.39

4.48

1.5

1.7

3.33

3.99

mg/l

0.88

145

933

Menorrhagia

767

3605

1.18

4.47

1.7

2.81

3.59

mg/l

3.38

546

2496

Focal epilepsy

207

2780

0.74

4.46

1.5

1.7

5.02

3.76

mg/l

0.66

153

1935

Focal epilepsy, mode (most common among epilepsy diagnosis)

174

2399

0.72

4.45

1.6

1.7

4.76

3.82

mg/l

0.40

128

1663

Viral haemorrhagic fevers, not elsewhere classified/unspecified

1005

0.57

4.45

1.2

1.7

3.65

4.11

mg/l

0.09

715

Temporomandibular joint disorders, including avohilmo

988

8608

1.15

4.44

1.7

1.6

2.88

3.48

mg/l

2.53

666

5879

Mucosal proctocolitis

150

2115

0.70

4.43

1.6

1.7

3.51

3.93

mg/l

0.36

114

1457

Anankastic personality disorder

102

663

1.58

4.41

1.4

1.7

2.88

4.16

mg/l

0.61

452

Secondary uncertain malignant neoplasm

1106

0.59

4.41

1.3

1.7

3.98

3.85

mg/l

0.05

781

MS-disease / Multiple Sclerosis

1285

0.62

4.39

1.6

1.7

5.05

4.01

mg/l

0.34

893

Explicit Sepsis

421

4958

0.81

4.36

1.9

1.6

6.10

3.46

mg/l

2.64

346

3444

Ovarian cyst

867

4317

1.17

4.35

1.5

1.6

3.42

3.63

mg/l

0.38

603

2941

Oligomenorrhoea

594

1.60

4.33

2.1

1.8

3.66

3.70

mg/l

0.02

398

Factors influencing health status and contact with health services

756

3224

1.18

4.31

1.8

1.4

5.15

3.05

mg/l

1.55

523

2131

Disorders of lens

855

6243

0.86

4.31

1.8

1.7

5.19

3.46

mg/l

1.60

656

4471

Alcohol abuse, main dg, excluding more controls

152

2126

0.71

4.27

1.6

1.7

4.46

3.69

mg/l

0.41

131

1402

Chronic pancreatitis

1305

0.63

4.27

1.4

1.7

5.89

3.30

mg/l

0.66

928

Emotional disorders starting during childhood or adolecense, excluding more controls

115

755

1.52

4.26

1.4

1.5

5.01

3.29

mg/l

1.41

441

Other degenerative diseases of the basal ganglia

108

0.00

4.25

0.0

2.0

—

2.72

—

Other and unspecified disorders of vitreous body

550

4569

1.20

4.24

1.7

3.33

3.52

mg/l

0.22

381

3298

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

101

1522

0.66

4.23

1.4

1.7

3.19

3.75

mg/l

0.31

1086

Spondylosis

650

6563

0.85

4.22

1.8

1.7

4.02

3.50

mg/l

0.51

487

4679

Sensorineural hearing loss

894

7203

0.87

4.22

1.6

1.7

4.05

3.56

mg/l

0.50

639

5177

Asthma, hospital admissions , main diagnosis only

1694

13697

1.11

4.21

1.7

1.6

4.82

3.33

mg/l

5.07

1242

9438

Other inflammation of eyelid

215

1612

1.35

4.20

1.5

1.7

3.62

3.67

mg/l

0.02

153

1138

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

729

0.51

4.16

1.6

1.7

7.86

3.64

mg/l

0.48

518

Other special examinations and investigations of persons without complaint or reported diagnosis

1539

6971

1.12

4.16

1.7

1.6

4.36

3.30

mg/l

2.35

1120

4624

Colorectal cancer

130

1860

0.69

4.14

1.4

1.7

3.32

3.61

mg/l

0.17

103

1354

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

642

5453

1.19

4.14

1.6

4.43

3.33

mg/l

2.82

522

3447

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

230

1815

0.76

4.09

1.4

1.7

3.30

4.31

mg/l

0.80

168

1272

Schizophrenia or delusion, excluding more controls

427

5154

0.82

4.09

1.6

1.7

4.50

3.33

mg/l

2.36

337

3343

Intracerebral haemorrhage

870

0.56

4.09

1.7

1.6

5.17

3.95

mg/l

0.19

630

Use of biperiden

671

0.50

4.09

2.1

1.8

4.38

4.39

mg/l

0.00

473

Autoimmune diseases related-to ILD

1439

14086

0.90

4.06

1.7

1.6

4.38

3.21

mg/l

3.43

1074

9729

Other diseases of blood and blood-forming organs, wide

204

2704

0.75

4.05

1.9

1.7

6.66

3.59

mg/l

1.42

164

1918

Bacterial Sepsis

393

4291

0.81

4.04

2.1

1.6

8.79

3.42

mg/l

5.42

329

3000

Desensitization to allergens

147

1048

1.43

4.02

1.3

1.7

3.27

4.64

mg/l

1.03

694

Other pulmonary diagnosis

1959

8914

1.10

4.01

1.8

1.4

4.63

2.87

mg/l

4.80

1435

5947

Septicaemia

368

4363

0.81

4.00

1.9

1.6

6.31

3.51

mg/l

2.45

309

3048

Nonalcoholic fatty liver disease

172

1258

1.39

3.99

1.8

1.7

4.10

4.12

mg/l

0.01

153

888

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

612

0.48

3.99

1.2

1.7

2.72

4.65

mg/l

0.96

420

Diseases of oesophagus, stomach and duodenum

2217

12327

1.10

3.98

1.7

1.6

4.65

3.29

mg/l

3.50

1691

8512

Gluteal tendinitis

473

1.64

3.96

1.5

1.7

2.89

4.21

mg/l

0.50

345

Combinations of oral blood glucose lowering drugs

258

3305

0.78

3.95

2.1

1.7

4.60

3.71

mg/l

0.50

219

2322

Gestational diabetes (for exclusion)

1064

6646

1.14

3.94

1.7

1.6

3.65

3.46

mg/l

0.41

827

4427

Erysipelas

617

6610

0.85

3.93

1.9

1.6

5.38

3.40

mg/l

2.96

509

4656

Procedures for purposes other than remedying health state

375

1.73

3.93

1.5

1.6

2.40

3.99

mg/l

0.50

266

Demyelinating diseases of the central nervous system

101

1490

0.67

3.91

1.6

1.7

4.43

4.05

mg/l

0.14

1039

L04AC Interleukin inhibitors

763

0.54

3.90

1.3

1.8

5.19

3.90

mg/l

0.54

527

Malignant neoplasm of other and unspecified parts of biliary tract

0.00

3.90

0.0

1.5

—

2.82

—

Other and unspecified disorders of autonomic nervous system

3.43

3.90

1.4

6.40

3.43

mg/l

—

malignant neoplasm of male genital organs

263

2143

0.78

3.89

1.5

1.7

3.35

4.45

mg/l

0.82

196

1521

Transient ischemic attack

447

4474

0.82

3.89

1.8

1.7

3.14

3.66

mg/l

0.59

315

3244

Renal failure

321

3662

0.80

3.89

2.5

1.6

7.54

3.72

mg/l

3.42

287

2606

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

815

0.56

3.88

1.8

1.7

4.26

4.21

mg/l

0.01

561

Schizoaffective disorder

1283

0.65

3.87

1.7

1.8

4.41

3.86

mg/l

0.30

891

Ulcerative ileocolitis

656

0.51

3.86

2.2

1.8

2.79

3.80

mg/l

0.75

456

Disorders of vitreous body

665

5574

1.17

3.85

1.7

3.28

3.51

mg/l

0.34

472

4024

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

802

0.56

3.85

1.3

1.7

2.91

3.98

mg/l

0.39

565

Focal epilepsy, strict definition

186

2477

0.75

3.85

1.6

1.7

5.13

3.81

mg/l

0.63

140

1725

Paroxysmal tachycardia

480

3379

1.21

3.83

3.8

1.4

4.59

3.29

mg/l

1.46

369

2224

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

618

0.50

3.83

1.2

1.6

5.16

4.00

mg/l

0.16

433

5-aminosalicylic acid

297

3721

0.79

3.81

1.5

3.44

3.30

mg/l

0.15

206

2513

Myeloproliferative diseases

773

0.55

3.81

1.6

1.7

5.52

3.56

mg/l

0.35

551

Coxarthrosis [arthrosis of hip](FG)

620

5253

0.85

3.77

1.7

1.6

3.84

3.24

mg/l

0.65

489

3670

Volume depletion

758

0.55

3.76

2.9

1.7

5.67

4.08

mg/l

0.21

533

ILD medications: prednisolone, methylprednisolone, prednisone

2434

12671

1.09

3.74

2.6

1.4

5.14

3.05

mg/l

10.92

1931

8513

Calcific aortic valvular stenosis, diagnosis (helper)

125

1729

0.70

3.74

1.5

1.6

3.82

3.86

mg/l

0.02

1263

Operations 2 for CAVS

125

1729

0.70

3.74

1.5

1.6

3.82

3.86

mg/l

0.02

1263

Early onset COPD, excluding more controls

190

2511

0.75

3.74

1.8

1.4

9.81

2.84

mg/l

4.57

158

1708

Other predominantly sexually transmitted diseases, not elsewhere classified

427

3537

1.22

3.73

1.5

1.6

2.88

3.64

mg/l

2.01

320

2381

Bruxism

299

1.80

3.70

1.8

1.7

4.06

2.91

mg/l

0.68

202

Calcific aortic valvular stenosis, including rheumatic fever

126

1736

0.71

3.70

1.5

1.6

3.78

3.92

mg/l

0.08

1269

Calcific aortic valvular stenosis, operated

126

1737

0.71

3.70

1.5

1.6

3.79

3.86

mg/l

0.04

1268

Calcific aortic valvular stenosis

126

1737

0.71

3.70

1.5

1.6

3.79

3.86

mg/l

0.04

1268

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

779

0.56

3.69

1.3

1.7

2.90

3.88

mg/l

0.34

549

Kidney diseases associated to Fabry's disease

4.37

3.68

3.9

1.7

1.25

2.69

mg/l

—

Other pleural conditions

740

0.55

3.67

1.6

1.7

5.51

3.55

mg/l

0.41

537

Crohn's disease NAS

1000

0.61

3.67

1.4

1.8

3.94

4.10

mg/l

0.05

692

Crohn disease

157

2122

0.73

3.64

1.7

3.82

mg/l

0.00

114

1471

Disorders of vitreous body and globe

679

5708

1.16

3.64

1.7

3.29

3.55

mg/l

0.40

484

4122

Autism spe

384

1.69

3.63

1.4

1.7

2.83

4.03

mg/l

0.99

245

Contact with and exposure to communicable diseases

612

7094

0.85

3.60

1.5

1.6

3.43

3.53

mg/l

0.07

372

4772

Other problems related to primary support group, including family circumstances

271

2094

1.28

3.57

1.8

1.6

4.36

3.90

mg/l

0.31

215

1415

Pustular psoriasis

587

0.50

3.57

1.5

1.7

3.33

4.05

mg/l

0.24

416

Crohn disease (strict definition, all UC cases excluded)

805

0.57

3.56

1.4

1.7

3.81

4.43

mg/l

0.25

556

Autism

402

1.66

3.55

1.4

1.7

2.92

3.90

mg/l

0.76

259

Aplastic and other anaemias

370

4265

0.82

3.54

1.7

1.6

6.22

3.50

mg/l

2.58

294

3029

Candidiasis

237

1850

1.29

3.53

1.7

6.50

3.92

mg/l

1.33

171

1297

Ethmoidectomy

240

1877

1.29

3.53

1.6

1.7

4.01

3.69

mg/l

0.18

185

1327

Other disorders of eyelid

540

4428

1.18

3.52

1.6

1.7

2.80

3.51

mg/l

1.39

394

3182

Agranulocytosis

1328

0.67

3.50

1.9

1.7

10.12

3.58

mg/l

1.32

940

Fissure and fistula of anal and rectal regions

423

3521

1.21

3.49

1.7

3.09

3.34

mg/l

0.27

315

2411

Other disorders of penis

126

897

1.42

3.46

1.7

3.11

3.68

mg/l

0.36

614

Injuries to the head

2010

14236

0.92

3.45

1.8

1.6

3.61

3.51

mg/l

0.17

1477

9790

Dental operations, only avohilmo

1218

6962

0.89

3.45

1.7

1.6

4.27

3.23

mg/l

1.15

882

4819

Pustulosis palmaris et plantaris

553

0.50

3.45

1.5

1.7

3.30

4.03

mg/l

0.23

391

Diseases of the skin and subcutaneous tissue

2381

11026

1.09

3.44

1.7

1.6

4.50

3.23

mg/l

3.31

1710

7453

Colorectal adenocarcinoma

101

1456

0.69

3.43

1.4

1.6

3.19

3.74

mg/l

0.29

1059

Epilepsy

350

4248

0.82

3.43

1.6

4.25

3.22

mg/l

0.97

251

2809

Parkinson's disease, excluding more controls

1010

0.63

3.43

1.4

1.6

2.00

3.91

mg/l

2.87

702

Chronic gastritis

334

2719

1.23

3.43

1.8

1.7

5.50

3.16

mg/l

0.78

264

1910

Mycoses

423

3528

1.21

3.43

1.7

5.27

3.65

mg/l

1.51

313

2469

Adenocarcinoma and papilloma adenocarcinoma of rectum

736

0.57

3.42

1.3

1.7

3.00

3.72

mg/l

0.22

536

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

761

0.57

3.42

1.3

1.7

2.94

3.68

mg/l

0.25

554

Disorders of other endocrine glands

769

6621

1.15

3.39

1.7

1.6

3.98

3.49

mg/l

0.80

572

4545

Kela-code for behavioural disturbances in mental retardation

0.00

3.37

0.0

1.7

—

3.73

—

Hypo-osmolality and hyponatraemia

102

1457

0.69

3.37

2.3

1.7

4.41

3.65

mg/l

0.32

1030

Voice disturbances

423

3536

1.20

3.36

1.6

1.7

3.14

3.48

mg/l

0.35

296

2510

Drug-induced neutropenia

830

0.59

3.35

1.9

1.7

5.52

3.90

mg/l

0.39

592

Migraine with aura and triptan purchases

366

3023

1.22

3.34

1.7

1.6

3.17

3.76

mg/l

0.87

267

2040

Other/unspecified rheumatoid arthritis

1221

0.67

3.34

1.5

1.6

9.70

3.49

mg/l

1.28

897

Diabetic retinopathy, strict definition

212

1440

1.30

3.34

1.6

2.1

4.25

4.87

mg/l

0.54

197

1237

Conductive and sensorineural hearing loss

1022

7937

0.89

3.31

1.6

1.7

4.06

3.50

mg/l

0.66

731

5682

Abdominal and pelvic pain

2272

10548

1.09

3.30

1.7

1.6

3.95

3.29

mg/l

1.96

1673

7100

Other disorders of skin and subcutaneous tissue

1090

8939

1.12

3.30

1.7

4.15

3.53

mg/l

0.93

830

6314

Dental operations

1152

6597

0.89

3.29

1.8

1.6

4.40

3.09

mg/l

1.50

829

4533

Inflammatory bowel disease

452

5348

0.84

3.29

1.6

1.7

3.43

3.63

mg/l

0.28

327

3700

Myocardial infarction, unclassifiable

1174

0.68

3.29

1.9

1.7

6.86

4.00

mg/l

0.58

856

Adverse effects, not elsewhere classified

395

3291

1.21

3.28

1.6

4.59

3.72

mg/l

0.77

288

2277

Acute and transient psychotic disorders

141

1902

0.73

3.28

1.6

1.7

4.25

3.67

mg/l

0.30

110

1331

Other diseases of biliary tract

751

0.58

3.27

1.5

1.6

8.96

3.28

mg/l

0.64

531

Alzheimer disease, excluding more controls

737

0.65

3.27

1.7

1.5

1.90

3.61

mg/l

1.76

542

Other septicaemia

323

3868

0.82

3.26

2.0

1.6

5.54

3.55

mg/l

1.87

271

2695

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

1250

0.67

3.26

1.4

1.6

4.56

3.93

mg/l

0.24

883

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

239

3006

0.79

3.25

1.6

1.7

3.17

3.76

mg/l

0.83

169

2073

FESS (DNB20)

231

1821

1.28

3.23

1.6

1.7

3.98

3.73

mg/l

0.13

177

1286

Any reimbursement code in KELA

1614

8860

0.91

3.22

1.8

1.5

4.70

2.69

mg/l

5.23

1202

5632

Tobacco use

769

0.59

3.21

1.6

1.7

4.69

4.04

mg/l

0.19

531

Medical treatment for female infertility

575

4949

1.17

3.20

1.6

3.62

3.44

mg/l

0.22

380

3380

Other and unspecified polyneuropathies, also in other diseases

220

1724

1.28

3.19

1.6

1.7

3.18

3.87

mg/l

0.71

173

1241

TMD related pain

566

1.52

3.18

1.4

1.6

3.74

3.92

mg/l

0.05

384

Sphingolipidosis, other/unspecified

3.86

3.18

3.9

1.6

1.25

2.50

mg/l

—

Abnormal findings on examination of blood, without diagnosis

627

5085

1.16

3.17

1.7

5.31

3.75

mg/l

2.29

499

3588

Temporomandibular joint disorders

354

2931

1.22

3.16

1.6

3.12

3.39

mg/l

0.30

256

1920

Asthma (diagnoses ohter than nonallergic)

1732

13595

1.09

3.16

1.8

1.6

4.99

3.32

mg/l

3.92

1312

9340

Nasal polyp

284

2299

1.24

3.14

1.5

1.7

4.26

3.78

mg/l

0.35

230

1608

Hyperhidrosis

487

1.55

3.13

1.7

1.5

3.54

2.90

mg/l

0.50

316

Postmenopausal bleeding

398

1816

1.21

3.13

1.9

1.7

2.95

3.66

mg/l

1.67

298

1331

Ulcerative colitis

334

4038

0.82

3.12

1.6

1.7

3.25

3.58

mg/l

0.48

244

2785

Exclusions for E4_PCOS_CONSORTIUM

1661

9530

1.10

3.12

1.7

1.6

3.49

3.44

mg/l

0.08

1215

6601

Polyneuropathies and other disorders of the peripheral nervous system

257

2059

1.26

3.11

1.5

1.7

3.75

3.84

mg/l

0.04

202

1487

Intestinal infectious diseases

1923

13802

1.09

3.10

1.8

1.6

4.76

3.33

mg/l

3.30

1447

9430

Benign neoplasm: Testis

3.61

3.10

1.2

1.7

1.96

2.96

mg/l

—

Diseases of the musculoskeletal system and connective tissue

1527

6977

1.10

3.10

1.7

1.5

4.03

3.24

mg/l

1.83

1099

4467

Malignant neoplasm of prostate

252

1990

0.80

3.10

1.4

1.7

2.92

4.41

mg/l

2.44

188

1417

Actinic keratosis

299

2310

1.23

3.09

1.9

1.6

3.68

3.44

mg/l

0.13

214

1683

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

1056

0.66

3.08

1.3

1.6

2.72

4.12

mg/l

0.90

753

Non-invasive ventilation

290

3335

0.81

3.07

1.7

1.4

7.14

2.65

mg/l

3.59

184

2050

Myeloproliferative diseases (CML excluded)

699

0.58

3.07

1.5

1.7

3.20

3.65

mg/l

0.16

502

Need for immunization against other single viral diseases

248

1.78

3.07

1.9

3.94

3.52

mg/l

0.12

180

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

453

0.48

3.06

3.5

1.7

4.09

3.96

mg/l

0.02

333

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

958

0.64

3.05

1.5

1.6

5.65

4.29

mg/l

0.41

667

Other disorders of peripheral nervous system

2.87

3.05

1.2

2.0

1.64

3.86

mg/l

—

Malignant neoplasm of rectum

748

0.60

3.04

1.3

1.7

3.02

3.75

mg/l

0.25

542

Artificial opening status

517

0.52

3.04

1.8

1.5

3.63

3.78

mg/l

0.04

375

Ptosis of eyelid

131

962

1.37

3.04

1.8

1.7

2.98

3.50

mg/l

0.24

698

837

7366

1.13

3.04

1.8

1.6

5.21

3.28

mg/l

4.13

643

5020

Non-follicular lymphoma, hilmo, excluding all cancers

834

0.62

3.04

1.5

1.7

3.07

3.91

mg/l

0.41

585

Blepharochalasis

345

2859

1.21

3.03

1.6

2.43

3.34

mg/l

1.66

259

2060

Implicit Sepsis

966

8391

0.89

3.02

2.2

1.6

6.54

3.35

mg/l

7.30

781

5846

Coxarthrosis

599

4682

0.86

3.01

1.7

3.93

3.46

mg/l

0.43

472

3287

Disorder of lipoprotein metabolism, unspecified

152

1144

1.34

3.00

2.0

1.7

4.54

3.95

mg/l

0.17

133

809

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

942

6684

0.89

2.98

1.8

1.4

3.66

3.14

mg/l

0.79

713

4464

GI-bleeding

249

3087

0.80

2.98

1.5

1.7

6.16

3.75

mg/l

0.59

194

2194

Symptoms and signs involving the digestive system and abdomen

2269

10548

1.08

2.98

1.7

1.6

4.23

3.29

mg/l

2.95

1671

7100

Endometriosis of intestine

289

1.71

2.97

2.0

1.9

3.53

3.42

mg/l

0.04

178

Speech therapy

271

3328

0.81

2.97

1.6

1.7

3.40

3.69

mg/l

0.29

193

2367

Hydrocephalus

629

0.57

2.96

1.6

6.09

3.85

mg/l

0.28

466

Acute tubulo-interstitial nephritis

851

8475

0.89

2.95

1.8

1.6

4.22

3.46

mg/l

1.63

651

5854

Malignant neoplasm of eye, brain and central nervous system

484

0.51

2.94

1.4

1.8

3.53

3.44

mg/l

0.03

348

Other disorders of skin and subcutaneous tissue, not elsewhere classified

201

1577

1.28

2.94

1.7

4.57

3.90

mg/l

0.35

157

1119

Skin changes due to chronic exposure to nonionizing radiation

314

2445

1.22

2.93

1.9

1.6

3.56

3.40

mg/l

0.09

227

1784

Dysplasia of cervi uteri

569

3814

1.16

2.90

1.8

1.6

2.98

3.58

mg/l

1.84

388

2594

Alcohol-induced chronic pancreatitis

736

0.60

2.89

1.5

1.8

8.56

4.93

mg/l

0.46

527

Testicular hypofunction

368

1.61

2.89

2.2

1.8

5.12

4.57

mg/l

0.07

265

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1263

9371

1.10

2.88

1.7

1.6

3.32

3.47

mg/l

0.26

852

6549

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

114

1556

0.73

2.88

1.4

1.6

3.64

3.83

mg/l

0.09

1106

Diseases of external ear

523

4515

1.16

2.87

1.6

1.7

3.95

3.62

mg/l

0.28

381

3139

Follicular lymphoma

414

0.48

2.87

1.3

1.7

5.62

4.73

mg/l

0.10

297

Hypertrophic cardiomyopathy

400

1.57

2.87

4.5

1.7

6.25

3.23

mg/l

1.38

292

Diseases of the respiratory system

1555

7130

1.10

2.86

1.7

1.5

4.43

2.82

mg/l

3.31

1116

4778

Lung diseases due to external agents

1087

0.68

2.86

2.1

1.7

10.25

4.08

mg/l

1.37

772

Other and unspecified anaemias

335

3885

0.83

2.86

1.7

1.6

5.80

3.48

mg/l

2.18

266

2763

Ulcerative colitis (strict definition, require KELA)

223

2779

0.80

2.85

1.6

1.7

3.20

3.69

mg/l

0.60

159

1917

Chronic nephritic syndrome

465

0.51

2.84

1.3

1.7

13.02

3.58

mg/l

1.08

338

Other anaemias

340

3925

0.83

2.84

1.7

1.6

5.79

3.49

mg/l

2.21

270

2792

Parkinson's disease

990

0.66

2.84

1.4

1.7

2.00

3.51

mg/l

1.52

728

Wide developmental disorders

474

1.53

2.84

1.4

1.7

2.81

3.69

mg/l

0.76

305

Rosacea

200

1578

1.28

2.83

1.7

3.70

3.59

mg/l

0.06

154

1110

Ovarian dysfunction

206

1635

1.28

2.82

1.6

4.15

3.84

mg/l

0.23

155

1090

Endometriosis ASRM stages 3,4

456

3907

1.17

2.80

1.6

1.7

3.46

3.39

mg/l

0.06

307

2751

Substance abuse, excluding more controls

832

8154

0.89

2.79

1.6

4.98

3.44

mg/l

3.49

704

5345

Other diseases of anus and rectum

408

3459

1.18

2.79

1.9

1.7

3.30

3.43

mg/l

0.11

314

2384

Undetermined asthma, excluding more controls

220

1758

1.26

2.77

1.7

1.4

5.58

2.78

mg/l

2.55

175

1171

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

215

2679

0.80

2.76

1.6

1.7

3.26

3.72

mg/l

0.53

155

1849

Problems related to lifestyle

130

1724

0.75

2.76

1.6

5.17

3.39

mg/l

1.97

112

1147

Hypertensive Heart Disease

158

1676

0.77

2.75

1.7

1.6

3.64

3.34

mg/l

0.10

131

1145

Premenstrual syndrome

205

1.82

2.75

1.6

1.9

3.79

3.84

mg/l

0.01

131

Other and unspecified psoriasis

774

0.63

2.74

1.8

1.6

2.82

3.98

mg/l

0.72

552

Endometriosis ASRM stages 1,2

399

3391

1.19

2.74

1.6

1.7

3.38

3.41

mg/l

0.03

282

2369

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

133

986

1.35

2.73

1.6

4.42

3.68

mg/l

0.55

622

Undetermined asthma

220

1762

1.26

2.72

1.7

1.4

5.58

2.83

mg/l

2.47

175

1177

Crohn's disease of small intestine

1107

0.69

2.72

2.0

1.8

4.30

4.28

mg/l

0.01

765

Contraceptive management

1012

6415

1.11

2.72

1.6

1.7

3.35

3.72

mg/l

0.68

721

4571

Certain infectious and parasitic diseases

2363

11039

1.07

2.72

1.8

1.6

4.30

3.14

mg/l

3.08

1733

7415

Convulsions, not elsewhere classified

315

3725

0.83

2.71

1.7

1.5

3.75

3.43

mg/l

0.29

242

2459

Lateral epicondylitis

170

2171

0.78

2.71

1.6

1.7

3.76

3.66

mg/l

0.05

135

1502

Non-small cell lung cancer, adenocarcinoma, helper endpoint

432

0.50

2.70

3.5

1.8

4.09

4.01

mg/l

0.01

333

Non-small cell lung cancer, adenocarcinoma

432

0.50

2.70

3.5

1.8

4.09

4.01

mg/l

0.01

333

Infective dermatitis

104

1422

0.73

2.70

1.7

4.08

3.18

mg/l

0.32

1001

Supernumerary teeth EXCLUDE clefts and syndromes

2.80

2.69

1.1

1.5

5.60

3.93

mg/l

—

Unspecified human immunodeficiency virus [HIV] disease

141

1.99

2.68

1.3

1.7

2.06

4.52

mg/l

1.50

101

Complications of medical and surgical care

1277

11078

1.10

2.68

1.8

1.6

4.12

3.48

mg/l

1.57

996

7749

Other diseases of hard tissues of teeth

1380

9425

1.09

2.67

1.7

1.6

4.16

3.08

mg/l

2.39

1009

6398

Hypersomnia

199

1.81

2.67

1.4

1.9

3.15

3.75

mg/l

0.24

139

Other/unspecified enthesopathies of lower limb, excluding foot

139

1058

1.33

2.62

1.7

1.6

3.63

3.90

mg/l

0.14

737

Ulcerative rectosigmoiditis

1285

0.72

2.61

1.9

1.7

2.80

3.99

mg/l

1.05

898

Acute alcohol intoxication ICD-9

359

0.47

2.61

1.2

1.8

11.85

3.47

mg/l

0.75

264

Retention of urine

260

2675

0.82

2.61

1.6

1.7

4.49

3.80

mg/l

0.32

201

1894

Female infertility, associated with anovulation

220

1777

1.25

2.61

1.7

1.6

3.86

3.57

mg/l

0.28

157

1154

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

862

0.66

2.60

1.5

1.6

6.00

4.23

mg/l

0.52

599

Left bundle-branch block

623

1.43

2.59

4.6

1.5

4.22

3.85

mg/l

0.09

445

Hydronephrosis

1180

0.71

2.59

1.5

1.6

5.19

3.55

mg/l

0.82

822

Disorders of eyelid, lacrimal system and orbit

1505

10873

1.09

2.58

1.7

3.38

3.57

mg/l

0.33

1100

7657

Speech and linguistic disorders, excluding more controls

158

1154

1.30

2.58

1.7

1.5

5.39

3.40

mg/l

1.14

122

667

Parkinson's disease, including avohilmo

1040

0.69

2.58

1.4

1.7

2.10

3.48

mg/l

1.42

765

Persistent delusional disorders

907

0.67

2.58

1.5

1.7

4.18

3.82

mg/l

0.11

645

6-mercaptopurine

512

0.56

2.57

1.4

1.5

3.91

3.31

mg/l

0.19

347

Other joint disorders

2176

10809

1.07

2.57

1.7

1.6

4.12

3.37

mg/l

2.03

1597

7209

Myocardial infarction, without ST-elevation

251

2821

0.82

2.57

2.5

1.7

4.72

3.84

mg/l

0.45

195

2057

Abdominal aortic aneurysm (AAA)

434

0.52

2.56

1.9

1.6

6.64

3.29

mg/l

0.50

310

Dentofacial anomalies [including malocclusion]

622

5429

1.14

2.55

1.6

3.24

3.07

mg/l

0.25

447

3610

Use of memantine

771

0.66

2.55

1.6

1.5

2.89

2.81

mg/l

0.03

589

Use of other anti-dementia drugs

771

0.66

2.55

1.6

1.5

2.89

2.81

mg/l

0.03

589

Alzheimer disease

901

0.71

2.55

1.6

1.5

2.18

2.86

mg/l

0.63

685

Golimumab

548

0.57

2.55

1.3

1.8

2.90

4.44

mg/l

0.62

377

Hernia of abdominal wall, postoperative

275

2277

1.21

2.52

1.6

6.71

2.77

mg/l

1.42

231

1536

Other and unspecified nonorganic psychotic disorders

306

3644

0.83

2.52

1.5

1.7

4.52

3.49

mg/l

1.42

251

2466

Follow-up care involving plastic surgery

529

1.46

2.50

1.6

3.44

3.86

mg/l

0.13

377

Other functional intestinal disorders

686

5803

1.13

2.49

1.6

3.53

3.37

mg/l

0.21

502

4007

Colonic or urogenital fistula

435

3751

1.17

2.49

1.7

3.19

3.66

mg/l

0.61

324

2622

Urticaria

596

5255

1.14

2.49

1.7

1.6

3.76

3.50

mg/l

0.29

441

3623

Asymptomatic human immunodeficiency virus [HIV] infection status

2.28

2.49

1.3

1.5

2.49

4.02

mg/l

0.44

Diabetes mellitus in pregnancy

970

5690

1.11

2.49

1.7

1.6

3.75

3.54

mg/l

0.43

767

3762

Suggestive for eosinophilic asthma

141

1085

1.31

2.47

1.7

6.10

3.50

mg/l

1.20

117

756

Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

2.47

0.0

1.7

—

3.36

—

Dissociative [conversion] disorders

623

1.42

2.46

1.4

1.6

2.94

4.00

mg/l

0.44

394

Bronchitis

2221

13630

1.07

2.46

1.8

1.6

4.62

3.28

mg/l

5.67

1631

9342

Secondary and unspecified malignant neoplasm of lymph nodes

814

0.66

2.45

1.3

1.7

3.74

3.88

mg/l

0.05

579

Non-follicular lymphoma

790

0.65

2.45

1.5

1.7

3.07

3.87

mg/l

0.37

572

Hypertensive Renal Disease

268

0.41

2.45

1.2

1.5

3.23

3.11

mg/l

0.02

193

Other ulcerative colitis

883

0.67

2.44

1.4

1.7

3.09

4.17

mg/l

0.67

616

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

441

0.54

2.42

1.3

1.7

7.23

2.86

mg/l

0.96

322

Other diseases of pancreas

726

0.64

2.41

1.3

1.7

7.83

3.47

mg/l

0.62

514

Generalized epilepsy

711

0.64

2.40

1.2

1.7

3.56

3.59

mg/l

0.02

484

Other diseases of the digestive system

260

3129

0.83

2.39

1.5

1.7

6.13

3.72

mg/l

0.63

203

2221

Vulvovaginal ulceration/inflammation in other diseases

142

1102

1.31

2.39

1.7

3.49

3.99

mg/l

0.28

742

Thyroiditis, unspecified

214

1.73

2.38

1.7

1.8

3.12

2.88

mg/l

0.09

152

Alzheimer disease, including avohilmo

113

1085

0.75

2.38

1.6

1.94

3.63

mg/l

1.74

815

Anorexia (incl.atypical)

144

1119

1.30

2.38

1.5

1.6

2.28

3.65

mg/l

2.41

726

Malignant neoplasm of ovary

462

0.56

2.36

1.6

1.7

8.76

3.77

mg/l

0.36

325

Physiological and behavioural disorders associated with sexual development and orientation

3.83

2.36

1.9

2.0

2.02

1.84

mg/l

—

Disorders of thyroid, IBD co-morbidities

454

2870

1.16

2.36

2.2

1.5

3.98

2.70

mg/l

2.55

355

1759

Disorders of muscle in diseases classified elsewhere

5.13

2.35

8.3

1.8

3.35

3.65

mg/l

—

Benign neoplasm: Testis

2.98

2.35

1.2

1.8

1.96

3.66

mg/l

—

Juvenile arthritis (FINNGEN)

862

0.68

2.34

1.5

1.6

3.96

4.38

mg/l

0.15

557

Benign neoplasm: Colon

554

4814

0.88

2.32

1.6

1.7

4.08

3.60

mg/l

0.37

430

3418

Implicit bacterial Sepsis

328

3538

0.85

2.32

2.2

1.6

8.85

3.54

mg/l

5.29

282

2500

Other peripheral vascular diseases

1003

0.70

2.31

1.5

1.7

4.50

3.82

mg/l

0.24

695

Unspecified visual impairment (binocular)

155

0.32

2.31

2.4

1.8

0.65

2.61

mg/l

—

112

Peripheral artery operations in Hilmo

875

0.68

2.31

1.8

1.7

6.90

4.09

mg/l

0.83

612

Other obstetric conditions, not elsewhere classified

970

5726

1.11

2.31

1.6

3.72

3.54

mg/l

0.28

671

3811

Striking against or struck by other objects

612

5433

1.13

2.30

1.7

1.6

3.41

3.71

mg/l

0.33

455

3687

349

2799

1.18

2.30

1.8

1.6

4.01

3.43

mg/l

0.32

252

2022

Suppurative and necrotic conditions of lower respiratory tract

508

0.58

2.28

1.7

4.37

4.67

mg/l

0.06

364

Symptoms and signs involving speech and voice

487

4265

1.15

2.28

1.6

1.7

3.23

3.52

mg/l

0.30

349

3035

Injury of muscle and tendon at shoulder and upper arm level

491

4302

1.15

2.28

1.7

3.50

3.66

mg/l

0.11

382

3060

Superficial injury of lower leg

440

3828

1.16

2.28

1.8

1.6

3.76

3.73

mg/l

0.03

339

2601

Parkinson's disease, strict definition, excluding more controls

890

0.69

2.27

1.4

1.6

1.85

3.64

mg/l

2.70

619

Pyothorax

392

0.53

2.27

1.9

1.7

2.90

3.75

mg/l

0.24

289

Other and unspecified urticaria

378

3255

1.17

2.26

1.7

4.16

3.68

mg/l

0.40

290

2249

Ductal carcinoma of pancreas

0.00

2.26

0.0

1.4

—

3.38

—

Spinal stenosis

538

4780

0.88

2.26

1.6

1.7

3.26

3.51

mg/l

0.24

415

3423

Poor fetal growth

239

2870

0.83

2.24

1.4

1.6

3.76

3.65

mg/l

0.07

152

1917

Follicular lymphoma, hilmo

377

0.52

2.23

1.3

1.7

5.62

4.62

mg/l

0.11

284

Impotence

425

1.47

2.22

1.3

1.7

2.30

4.56

mg/l

1.71

299

Erectile dysfunction

491

1.44

2.21

2.8

1.6

9.48

2.92

mg/l

2.51

335

Hyperkinetic disorders (excl. ADHD)

263

1.62

2.21

1.2

1.8

4.83

3.02

mg/l

0.71

166

Follow-up examination after treatment for malignant neoplasms

972

0.71

2.21

1.8

1.6

6.62

3.43

mg/l

0.53

675

Unspecified jaundice

452

0.57

2.19

1.5

1.7

3.13

4.54

mg/l

0.43

329

Other disorders starting during childhood or adolescence

118

897

1.32

2.19

1.4

1.5

4.31

3.80

mg/l

0.31

565

Benign neoplasm of colon, rectum, anus and anal canal

690

5495

0.89

2.18

1.7

4.16

3.52

mg/l

0.59

536

3888

Hallux valgus (acquired)

454

3756

0.87

2.18

1.6

1.7

2.74

3.17

mg/l

0.68

321

2612

Total colectomy operation

549

0.61

2.17

1.4

1.8

2.95

3.53

mg/l

0.41

389

Total colectomy

549

0.61

2.17

1.4

1.8

2.95

3.53

mg/l

0.41

389

Osteonecrosis

635

0.64

2.17

2.1

1.7

5.94

3.88

mg/l

0.58

450

Impacted cerumen

116

887

1.32

2.16

1.5

1.7

2.59

3.65

mg/l

0.64

623

Subarachnoid haemorrhage

979

0.71

2.16

1.7

1.6

4.39

4.00

mg/l

0.07

701

Additional codes for the location of defect, injury or illness

706

0.66

2.16

1.7

1.8

5.26

4.06

mg/l

0.27

494

Other noninflammatory disorders of vagina

141

1108

1.28

2.16

1.9

1.8

3.58

3.51

mg/l

0.02

100

760

Chronic viral hepatitis

917

0.70

2.15

1.4

1.7

4.50

3.48

mg/l

0.52

623

Systemic atrophies primarily affecting the central nervous system

372

0.53

2.15

1.7

1.38

2.82

mg/l

1.59

278

Pruritus

179

1447

1.25

2.15

1.6

3.77

3.30

mg/l

0.41

139

1016

Myocardial infarction, with ST-elevation

1255

0.75

2.14

2.8

1.7

3.84

4.14

mg/l

0.12

906

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

358

0.52

2.14

1.6

1.7

4.59

4.23

mg/l

0.06

257

Maternal care for other known or suspected fetal problems

724

4177

1.12

2.14

1.6

3.58

3.83

mg/l

0.38

507

2796

Enlarged lymph nodes

272

2294

1.19

2.12

3.4

1.6

3.59

3.51

mg/l

0.05

208

1546

Other disorders of bone

368

3182

1.16

2.11

1.6

1.7

5.33

3.60

mg/l

1.29

268

2206

Polycystic ovarian syndrome, broad definition

307

2622

1.18

2.10

1.7

1.6

3.67

3.72

mg/l

0.03

223

1719

Single delivery by forceps and vacuum extractor

358

2525

0.86

2.10

1.4

1.6

3.54

4.19

mg/l

0.97

221

1759

Outcome of delivery

498

2716

1.14

2.10

1.6

3.03

4.03

mg/l

1.84

321

1890

Urticaria and erythema

698

6285

1.11

2.10

1.7

1.6

3.75

3.43

mg/l

0.44

521

4327

Impingement syndrome of shoulder

404

3518

1.15

2.09

1.7

3.85

3.56

mg/l

0.18

316

2449

Other or unspecified ileus, impaction or obstruction

137

1732

0.79

2.08

1.6

1.7

2.97

3.47

mg/l

0.41

1240

Hypokalaemia

1179

0.74

2.08

2.2

1.7

3.44

3.99

mg/l

0.29

830

Malignant neoplasm of urinary organs

749

0.68

2.08

1.4

1.7

5.76

3.64

mg/l

0.60

541

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

736

0.67

2.08

1.6

1.7

5.32

3.57

mg/l

0.51

511

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

948

5621

1.10

2.07

1.6

3.75

3.56

mg/l

0.30

658

3735

Granuloma annulare

208

1.68

2.06

1.4

1.7

2.16

2.57

mg/l

0.32

142

Fall on same level

2327

13773

0.94

2.05

1.6

3.85

3.46

mg/l

0.93

1742

9407

Anogenital herpesviral [herpes simplex] infection

150

1198

1.27

2.05

1.6

1.7

2.50

4.46

mg/l

2.48

115

804

Habitual aborter

385

1.49

2.05

2.0

1.9

2.12

3.48

mg/l

1.42

239

Generalized epilepsy, mode (most common among epilepsy diagnosis)

527

0.62

2.04

1.2

1.7

3.66

3.43

mg/l

0.08

364

Unspecified kidney failure

675

0.66

2.04

2.9

1.7

7.28

3.61

mg/l

0.72

486

Malignant neoplasm of stomach

366

0.54

2.04

1.3

1.7

8.44

3.14

mg/l

1.00

280

Varicose veins

798

6642

0.91

2.03

1.7

3.28

3.53

mg/l

0.30

594

4772

Other general symptoms and signs

733

1.34

2.02

1.6

7.56

4.25

mg/l

0.64

480

Disorders of skin appendages

945

8651

1.10

2.02

1.6

4.06

3.46

mg/l

1.09

703

5912

Emotional disorders and disorders of social functioning with onset specific to childhood

125

965

1.29

2.02

1.4

1.5

5.06

3.53

mg/l

1.24

614

Anisometropia and aniseikonia

353

1.49

2.00

1.4

1.7

2.51

4.67

mg/l

0.73

261

Non-selective monoamine reuptake inhibitors

567

4909

1.12

1.99

1.7

3.81

3.45

mg/l

0.34

454

3366

Ulcerative colitis (strict definition, all Crohn cases excluded)

194

2348

0.82

1.99

1.6

1.7

3.16

3.84

mg/l

0.84

138

1616

DVT of lower extremities

166

2042

0.81

1.99

1.8

1.7

3.18

3.88

mg/l

0.82

136

1441

Malignant neoplasm of colon

1079

0.74

1.98

1.4

1.7

3.59

3.66

mg/l

0.03

773

Lymphoid leukaemia

462

0.60

1.97

1.3

1.6

4.14

4.31

mg/l

0.03

333

Delirium, not induced by alcohol and other psychoactive substances

763

0.69

1.97

1.5

1.7

4.45

3.46

mg/l

0.58

560

Complications of procedures, not elsewhere classified

1501

12102

1.07

1.96

1.8

1.6

3.93

3.49

mg/l

1.05

1163

8416

Amenorrhoea

171

1394

1.24

1.95

1.7

1.6

4.11

3.75

mg/l

0.27

118

911

Toxic effect of ethanol

653

0.66

1.95

1.5

1.7

4.56

3.87

mg/l

0.24

448

Parkinson's disease, strict definition

879

0.71

1.94

1.4

1.7

1.85

3.53

mg/l

1.56

648

Glomerulonephritis

1175

0.75

1.93

1.7

6.81

3.99

mg/l

0.70

834

Tic and related disorders

158

1.75

1.93

1.4

2.0

4.12

2.45

mg/l

0.85

Other and unspecified diseases of spleen

0.00

1.92

0.0

1.9

—

6.44

—

Optic neuritis

698

0.68

1.92

1.3

1.7

3.17

3.53

mg/l

0.16

480

Insulin, fast-acting

474

5338

0.88

1.92

1.8

1.6

5.06

3.41

mg/l

2.36

434

3662

Duodenal ulcer

795

0.70

1.92

1.5

1.7

5.36

3.00

mg/l

0.53

555

Childhood asthma (age<16), excluding more controls

383

2652

1.15

1.91

1.5

1.3

4.30

2.95

mg/l

1.46

246

1574

Correction of physiology of bite - very demanding therapy visit

466

1.42

1.91

1.2

1.7

2.07

4.44

mg/l

1.08

315

Injury of muscle and tendon at lower leg level

232

1951

1.20

1.90

1.8

1.7

4.70

4.02

mg/l

0.24

163

1358

Alzheimer’s disease, wide definition, excluding more controls

638

0.72

1.90

1.7

1.5

2.34

3.26

mg/l

0.46

475

Gout

195

2143

0.83

1.90

2.1

1.7

5.87

3.71

mg/l

1.53

171

1490

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

141

0.35

1.89

1.2

1.5

10.44

4.11

mg/l

—

102

Other obstructive and reflux uropathy

601

0.66

1.88

1.4

1.6

3.52

3.09

mg/l

0.15

417

Ulcer of oesophagus

602

0.66

1.88

1.5

1.7

3.07

2.82

mg/l

0.15

435

Traumatic subdural haemorrhage

927

0.73

1.88

1.7

1.6

3.43

3.95

mg/l

0.25

649

Pneumonia derived septicemia

380

0.57

1.87

1.1

1.7

4.53

2.97

mg/l

0.44

270

Retinal detachment with retinal break

150

1211

1.25

1.86

1.5

1.7

2.22

4.16

mg/l

2.48

111

857

conjunctival haemorrhage

690

1.33

1.86

1.9

1.7

3.61

3.79

mg/l

0.04

504

Transport accidents

990

8086

1.09

1.85

1.5

1.6

3.76

3.35

mg/l

0.75

700

5399

Kela-code for severe mental illness

591

6561

0.90

1.85

1.6

1.7

4.03

3.49

mg/l

1.09

481

4490

Childhood asthma (age<16)

383

2661

1.15

1.85

1.5

1.4

4.30

3.02

mg/l

1.34

246

1585

Statin medication

1419

8528

0.93

1.84

1.9

1.6

4.17

3.14

mg/l

2.49

1148

5868

Alzheimer’s disease (Early onset), excluding more controls

223

0.46

1.83

1.4

1.5

3.91

3.01

mg/l

—

172

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

1242

0.77

1.83

1.6

1.7

6.46

3.86

mg/l

0.76

827

Supplementary factors related to causes of morbidity and mortality classified elsewhere

412

4666

0.88

1.83

1.6

4.35

3.58

mg/l

0.88

296

3225

2415

12084

1.06

1.83

1.7

1.6

4.33

3.17

mg/l

5.28

1772

8213

Focal brain injury

716

0.69

1.83

1.5

1.7

2.95

3.66

mg/l

0.42

472

400

0.59

1.82

1.4

1.7

4.75

3.14

mg/l

0.47

263

Vasomotor rhinitis (mode)

120

948

1.28

1.82

1.6

1.7

3.87

3.83

mg/l

0.01

670

Shoulder lesions

1439

8226

1.07

1.81

1.6

1.7

3.50

3.53

mg/l

0.04

1095

5688

Serous carcinoma of ovary

338

0.56

1.81

1.6

1.8

4.58

3.89

mg/l

0.13

249

Injury of muscle and tendon at wrist and hand level

154

1885

0.81

1.80

1.6

1.7

3.32

3.71

mg/l

0.28

110

1297

Use of glatiramer acetate

323

0.54

1.80

1.3

1.7

5.11

2.83

mg/l

—

216

Osteoporosis

177

2040

0.82

1.80

2.7

1.6

6.37

3.35

mg/l

1.48

145

1468

Type of accident

369

4202

0.87

1.79

1.6

4.15

3.62

mg/l

0.51

265

2902

Use of interferon beta-1a

435

0.61

1.79

1.5

1.7

4.54

3.45

mg/l

0.27

296

Inguinal or femoral hernia, bilateral

111

869

1.28

1.79

1.8

1.7

5.54

3.20

mg/l

0.67

618

Fibrosis and cirrhosis of liver

736

0.70

1.79

2.4

1.7

5.41

3.91

mg/l

0.63

527

Implicit viral Sepsis

242

2055

1.18

1.79

2.6

1.6

7.45

3.60

mg/l

2.47

196

1433

Diabetic nephropathy

148

1183

1.24

1.79

1.7

2.0

4.97

4.64

mg/l

0.11

140

1015

Low back pain

1532

11057

1.07

1.78

1.7

1.6

4.16

3.46

mg/l

1.53

1130

7539

Bacterial, viral and other infectious agents

159

1301

1.23

1.77

1.9

1.8

3.56

4.05

mg/l

0.28

116

910

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

817

0.72

1.77

1.4

1.7

3.30

3.62

mg/l

0.11

584

Appendicitis, broad definition

1536

13174

1.07

1.77

1.7

1.6

3.33

3.54

mg/l

0.48

1119

9152

Malignant neoplasm of kidney, except renal pelvis

700

0.70

1.77

1.4

1.7

5.97

3.78

mg/l

0.59

508

Other noninflammatory disorders of vulva and perineum

171

1410

1.22

1.77

1.6

1.7

2.46

3.58

mg/l

2.51

111

964

Other necrotizing vasculopathies

664

0.69

1.77

2.9

1.6

12.96

3.83

mg/l

0.95

486

Secondary hypertension

1012

0.75

1.77

1.5

1.4

2.98

3.51

mg/l

0.29

665

Intentional self-harm by unspecified means

202

1.63

1.76

1.6

1.8

4.23

4.13

mg/l

0.03

133

Presence of cardiac and vascular implants and grafts

483

3254

1.13

1.76

6.3

1.5

5.05

3.28

mg/l

2.16

425

2309

Chronic conjunctivitis

372

1.45

1.76

1.5

1.8

4.15

4.64

mg/l

0.08

265

Diarrhoea and gastroenteritis of presumed infectious origin

1376

11688

1.07

1.76

1.8

1.6

4.55

3.26

mg/l

3.54

1053

7950

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

553

4975

1.12

1.76

2.0

1.7

4.10

3.50

mg/l

0.82

417

3482

Viral Sepsis

242

2059

1.18

1.75

2.6

1.6

7.45

3.60

mg/l

2.47

196

1436

UC patients in KELA-register (code 208), prior to 1994

531

0.65

1.75

1.3

1.7

2.47

4.45

mg/l

0.93

382

Intestinal stricture

271

3148

0.86

1.75

1.6

1.7

4.34

3.57

mg/l

0.52

193

2248

Disorders of synovium and tendon

1037

8646

1.08

1.74

1.6

3.41

3.49

mg/l

0.11

790

5868

Finngen Rheumatological endpoints

2005

12091

0.94

1.74

1.8

1.6

4.55

3.26

mg/l

4.48

1579

8169

Persons with potential health hazards related to communicable diseases

756

8190

0.91

1.73

1.6

3.46

3.55

mg/l

0.07

498

5531

Female genital prolapse

495

2546

1.13

1.73

1.6

1.7

2.37

3.55

mg/l

6.30

367

1816

Postprocedural disorders of nervous system

162

1333

1.23

1.73

1.8

1.7

3.81

4.12

mg/l

0.09

124

907

Benign neoplasms

2215

11715

1.06

1.73

1.6

3.50

3.56

mg/l

0.09

1570

8057

Insulin, fast-acting or short human

478

5341

0.89

1.73

1.7

5.04

3.45

mg/l

2.25

438

3680

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

359

0.58

1.73

1.2

1.7

5.95

3.06

mg/l

0.40

264

Otitis media, unspecified

163

1817

0.82

1.73

1.5

3.38

3.89

mg/l

0.41

125

1185

Diseases of appendix

1543

13205

1.07

1.72

1.7

1.6

3.32

3.53

mg/l

0.51

1124

9173

Non-ischemic cardiomyopathy

232

2237

0.85

1.71

4.0

1.6

6.27

3.47

mg/l

2.23

216

1608

Cervicalgia

330

2883

1.15

1.70

1.7

3.18

3.66

mg/l

0.64

248

1995

Alzheimer’s disease (Early onset)

229

0.48

1.70

1.4

1.9

3.91

2.90

mg/l

—

181

severe traumatic brain injury, does not include concussion

164

1983

0.82

1.70

1.9

1.7

3.07

3.92

mg/l

0.86

115

1412

Melanocytic naevi of upper limb, including shoulder

318

0.56

1.70

1.3

1.8

4.85

3.18

mg/l

0.25

228

Certolizumab pegol

317

0.56

1.70

1.3

1.8

4.04

3.06

mg/l

0.19

217

Other benign neoplasms of skin

516

4634

1.12

1.70

1.6

1.7

3.70

3.49

mg/l

0.16

367

3287

Guttate psoriasis

213

0.46

1.69

5.1

1.8

1.41

3.64

mg/l

—

153

Other viral hepatitis

1080

0.76

1.69

1.4

1.7

4.26

4.05

mg/l

0.08

735

Traumatic amputation of wrist and hand

454

0.63

1.68

1.6

1.82

3.60

mg/l

1.99

331

Budesonide

175

2098

0.83

1.68

1.5

3.44

3.45

mg/l

0.00

131

1438

Dorsopathies

2397

11621

1.05

1.68

1.6

3.44

3.47

mg/l

0.04

1726

7875

Radiculopathy

153

1859

0.82

1.68

1.8

1.6

2.90

3.78

mg/l

0.98

126

1311

Overexertion and strenuous or repetitive movements

172

1428

1.21

1.68

1.9

1.7

5.60

3.97

mg/l

0.68

129

988

Lumbosacral root disorders, not elsewhere classified

146

0.40

1.67

1.5

1.8

2.56

2.69

mg/l

—

112

Complications associated with artificial fertilization

327

1.47

1.67

1.2

1.8

2.71

3.55

mg/l

0.61

203

Other diseases of liver

273

2357

1.16

1.67

1.7

3.80

3.74

mg/l

0.05

229

1656

Disorders of sclera, cornea, iris and ciliary body

951

8797

1.08

1.67

1.7

1.6

3.67

3.55

mg/l

0.16

696

6151

Other necrotizing vasculopathies (FG)

597

0.68

1.67

2.1

1.7

12.90

4.06

mg/l

0.77

418

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1150

8413

1.08

1.67

1.7

1.6

3.08

3.39

mg/l

0.81

771

5866

Injuries to the hip and thigh

488

4978

0.89

1.66

1.5

1.7

4.10

3.50

mg/l

0.72

374

3459

Other abnormal findings of blood chemistry

536

0.66

1.66

1.4

1.6

4.73

4.08

mg/l

0.15

374

Crushed, pushed or stepped on by crowd or human stampede

150

1231

1.23

1.66

1.5

1.7

3.01

3.79

mg/l

0.86

820

Melanocytic naevi of upper limb, including shoulder

315

0.56

1.65

1.3

1.7

4.85

3.15

mg/l

0.25

217

Multiple delivery

130

1599

0.81

1.65

1.7

2.79

3.90

mg/l

1.63

1163

Acute appendicitis

1452

12866

1.07

1.65

1.7

1.6

3.35

3.55

mg/l

0.45

1059

8934

Chondropathies

274

2370

1.16

1.65

1.6

1.7

5.36

3.82

mg/l

0.81

197

1659

Preterm labour and delivery

442

4942

0.89

1.65

1.7

1.6

3.59

3.47

mg/l

0.12

321

3468

Hyperplasia of prostate

433

2191

1.13

1.64

1.7

4.36

3.97

mg/l

0.17

310

1571

Colon adenocarcinoma

804

0.73

1.63

1.4

1.6

3.30

3.49

mg/l

0.06

590

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

628

0.70

1.62

1.6

4.57

4.28

mg/l

0.05

441

Memory loss

706

1.30

1.61

1.4

1.7

2.95

3.88

mg/l

0.44

527

Lymphoid leukaemia

437

0.64

1.61

1.3

1.6

4.14

3.03

mg/l

0.39

330

Other maternal disorders predominantly related to pregnancy

1398

8244

1.07

1.60

1.7

1.6

3.58

3.39

mg/l

0.38

1032

5617

Colectomy operation

128

1575

0.81

1.60

1.6

1.7

4.64

3.77

mg/l

0.48

1120

Localized swelling, mass and lump of skin and subcutaneous tissue

481

4321

1.12

1.60

1.7

3.73

3.47

mg/l

0.28

345

3030

Other disorders of conjunctiva

169

1407

1.21

1.60

2.0

1.7

3.74

3.91

mg/l

0.06

119

1017

Maltreatment syndromes

969

0.76

1.60

1.7

4.87

3.86

mg/l

0.66

639

Other demyelinating diseases of the central nervous system

659

0.70

1.59

1.7

1.8

3.95

4.20

mg/l

0.07

454

Other dorsopathies, not elsewhere classified

2309

11582

1.05

1.59

1.6

3.56

3.46

mg/l

0.18

1680

7855

Barrett oesophagus

439

1.38

1.59

1.6

1.8

7.50

3.12

mg/l

0.78

319

Cholelithiasis

1490

9824

1.07

1.59

1.8

1.7

4.42

3.37

mg/l

1.90

1200

6901

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

360

0.60

1.58

1.7

1.6

1.43

2.81

mg/l

2.65

244

Symptoms and signs involving cognition, perception, emotional state and behaviour

1680

12461

0.94

1.57

1.8

1.6

3.34

3.60

mg/l

0.68

1268

8679

Spermatocele

560

1.33

1.57

1.5

1.7

3.93

4.21

mg/l

0.06

395

Noninfective enteritis and colitis

702

7645

0.91

1.57

1.6

1.7

3.77

3.50

mg/l

0.41

516

5291

Other symptoms and signs involving the digestive system and abdomen

260

2250

1.16

1.56

1.7

4.29

3.35

mg/l

0.64

191

1567

Oral lichen ruber planus wide, hypothyreosis or thyroxin

544

1.34

1.56

1.9

1.7

3.52

3.74

mg/l

0.06

392

Endometriosis of rectovaginal septum and vagina

125

1013

1.24

1.56

1.5

1.7

4.59

3.49

mg/l

0.51

691

Hair colour and hair shaft abnormalities

2.51

1.56

1.3

1.6

2.26

5.89

mg/l

—

Inguinal hernia, bilateral

107

851

1.26

1.56

1.9

1.7

4.83

3.24

mg/l

0.40

605

L02BB Anti-androgens

398

0.63

1.56

1.6

1.7

3.23

3.52

mg/l

0.09

285

Type 1 diabetes, strict definition, subgroup 2

0.00

1.56

0.0

1.7

—

3.39

—

Other disorders of patella

366

3244

1.13

1.56

1.6

1.7

4.25

3.31

mg/l

0.95

286

2192

Myopia

264

2290

1.16

1.56

1.5

1.6

4.31

3.81

mg/l

0.25

189

1549

Inflammatory disease of uterus

305

2673

1.15

1.56

1.6

2.95

3.54

mg/l

0.97

235

1826

Pneumonia due to Haemophilus influenzae

0.00

1.56

0.0

1.3

—

2.28

—

Disorders of optic nerve and visual pathways

110

1368

0.80

1.55

1.7

1.6

5.84

3.89

mg/l

0.53

953

Opioids

2333

11659

1.05

1.55

1.7

1.6

4.14

3.12

mg/l

3.05

1833

7727

Foreign body or object entering through skin

919

0.75

1.54

1.5

1.7

2.31

4.44

mg/l

1.91

640

Nephropathy related operations

156

1296

1.21

1.53

2.2

1.7

11.17

3.71

mg/l

3.72

143

914

Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)

0.00

1.53

0.0

1.7

—

4.63

—

Achilles tendinitis

169

1416

1.20

1.52

1.7

3.09

4.01

mg/l

0.80

139

1001

Vitamin deficiency

538

1.33

1.52

1.6

3.23

2.84

mg/l

0.23

370

Vitamin deficiency, wide

538

1.33

1.52

1.6

3.23

2.84

mg/l

0.23

370

Other disorders of binocular movement

380

0.62

1.51

1.8

1.6

1.97

3.07

mg/l

0.72

260

Thyroiditis

124

1009

1.24

1.51

1.9

1.7

3.40

3.73

mg/l

0.18

701

Venous thromboembolism

596

6343

0.91

1.51

1.9

1.7

4.51

3.48

mg/l

1.30

471

4496

Disorders of ocular muscles, binocular movement, accommodation and refraction

914

8413

1.08

1.51

1.7

1.6

3.93

3.45

mg/l

0.61

651

5746

Endovascular or surgical operations to intracerebral aneurysms

734

0.73

1.51

1.4

1.7

5.92

3.70

mg/l

0.38

521

Other arthritis (FG)

431

4798

0.90

1.49

2.0

1.6

5.26

3.23

mg/l

2.23

337

3246

Cholangitis (primary sclerosing, PSC)

606

0.70

1.49

1.4

1.7

2.97

3.15

mg/l

0.09

420

Soft tissue disorders related to use, overuse and pressure

405

3621

1.12

1.49

1.9

1.7

4.10

3.53

mg/l

0.40

316

2480

Cardiovascular diseases (excluding rheumatic etc)

1800

9848

1.06

1.48

2.3

1.4

4.37

3.13

mg/l

2.63

1396

6419

Heart failure and bmi 25plus

272

2151

0.87

1.48

3.5

1.7

6.79

3.94

mg/l

2.25

253

1666

Benign neoplasm of breast

193

1642

1.18

1.47

1.5

1.7

2.80

3.67

mg/l

0.86

124

1171

External causes of morbidity and mortality

1669

7902

1.06

1.47

1.7

1.6

4.06

3.26

mg/l

1.25

1207

5225

Malignant neoplasm of cervix uteri

227

0.52

1.47

1.7

1.8

1.57

2.42

mg/l

—

156

Lactose intolerance

438

1.36

1.47

1.5

1.6

3.21

3.27

mg/l

0.03

295

Aortic valve malfunction, age under 60 years

1236

0.80

1.46

2.3

1.7

3.51

4.34

mg/l

0.58

884

Any operation in hilmo

135

561

1.23

1.46

2.0

1.3

3.72

2.44

mg/l

1.10

313

Pneumococcal septicemia

353

0.62

1.46

1.1

1.8

4.53

3.01

mg/l

0.43

257

Gout, FINNGEN

195

2285

0.85

1.46

2.1

1.7

5.87

3.79

mg/l

1.47

171

1639

DVT of lower extremities and pulmonary embolism

407

4524

0.89

1.46

1.9

1.7

4.74

3.59

mg/l

1.25

329

3215

Eustachian salpingitis and obstruction

169

1425

1.20

1.45

1.6

1.7

3.45

3.91

mg/l

0.32

126

968

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

506

0.68

1.45

1.6

1.7

4.36

3.73

mg/l

0.14

337

Phlebitis and thrombophlebitis (not including DVT)

250

2871

0.87

1.45

1.9

1.7

3.41

3.72

mg/l

0.30

200

2019

Opening and dilatation of root channel of tooth

123

1006

1.23

1.45

1.8

1.7

4.84

4.31

mg/l

0.18

107

692

Striae atrophicae

181

1.59

1.44

1.8

1.7

2.40

2.96

mg/l

0.32

129

Malaise and fatigue

763

5867

1.09

1.44

1.8

1.6

3.80

3.31

mg/l

0.71

570

4006

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

507

0.68

1.44

1.5

1.7

3.61

4.10

mg/l

0.14

376

Other specified and unspecified disorders of eye and adnexa

448

1.35

1.43

2.1

1.7

2.35

4.16

mg/l

0.72

316

Complications of labour and delivery

1426

7491

1.06

1.43

1.6

3.09

3.49

mg/l

1.50

976

5199

Nonischemic cardiomyopathy

614

1.30

1.42

4.7

1.7

8.61

4.31

mg/l

1.17

445

Other CVD (FINNGEN)

105

1024

0.80

1.42

2.4

1.4

3.36

3.72

mg/l

0.17

675

Emotional disorders starting during childhood or adolescence

115

929

1.24

1.42

1.4

1.5

5.01

3.69

mg/l

0.96

603

Primary coxarthrosis, bilateral

205

2385

0.86

1.41

1.9

1.7

4.17

3.57

mg/l

0.31

158

1707

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

642

5897

1.09

1.41

1.6

4.43

3.52

mg/l

2.09

522

3968

Generalized epilepsy, strict definition

385

0.64

1.41

1.2

1.8

3.37

3.50

mg/l

0.06

254

Thrombocytopenia, unspecified

748

0.74

1.41

1.9

1.7

10.99

3.74

mg/l

0.89

520

Type 1 diabetes, wide definition, subgroup 2

138

0.43

1.41

2.7

1.7

1.44

3.03

mg/l

—

Sub-endpoint used in defining T1D endpoints

399

4369

0.90

1.41

1.6

1.7

3.96

3.61

mg/l

0.35

369

2980

Granulomatous disorders of skin and subcutaneous tissue

373

1.39

1.41

1.4

1.7

1.85

4.36

mg/l

0.94

262

Cardiomyopathy in other diseases

2.47

1.40

3.7

1.4

2.66

3.06

mg/l

—

Other and unspecified trigeminal disorders

198

1.54

1.40

2.4

1.9

2.81

2.55

mg/l

0.13

140

Diseases of the digestive system

505

5542

0.91

1.40

1.6

1.7

4.84

3.46

mg/l

0.68

387

3893

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

275

0.58

1.40

1.3

1.7

5.09

3.19

mg/l

—

200

Oedema, not elsewhere classified

434

3891

1.11

1.40

1.9

1.6

4.23

3.30

mg/l

1.26

348

2677

Other external causes of accidental injury

1975

9407

1.05

1.39

1.7

1.6

3.90

3.36

mg/l

0.86

1427

6339

Disorders of choroid and retina

1064

8276

0.93

1.39

1.7

3.43

3.59

mg/l

0.23

824

5858

Other assisted single delivery

394

0.65

1.39

1.1

1.9

3.85

4.27

mg/l

0.12

285

Left ventricular outflow tract obstruction (LVOTO), broad definition

110

1348

0.81

1.39

2.2

1.7

3.50

4.25

mg/l

0.56

957

Thyrotoxicosis, other and/or unspecified

325

2885

1.13

1.38

2.4

1.6

3.98

3.60

mg/l

0.28

256

1988

Diseases of middle ear and mastoid

1250

9635

1.06

1.38

1.6

3.84

3.44

mg/l

0.68

855

6488

Oher contracture of tendon (sheath)

2.22

1.37

1.2

1.9

2.11

4.57

mg/l

—

Dialysis, with operation codes

162

1367

1.19

1.37

2.3

1.7

11.90

3.44

mg/l

4.44

151

957

Benign neoplasm: Colon, unspecified

197

2280

0.86

1.37

1.6

1.7

3.62

3.79

mg/l

0.08

159

1607

Benign neoplasms

1928

10380

1.05

1.36

1.6

3.55

3.52

mg/l

0.04

1366

7050

Metatarsalgia

162

1369

1.19

1.36

2.0

1.7

3.49

3.80

mg/l

0.17

122

930

Other aneurysm

431

0.67

1.36

1.6

1.8

5.67

4.34

mg/l

0.12

315

Viral infections characterized by skin and mucous membrane lesions

697

6429

1.09

1.36

1.9

1.6

4.57

3.51

mg/l

1.16

522

4442

Pain associated with micturition

168

1425

1.19

1.35

1.6

1.7

3.23

3.76

mg/l

0.41

125

1001

Malignant neoplasm of mesothelium and soft tissue

358

0.64

1.35

1.9

1.7

5.97

2.87

mg/l

0.55

268

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

923

0.78

1.35

1.3

1.8

3.92

3.96

mg/l

0.01

650

Oral lichen ruber planus, hypothyreosis or thyroxin

184

1.55

1.34

2.3

1.9

2.32

5.35

mg/l

0.52

140

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

855

0.77

1.34

1.5

1.7

4.48

3.48

mg/l

0.36

622

Fracture of lower leg, including ankle

802

8592

0.93

1.33

1.6

1.7

3.26

3.46

mg/l

0.41

593

5966

Artificial joint operation, meniscal resection

1484

9341

1.06

1.33

1.6

1.7

3.35

3.62

mg/l

0.51

1130

6623

Malignant neoplasm of head and neck

684

0.74

1.33

1.3

1.8

3.90

3.43

mg/l

0.15

496

Diabetic neuropathy

749

1.25

1.33

1.4

2.1

3.10

4.51

mg/l

1.93

655

Deep endometriosis

170

1447

1.18

1.33

1.6

1.7

4.40

3.53

mg/l

0.46

122

993

Right hemicolectomy

440

0.68

1.32

2.0

1.7

6.55

4.35

mg/l

0.50

339

Hypothyroidism, drug reimbursement

356

2274

1.12

1.32

1.9

1.3

3.90

2.65

mg/l

3.16

290

1364

Cardiodefibrillation

339

3020

1.12

1.32

3.4

1.6

5.00

3.86

mg/l

0.79

275

2198

Ankylosing spondylitis, strict definition

738

0.75

1.32

2.3

1.8

6.99

3.74

mg/l

0.53

509

Atrial fibrillation and flutter with reimbursement

388

2767

0.90

1.32

3.2

1.4

5.09

3.25

mg/l

2.05

324

1846

Unspecified acute lower respiratory infection

171

2002

0.85

1.31

1.6

1.7

8.16

4.03

mg/l

1.51

125

1389

Other retinal disorders

703

6106

0.92

1.31

1.6

1.7

3.40

3.60

mg/l

0.27

567

4283

Injury of muscle and tendon at hip and thigh level

148

1246

1.20

1.31

1.4

1.8

3.76

4.31

mg/l

0.20

100

877

Short Achilles tendon (acquired)

378

0.65

1.31

2.0

1.7

6.47

5.13

mg/l

0.16

254

Artificial joint re-operation

543

0.71

1.30

1.7

3.17

4.02

mg/l

0.32

413

Ankylosing spondylitis, ICD10

111

1347

0.82

1.29

2.0

1.7

5.14

4.13

mg/l

0.26

937

Drug-induced osteoporosis with pathological fracture

134

0.44

1.29

3.8

1.9

4.15

2.06

mg/l

—

103

Other and unspecified injuries of shoulder and upper arm

389

0.66

1.29

1.4

1.8

2.46

3.71

mg/l

0.71

272

Crystal arthropathies, rheuma endpoint

133

0.45

1.29

5.0

1.5

2.29

2.41

mg/l

—

102

Biological medicines for asthma

211

1.50

1.29

1.5

1.8

3.84

3.68

mg/l

0.05

149

Malignant neoplasm of corpus uteri

634

0.74

1.28

1.4

1.7

3.50

3.70

mg/l

0.07

476

Viral hepatitis

1202

0.81

1.28

1.5

1.7

4.39

3.86

mg/l

0.24

831

Fracture of neck

564

0.72

1.27

1.5

1.7

3.49

3.31

mg/l

0.07

407

Polyarthritis, unspecified

481

0.70

1.26

1.7

2.93

4.23

mg/l

0.41

332

Benign leiomyoma with endometriosis

221

1928

1.15

1.26

1.4

1.7

3.31

3.43

mg/l

0.06

148

1390

Fitting and adjustment of other devices

294

3075

0.89

1.25

1.6

1.5

3.55

3.50

mg/l

0.03

223

2174

Asthma, hospital admission 2, infections

1000

9232

1.07

1.25

1.8

1.6

5.75

3.23

mg/l

6.43

783

6317

Asthma-related infections

1000

9232

1.07

1.25

1.8

1.6

5.75

3.23

mg/l

6.43

783

6317

Paralytic ileus and intestinal obstruction

231

2634

0.87

1.25

1.6

3.80

3.46

mg/l

0.19

155

1859

Pre-eclampsia or poor fetal growth

630

6795

0.92

1.25

1.6

3.61

3.37

mg/l

0.43

454

4628

Intracranial trauma

1104

8760

0.94

1.24

1.8

1.6

3.40

3.25

mg/l

0.24

810

5734

Benign leiomyoma with endometriosis

221

1930

1.15

1.24

1.4

1.7

3.31

3.28

mg/l

0.02

148

1373

Unspecified mental disorder

699

7529

0.93

1.24

1.6

1.7

4.12

3.48

mg/l

1.52

572

5136

Other diseases of stomach and duodenum

627

1.27

1.24

1.6

1.7

3.89

3.02

mg/l

0.44

445

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

118

1046

0.83

1.24

2.1

1.5

25.74

2.47

mg/l

6.65

102

671

Use of levodopa decarboxylase inhibitor

800

0.77

1.23

1.5

1.6

2.24

3.68

mg/l

1.06

592

Other encephalitis

349

0.65

1.23

1.2

1.8

3.41

3.08

mg/l

0.10

244

Glaucoma

550

5254

0.92

1.23

1.7

3.83

3.54

mg/l

0.23

410

3767

Gingivitis and periodontal diseases

1759

9531

0.95

1.23

1.8

1.6

4.57

3.07

mg/l

3.08

1277

6476

Dental caries 3 and operation codes, only avohilmo

582

3181

0.92

1.23

1.7

1.6

4.73

3.65

mg/l

0.50

402

2142

Complications of internal orthopaedic prosthetic devices, implants and grafts

172

2000

0.86

1.22

1.4

1.6

3.28

3.40

mg/l

0.06

135

1426

Personal history of certain other diseases

371

0.66

1.22

1.5

4.96

3.37

mg/l

0.50

246

Benign neoplasm: Conjunctiva

357

1.36

1.22

1.7

7.60

4.61

mg/l

0.27

268

Benign neoplasm: Stomach

112

926

1.22

1.9

1.7

8.34

3.58

mg/l

1.24

678

Sequelae of other and unspecified infectious and parasitic diseases

105

864

1.23

1.21

1.6

1.7

4.16

4.23

mg/l

0.01

610

Other diseases of blood and blood-forming organs

740

0.77

1.21

1.9

1.7

4.08

3.87

mg/l

0.06

526

Medicines for HER+ breast cancer

515

4601

1.09

1.21

1.7

2.46

3.28

mg/l

2.68

407

3296

Cervicocranial syndrome

175

1507

1.17

1.20

2.1

1.7

2.19

3.98

mg/l

2.92

119

1053

Polycystic ovarian syndrome, consortium definition

1614

9265

1.05

1.20

1.7

1.6

3.99

3.28

mg/l

1.19

1211

6333

Glaucoma-related operations

383

0.67

1.20

1.2

1.7

2.48

4.65

mg/l

0.68

292

Haematosalpinx/Haematoma of broad ligament

0.00

1.19

0.0

2.8

—

2.18

—

Speech disturbances, not elsewhere classified

817

0.78

1.19

2.4

1.7

3.84

3.61

mg/l

0.07

587

Other juvenile arthritis

736

0.77

1.18

1.5

1.6

4.11

4.52

mg/l

0.13

480

Exposure to controlled fire, not in building or structure

0.00

1.18

0.0

1.7

—

2.82

—

Adrenomedullary hyperfunction

0.00

1.18

0.0

2.2

—

1.75

—

Pseudopolyposis of colon

0.00

1.18

0.0

1.8

—

4.60

—

Otalgia

126

1058

1.20

1.18

1.9

1.7

3.20

3.54

mg/l

0.21

742

Congenital malformations of the urinary system

770

0.77

1.18

1.8

1.7

3.00

3.93

mg/l

0.42

531

Macular pucker

127

1066

1.20

1.18

1.6

1.7

3.39

3.65

mg/l

0.09

775

Left side

0.00

1.17

0.0

1.7

—

4.49

—

Corneal pigmentations and deposits

0.00

1.17

0.0

1.6

—

2.55

—

Sudden idiopathic hearing loss

126

1058

1.20

1.17

1.6

1.7

3.33

3.67

mg/l

0.18

749

Other crystal arthropathies

129

0.46

1.17

5.0

1.7

2.28

2.73

mg/l

—

101

Perforation of tympanic membrane

106

1277

0.83

1.17

1.8

1.7

5.04

3.98

mg/l

0.32

881

Lactose intolerance, other/unspecified

386

1.34

1.17

1.6

1.7

3.35

2.96

mg/l

0.20

268

Other and unspecified effects of external causes

528

4859

1.09

1.17

1.6

1.7

4.42

3.57

mg/l

1.08

388

3318

Unknown and unspecified causes of morbidity

1013

0.80

1.16

1.6

4.92

3.97

mg/l

0.18

676

Vascular dementia (multiple infarctions)

0.00

1.16

0.0

1.6

—

2.52

—

Fracture of lumbar spine and pelvis

171

1976

0.86

1.16

1.4

1.7

4.60

3.70

mg/l

0.53

123

1407

Persons encountering health services in other circumstances

691

6423

1.08

1.16

1.6

3.89

3.24

mg/l

1.55

526

4289

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

430

1.31

1.16

1.8

1.7

2.40

4.22

mg/l

0.73

311

Osteoporosis with pathological fracture (FG)

485

0.72

1.16

4.0

1.7

2.78

3.94

mg/l

0.43

357

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

645

0.76

1.15

1.5

1.7

2.67

3.82

mg/l

0.50

475

Disorders of psychological development

244

2000

1.14

1.15

1.6

1.5

4.65

3.67

mg/l

0.71

190

1280

Other symptoms and signs involving the nervous and musculoskeletal systems

604

6518

0.92

1.15

1.6

1.7

3.56

3.52

mg/l

0.03

432

4551

Dysphagia

304

2725

1.12

1.14

1.7

5.08

3.35

mg/l

0.92

213

1898

Heartburn

159

1366

1.17

1.14

1.7

1.6

3.53

3.75

mg/l

0.13

117

933

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

922

0.80

1.14

2.1

1.7

4.16

3.79

mg/l

0.11

658

Other vitreous opacities

401

0.69

1.13

1.9

1.7

3.81

4.31

mg/l

0.11

301

Labour and delivery complicated by umbilical cord complications

919

0.80

1.13

1.3

1.7

3.51

4.08

mg/l

0.28

644

Diseases of oral cavity, salivary glands and jaws

1777

9540

0.95

1.12

1.7

1.6

4.50

3.08

mg/l

2.86

1275

6483

Malignant neoplasm of endocrine gland

909

0.80

1.12

2.2

1.7

3.45

3.97

mg/l

0.20

644

Postpartum hemorraghe, parous women as controls

616

5003

1.08

1.12

1.6

3.36

3.26

mg/l

0.14

411

3405

Intestinal malabsorption

595

0.75

1.12

1.8

1.7

2.58

3.61

mg/l

0.81

421

Rare circulating lymphoid malignancy

257

0.62

1.12

1.3

1.6

5.09

3.13

mg/l

—

187

Other disorders of eye and adnexa

229

2024

1.14

1.11

2.1

1.7

3.52

3.74

mg/l

0.12

168

1427

Car occupant injured in other and unspecified transport accidents

356

3227

1.11

1.6

1.7

3.94

3.74

mg/l

0.19

267

2195

Gout, idiopatic and unspecified

161

1864

0.86

1.11

2.1

1.7

6.17

3.89

mg/l

1.32

143

1333

Use of teriflunomide

193

0.56

1.10

1.3

1.9

1.97

2.60

mg/l

—

137

Hypermobility syndrome

124

1049

1.19

1.10

1.8

1.7

3.18

3.94

mg/l

0.53

704

Wegener granulomatosis

181

0.54

1.10

4.3

1.9

5.28

2.98

mg/l

—

130

347

1.35

1.10

1.3

1.7

3.34

4.00

mg/l

0.38

216

Accidents

1961

9407

1.05

1.10

1.7

1.6

3.99

3.36

mg/l

1.08

1417

6339

Other endocrine disorders

679

0.77

1.10

1.7

1.6

3.28

4.32

mg/l

0.41

463

Symptoms and signs involving the nervous and musculoskeletal systems

820

8733

0.94

1.09

1.5

1.7

3.61

3.49

mg/l

0.15

599

6122

Encephalitis

374

0.69

1.09

1.2

1.7

3.05

3.16

mg/l

0.03

264

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

550

5088

1.08

1.09

1.6

1.7

4.39

3.54

mg/l

0.38

405

3456

Inguinal hernia

858

6162

0.94

1.09

1.6

1.7

3.75

3.43

mg/l

0.29

564

4297

Varicella [chickenpox]

694

1.24

1.09

2.2

1.9

2.99

4.06

mg/l

0.72

477

Prolonged pregnancy

353

3543

0.90

1.08

1.5

1.6

2.77

3.70

mg/l

2.17

222

2366

Alzheimer’s disease (Late onset), excluding more controls

480

0.78

1.08

1.8

1.5

1.27

3.30

mg/l

2.86

356

Care involving dialysis

821

1.21

1.08

1.9

1.6

6.28

4.02

mg/l

0.76

582

Thyrotoxicosis

397

3624

1.10

1.07

2.2

1.7

4.05

3.49

mg/l

0.57

313

2546

Malignant neoplasm of thyroid gland

859

0.80

1.07

2.2

1.7

3.69

3.92

mg/l

0.08

611

Acute pancreatitis (for exclusion)

195

2220

0.88

1.07

1.5

1.7

5.58

3.87

mg/l

0.94

170

1581

Acute gastritis

793

0.79

1.07

2.3

1.7

4.08

3.20

mg/l

0.42

566

Other and unspecified tonsillitis

825

6571

1.07

1.7

1.6

4.40

3.47

mg/l

1.47

592

4273

SLE, ICD10

476

0.73

1.07

1.5

1.7

7.86

4.28

mg/l

0.47

335

SLE, strict definition

476

0.73

1.07

1.5

1.7

7.86

4.28

mg/l

0.47

335

Acute renal failure

146

1696

0.86

1.06

2.7

1.7

11.50

3.54

mg/l

4.28

133

1213

Premature separation of placenta [abruptio placentae]

452

0.72

1.06

1.2

1.8

3.96

4.83

mg/l

0.20

307

Sequelae of injuries of lower limb

155

1339

1.16

1.06

1.7

3.15

4.01

mg/l

0.53

127

929

Postprocedural musculoskeletal disorders, not elsewhere classified

691

0.78

1.06

1.6

1.7

6.08

3.92

mg/l

0.45

502

Tic and related disorders

187

1.47

1.06

1.4

1.8

4.12

3.28

mg/l

0.33

117

Congenital malformations and deformations of the musculoskeletal system

172

1491

1.15

1.05

1.7

1.6

3.70

4.23

mg/l

0.38

123

988

Benign neoplasm of breast

193

1695

1.14

1.05

1.5

1.7

2.80

3.57

mg/l

0.75

124

1196

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

889

0.80

1.05

2.2

1.7

3.62

3.81

mg/l

0.07

618

Complications of other internal prosthetic devices, implants and grafts

371

0.70

1.05

1.3

1.6

4.18

4.26

mg/l

0.01

269

Mental and behavioural disorders due to cannabinoids

553

0.75

1.04

1.5

1.8

2.23

3.81

mg/l

1.17

351

Iron deficiency anaemia secondary to blood loss (chronic)

138

1606

0.86

1.04

1.6

5.85

3.44

mg/l

0.81

111

1154

Acute appendicitis, no complications

1161

10995

1.06

1.04

1.7

1.6

3.35

3.54

mg/l

0.36

844

7594

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

1041

0.82

1.04

1.5

1.7

4.74

4.32

mg/l

0.16

712

Benign neoplasm: Pituitary gland, craniopharyngeal duct

721

0.78

1.03

1.8

1.7

3.30

4.41

mg/l

0.48

494

Deposits [accretions] on teeth

112

912

1.19

1.03

2.0

1.6

6.78

3.24

mg/l

1.18

633

Injuries to the ankle and foot

1479

12870

1.05

1.03

1.7

1.6

4.23

3.41

mg/l

2.22

1122

8750

Rubella [German measles]

430

1.29

1.03

1.5

1.7

2.89

4.80

mg/l

0.83

314

L04AA Selective immunosuppressants

294

3255

0.90

1.02

3.8

1.6

12.76

3.37

mg/l

7.17

252

2262

Benign neoplasm of brain and other parts of central nervous system

787

0.80

1.02

1.6

1.7

5.11

3.93

mg/l

0.24

532

Nontoxic goitre/thyroid nodule

392

3587

1.10

1.02

1.5

1.7

3.01

3.32

mg/l

0.42

298

2559

Peripheral retinal degeneration

380

0.70

1.02

1.9

1.8

2.49

4.50

mg/l

0.56

272

Primary open-angle glaucoma

201

2217

0.88

1.02

1.5

1.6

5.01

3.62

mg/l

0.54

148

1607

Gastroduodenal ulcer

200

2258

0.88

1.01

1.8

1.7

5.37

3.27

mg/l

1.24

165

1602

Carpal tunnel syndrome

933

8912

0.94

1.01

1.7

3.94

3.36

mg/l

1.06

725

6301

COPD-related respiratory insufficiency

820

0.80

1.01

2.1

1.7

19.07

3.62

mg/l

3.72

589

Explicit bacterial Sepsis

1082

0.83

1.01

1.6

9.36

3.74

mg/l

1.11

748

Other and unspecified disorders of white blood cells

437

0.73

1.01

1.4

1.7

4.52

3.04

mg/l

0.87

320

Sciatica+with lumbago

824

8305

0.94

1.01

1.5

1.7

3.80

3.46

mg/l

0.55

631

5777

Sequelae of infectious and parasitic diseases

116

984

1.19

1.01

1.6

1.7

5.86

3.98

mg/l

0.35

698

Cardiac arrest

630

0.79

1.00

4.7

1.4

7.98

3.61

mg/l

1.22

413

Olecranon bursitis

628

1.23

1.00

2.3

1.9

2.26

5.13

mg/l

1.83

434

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1752

12410

0.96

1.00

2.9

1.5

5.66

3.27

mg/l

8.10

1373

8584

Benign neoplasm of ovary

247

2211

1.12

1.00

1.5

1.6

3.57

3.31

mg/l

0.16

172

1576

Hypothalamic dysfunction, including iatrogenic, not elsewhere classified

0.00

1.00

0.0

2.1

—

2.51

—

Hirsutism in women

389

1.31

0.99

1.5

1.7

4.25

3.03

mg/l

0.94

257

Obstructed labour due to malposition and malpresentation of fetus

493

5013

0.92

0.99

1.6

3.37

3.58

mg/l

0.29

335

3457

Tic disorders

173

1.47

0.99

1.4

1.8

3.04

2.88

mg/l

0.06

108

Bitten or struck by other mammals

206

1826

1.13

0.99

1.9

1.7

3.11

4.09

mg/l

1.22

145

1255

Macular cyst

181

1.45

0.99

1.2

1.6

2.50

3.22

mg/l

0.18

141

Drug-induced dystonia

2.01

0.99

1.6

2.1

3.96

1.85

mg/l

—

Use of riluzole

0.00

0.99

0.0

1.6

—

2.53

—

ILD, hospital admissions 3, with pneumonia sepsis

617

0.77

0.99

2.1

1.7

33.25

3.31

mg/l

4.29

452

Systemic lupus erythematosus

503

0.75

0.98

1.5

1.7

7.39

4.21

mg/l

0.44

354

Rheumatoid lung disease

0.00

0.98

0.0

2.2

—

2.53

—

Other disorders of urethra and urinary system

1279

9131

1.05

0.98

1.6

3.82

3.47

mg/l

0.62

941

6335

Varicose veins of other sites

803

1.20

0.98

1.8

4.32

4.39

mg/l

0.02

564

Gout, unspecified

127

1479

0.86

0.98

2.3

1.7

6.51

3.99

mg/l

1.16

115

1067

ILD medications: pirfenidone

1.77

0.98

2.8

1.4

73.50

2.82

mg/l

2.75

Benign neoplasm of middle ear and respiratory system

100

840

1.20

0.97

1.7

2.83

4.14

mg/l

0.75

591

Tuberculosis, IBD comorbidity

526

0.76

0.97

2.3

1.7

13.92

2.57

mg/l

1.00

395

Hypoparathyroidism

365

0.71

0.97

1.5

1.7

4.98

3.94

mg/l

0.19

266

Tuberculosis, wide

537

0.76

0.97

2.2

1.7

13.92

2.86

mg/l

0.96

407

Valvular operations

104

1229

0.84

0.96

2.0

1.5

3.78

4.16

mg/l

0.19

871

Schizotypal disorder

421

0.73

0.96

1.6

1.9

3.81

3.80

mg/l

0.00

290

Other specified/unspecified disorders of bone/cartilage

346

1.31

0.96

1.6

1.8

6.21

3.12

mg/l

0.51

249

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

162

1418

1.15

0.96

1.8

1.6

3.07

3.45

mg/l

0.28

118

941

Other symptoms and signs involving cognitive functions and awareness

535

4663

1.08

0.96

1.7

1.6

2.98

3.63

mg/l

1.28

406

3275

Other articular cartilage disorders

317

0.69

0.96

1.6

1.7

2.20

5.31

mg/l

0.91

220

Atopic conjunctivitis

678

1.22

0.96

1.4

1.7

3.47

4.47

mg/l

0.48

472

Caries in Clefts patients

172

0.57

0.96

1.4

1.7

2.84

2.52

mg/l

—

113

Other and unspecified glaucoma

456

0.74

0.95

1.5

1.7

2.32

4.14

mg/l

0.74

348

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

2.31

0.95

1.3

1.6

2.05

1.44

mg/l

—

Other fall from one level to another

298

3280

0.91

0.95

1.6

3.42

3.82

mg/l

0.41

206

2238

Gonarthrosis, primary, with knee surgery

558

4893

0.93

0.95

1.7

3.85

3.49

mg/l

0.35

457

3495

Other benign neoplasms of skin

516

4703

1.08

0.94

1.6

1.7

3.70

3.58

mg/l

0.08

367

3282

Gonarthrosis

1147

6254

1.05

0.94

1.7

3.96

3.38

mg/l

0.90

918

4400

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

778

0.80

0.94

1.3

1.7

2.67

4.30

mg/l

1.11

539

Cholelithiasis, broad definition with cholecystitis

1526

10014

1.05

0.94

1.8

1.7

4.48

3.38

mg/l

2.09

1229

7027

Hypertrophic scar

835

1.19

0.94

1.4

1.6

4.06

4.33

mg/l

0.07

571

Complications of genitourinary prosthetic devices, implants and grafts

304

0.68

0.94

1.5

1.7

3.46

2.99

mg/l

0.15

215

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

631

5843

1.07

0.94

1.6

3.75

3.48

mg/l

0.37

480

3928

SLE (Finngen)

499

0.75

0.94

1.5

1.7

7.39

3.89

mg/l

0.50

359

Vocal cord dysfunction

256

2141

1.11

0.94

1.8

1.4

3.26

2.84

mg/l

0.43

185

1336

Other complications of surgical and medical care, not elsewhere classified

149

1298

1.15

0.94

1.6

3.39

3.72

mg/l

0.21

113

908

Other specified/unspecified arthritis

375

4083

0.92

0.94

2.0

1.6

5.72

3.30

mg/l

2.40

295

2765

Moderate visual impairment, binocular

200

1.41

0.94

2.0

1.7

7.62

2.45

mg/l

0.98

147

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

710

4938

0.94

1.7

2.48

3.28

mg/l

3.11

544

3528

Iridocyclitis in diseases classified elsewhere

209

1.41

0.94

3.8

1.9

2.43

3.83

mg/l

0.77

147

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

710

4938

0.94

1.7

2.48

3.28

mg/l

3.11

544

3528

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

217

2348

0.89

0.93

1.6

1.7

4.51

3.88

mg/l

0.27

145

1598

Acute pancreatitis

195

2195

0.89

0.93

1.5

1.7

5.58

3.63

mg/l

1.18

170

1564

Effects of other external causes

464

0.75

0.93

1.4

1.7

2.57

3.42

mg/l

0.56

311

Inflammatory diseases of the central nervous system

1104

0.84

0.93

1.7

5.00

4.06

mg/l

0.21

777

Coxarthrosis, primary

583

5417

0.93

1.7

3.67

3.51

mg/l

0.14

461

3896

Cluster headache, strict

563

1.24

0.93

1.8

2.19

3.92

mg/l

1.84

366

Other disorders of binocular vision

219

0.63

0.92

1.6

1.7

2.83

3.32

mg/l

—

139

Other abnormal products of conception

882

5559

1.06

0.92

1.7

1.6

2.93

3.53

mg/l

2.05

573

3791

Pedal cyclist injured in other and unspecified transport accidents

138

1585

0.87

0.91

1.5

1.7

4.78

4.07

mg/l

0.18

1108

Dizziness and giddiness

1147

9765

0.95

0.91

1.8

1.6

3.38

3.58

mg/l

0.35

873

6841

Arthropathy in ulcerative colitis

206

0.62

0.91

4.3

1.8

2.51

2.74

mg/l

0.09

149

Faecal incontinence

109

930

1.18

0.90

1.3

1.6

2.23

3.56

mg/l

1.24

664

Other and unspecified iron deficiency

424

3917

1.08

0.90

1.9

1.6

4.70

3.40

mg/l

1.45

316

2755

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

181

1604

1.14

0.90

1.8

1.6

2.92

3.37

mg/l

0.41

135

1081

Supervision of normal pregnancy

615

3288

1.07

0.90

1.5

1.6

3.56

3.90

mg/l

0.37

399

2314

Cardiomyopathy, Hypertrophic obstructive

185

1.42

0.90

5.5

1.4

7.88

3.08

mg/l

1.36

133

Unspecified chronic bronchitis

313

0.70

0.90

2.8

1.8

6.25

3.11

mg/l

0.64

233

Convergence insufficiency and excess

253

0.66

0.90

1.7

2.30

2.73

mg/l

0.18

171

Calculus of kidney and ureter

376

3460

1.09

0.89

1.6

1.7

4.34

3.85

mg/l

0.31

277

2447

Benign neoplasm: Conjunctiva

377

1.28

0.89

1.7

7.60

4.52

mg/l

0.28

270

Venous complications and haemorrhoids in pregnancy

380

0.73

0.89

1.4

1.7

2.13

3.40

mg/l

1.01

240

Other embolism and thrombosis

124

1432

0.86

0.89

2.0

1.8

4.88

4.05

mg/l

0.27

1009

Benign neoplasm of middle ear and respiratory system

100

849

1.18

0.89

1.8

2.83

4.44

mg/l

0.96

586

Acute generalized exanthematous pustulosis

539

1.23

0.88

2.7

1.6

4.49

3.31

mg/l

0.67

384

Spondyloarthritis

239

2647

0.90

0.88

1.8

1.7

5.19

3.66

mg/l

0.73

183

1824

Other specified and unspecified disorders of eyelid

136

1.49

0.88

1.4

2.2

3.29

3.10

mg/l

0.07

101

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

549

1.23

0.88

1.4

1.8

3.01

3.34

mg/l

0.17

376

Use of anticholinesterases

122

1143

0.86

0.88

1.5

1.6

2.00

3.55

mg/l

1.41

854

N06DA Anticholinesterases

122

1143

0.86

0.88

1.5

1.6

2.00

3.55

mg/l

1.41

854

Other abnormal immunological findings in serum

264

1.34

0.87

1.3

1.8

9.09

3.15

mg/l

0.62

180

Carcinoma in situ of other and unspecified genital organs

228

0.65

0.87

1.3

1.8

3.32

4.70

mg/l

—

163

Chronic lower respiratory diseases

2589

13562

1.03

0.87

1.7

1.6

4.94

3.20

mg/l

6.53

1907

9285

Benign neoplasm of brain and other parts of central nervous system

770

0.81

0.87

1.6

1.7

5.11

3.73

mg/l

0.29

534

Other infectious diseases

836

0.82

0.87

2.0

1.7

12.09

3.62

mg/l

1.36

594

Toxic effects of substances chiefly nonmedicinal as to source

150

1705

0.88

0.87

1.6

1.7

4.62

3.93

mg/l

0.28

111

1176

Other and unspecified mononeuropathies, also in other diseases

317

1.30

0.86

1.5

1.8

2.40

4.62

mg/l

0.64

239

Haemorrhagic and haematological disorders of fetus and newborn

146

1.45

0.86

1.2

1.4

3.53

4.64

mg/l

0.21

ILD medications

2453

13034

1.03

0.86

2.6

1.4

5.23

3.05

mg/l

11.06

1957

8741

Disturbances of smell and taste

523

1.23

0.86

1.5

1.7

2.44

3.92

mg/l

0.64

366

Ocular pain

135

1178

1.15

0.86

2.4

1.7

3.86

4.08

mg/l

0.07

100

822

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

659

4786

0.94

0.86

1.6

1.7

2.86

3.56

mg/l

1.24

465

3403

Abnormal findings on antenatal screening of mother

176

1977

0.88

0.86

1.5

1.6

3.03

3.67

mg/l

1.05

109

1239

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

406

1.27

0.86

1.8

1.7

4.66

4.16

mg/l

0.10

295

Endocrine disorders, other/unspecified

274

0.69

0.85

2.5

1.8

3.96

3.10

mg/l

0.24

193

Other disorders of white blood cells

636

0.80

0.85

2.0

1.6

3.90

3.85

mg/l

0.01

455

Calculus of lower urinary tract

424

0.75

0.85

1.5

1.7

3.40

3.17

mg/l

0.09

318

Diving or jumping into water causing injury other than drowning or submersion

1.80

0.85

1.1

1.7

2.51

4.29

mg/l

—

Benign neoplasm: Pancreas

227

0.65

0.85

1.5

1.7

1.54

5.36

mg/l

—

164

Other systemic involvement of connective tissue

380

3509

1.09

0.85

1.8

1.7

4.76

3.39

mg/l

1.15

299

2448

Other acquired deformities of ankle and foot

112

0.53

0.85

1.7

1.8

3.17

2.80

mg/l

—

Other mental disorders due to brain damage and dysfunction and to physical disease

888

0.83

0.85

1.9

1.7

4.75

3.86

mg/l

0.17

644

Other misadventures during surgical and medical care

250

0.67

0.85

4.2

1.7

2.17

3.37

mg/l

0.89

183

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

452

1.25

0.84

1.8

1.7

2.40

4.34

mg/l

0.81

316

Benign neoplasm: Pituitary gland, craniopharyngeal duct

700

0.81

0.84

1.8

1.7

3.30

4.22

mg/l

0.38

490

Family history of other conditions

223

1.37

0.84

1.4

1.6

2.92

2.49

mg/l

0.23

151

Sequelae of injuries, of poisoning and of other consequences of external causes

386

3570

1.08

0.84

1.6

1.7

3.81

3.60

mg/l

0.13

300

2481

Nummular dermatitis

875

0.83

1.7

2.75

3.23

mg/l

0.51

611

Chronic ulcer of skin, not elsewhere classified

590

0.79

0.83

1.8

1.7

6.41

4.07

mg/l

0.75

429

Primary open-angle glaucoma, strict

166

1867

0.89

0.83

1.5

1.6

5.73

3.49

mg/l

0.83

123

1358

Primary ovarian failure

364

0.73

0.83

1.3

1.7

3.22

3.05

mg/l

0.07

241

Abnormal spermatozoa

821

0.83

1.2

1.7

3.78

3.94

mg/l

0.06

585

Other enthesopathy of foot (+metatarsalgia)

170

1510

1.13

0.83

2.0

1.6

3.51

3.87

mg/l

0.22

129

1027

Other diseases of jaws

119

1032

1.16

0.83

1.5

1.6

4.05

3.21

mg/l

0.53

723

Other and unspecified injuries of thorax

237

0.67

0.83

3.9

1.9

2.70

2.81

mg/l

0.04

174

Vitamin B12 deficiency anaemia

102

873

1.17

0.83

1.8

1.7

4.81

3.38

mg/l

0.52

634

Type 1 diabetes

400

4308

0.92

0.83

1.6

4.00

3.31

mg/l

0.86

371

2856

Contact with other sharp object(s)

1057

0.85

0.83

1.4

1.7

2.90

4.46

mg/l

0.98

721

Hallux rigidus

180

1605

1.13

0.82

1.4

1.7

3.63

3.27

mg/l

0.15

140

1104

Benign neoplasm of urinary organs

443

0.76

0.82

1.5

1.7

2.64

4.13

mg/l

0.52

319

Heterophoria

108

1249

0.86

0.82

1.7

1.6

2.69

3.92

mg/l

1.04

852

Melanocytic naevi, other sites/unspecified

131

1146

1.15

0.82

1.5

1.7

2.43

4.01

mg/l

1.44

794

Androgenic alopecia

139

1.47

0.81

1.5

1.8

3.33

2.22

mg/l

0.36

Gingival hyperplasia

386

0.75

0.81

1.2

1.6

5.82

2.83

mg/l

0.65

272

Dislocation, sprain and strain of joints and ligaments at neck level

297

2722

1.10

0.81

1.5

1.7

3.27

3.85

mg/l

0.59

214

1855

Atrial fibrillation and flutter

561

3904

0.94

0.81

3.0

1.4

4.80

3.15

mg/l

2.28

448

2596

Traumatic subarachnoid haemorrhage

306

0.71

0.81

2.8

1.6

2.48

3.68

mg/l

0.49

214

Tuberous sclerosis 1

0.00

0.80

0.0

2.2

—

3.04

—

Histrionic personality disorder

1.71

0.80

1.5

1.8

3.60

2.37

mg/l

0.33

Perioral dermatitis

339

1.28

0.80

2.1

1.7

5.23

2.75

mg/l

1.36

229

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

536

3923

0.94

0.80

1.6

1.7

2.91

3.60

mg/l

0.93

376

2784

Other leukaemias of specified cell type

0.00

0.80

0.0

1.5

—

3.00

—

Hodgkin lymphoma

396

0.75

0.80

1.3

1.8

5.08

3.12

mg/l

1.08

270

Monosomies and deletions from the autosomes, not elsewhere classified

0.00

0.80

0.0

1.5

—

2.92

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

761

0.82

0.80

1.7

2.93

3.74

mg/l

0.40

547

Squamous cell neoplasms and carcinomas of the skin

609

0.80

1.5

1.6

2.67

4.00

mg/l

0.59

466

Drug-induced myopathy

0.00

0.80

0.0

1.3

—

3.86

—

Fourth [trochlear] nerve palsy

235

0.67

0.80

1.4

1.7

2.94

3.12

mg/l

0.04

174

Basal cell carcinoma

537

4008

1.07

0.80

1.6

1.7

2.90

3.69

mg/l

1.16

385

2903

Injuries to the neck

407

3782

1.08

0.80

1.8

1.7

3.24

3.68

mg/l

0.53

295

2586

Contact with heat and hot substances

739

0.82

0.80

1.7

2.89

4.53

mg/l

0.86

514

Unspecified protein-energy malnutrition

1.85

0.80

1.2

2.0

0.90

2.95

mg/l

—

Crowding of teeth, including avohilmo

152

1415

0.88

0.80

1.6

1.5

2.70

4.16

mg/l

1.97

101

925

Antepartum haemorrhage, not elsewhere classified

215

1944

1.11

0.79

1.6

1.7

3.17

3.83

mg/l

0.75

146

1312

Melanocytic naevi, other sites/unspecified

131

1149

1.15

0.79

1.5

1.7

2.43

4.17

mg/l

1.62

789

Benign neoplasm of ovary

247

2247

1.10

0.79

1.5

1.7

3.57

3.26

mg/l

0.19

172

1578

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1064

0.85

0.79

1.9

1.6

3.79

3.77

mg/l

0.01

749

Exposure to excessive natural cold

0.51

0.79

1.6

1.9

2.77

3.94

mg/l

—

Cluster headache, wide

593

1.21

0.79

1.8

2.18

3.84

mg/l

1.85

391

Carcinoma in situ of skin

501

1.22

0.79

2.8

1.6

2.62

4.01

mg/l

0.59

385

Need for other prophylactic measures

657

1.19

0.79

2.4

1.7

3.17

4.28

mg/l

0.53

467

Other leukaemias of specified cell type

0.00

0.79

0.0

1.4

—

1.86

—

Allergic contact dermatitis due to drugs in contact with skin

287

1.30

0.78

1.9

1.8

2.88

3.16

mg/l

0.09

208

Malignant neoplasm of uterus, part unspecified, excluding all cancers (controls excluding all cancers)

0.00

0.78

0.0

2.1

—

1.66

—

Ulcer of oesophagus, drug-induced

0.00

0.78

0.0

1.7

—

5.00

—

Benign neoplasm: Pancreas

222

0.67

0.78

1.5

1.8

1.54

2.85

mg/l

—

169

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

759

0.83

0.78

1.3

1.7

2.67

4.13

mg/l

0.96

538

Personal history of malignant neoplasm

439

1.24

0.78

1.7

1.6

3.15

3.97

mg/l

0.24

304

Superficial injury of abdomen, lower back and pelvis

242

2202

1.10

0.78

1.6

1.7

4.91

3.84

mg/l

0.71

176

1516

Dental caries 1 and operation codes, only avohilmo

485

2610

0.93

0.78

1.8

1.6

5.36

3.77

mg/l

0.63

340

1776

Other acute lower respiratory infections

773

7767

0.95

0.77

1.7

1.6

5.42

3.50

mg/l

3.34

592

5360

Sexual dysfunction

209

1.36

0.77

2.5

1.7

3.89

3.44

mg/l

0.16

145

Nontoxic multinodular goitre

237

2155

1.10

0.77

1.6

2.78

3.28

mg/l

0.62

179

1530

Purpura and other haemorrhagic conditions

142

1604

0.88

0.77

1.9

1.7

5.98

3.91

mg/l

0.56

105

1130

Sequelae of injuries of neck and trunk

393

0.76

0.77

1.6

1.9

5.82

3.29

mg/l

0.40

275

Other and unspecified myopathies

769

0.83

0.77

1.9

1.7

5.76

3.89

mg/l

0.32

554

Papillary adenocarcinoma of thyroid gland

659

0.81

0.77

2.3

1.8

3.91

3.96

mg/l

0.01

470

Inflammatory disease of cervix uteri

798

1.17

0.76

1.7

3.03

3.55

mg/l

0.26

572

Contact with other hot fluids

437

0.77

0.76

1.6

1.7

2.96

3.39

mg/l

0.16

297

Glomerular disorders in diseases classified elsewhere

143

1266

1.13

0.76

1.8

1.7

5.30

4.14

mg/l

0.40

129

883

Sequelae with surgical and medical care as external cause

202

2234

0.90

0.76

1.7

5.31

3.55

mg/l

0.82

161

1595

Atrophic disorders of skin

208

1882

1.11

0.75

2.3

1.7

4.91

3.80

mg/l

0.43

155

1335

Isolated proteinuria

358

0.75

2.0

1.8

11.81

3.35

mg/l

0.78

257

Keratitis

574

5410

1.06

0.75

1.6

1.7

3.43

3.58

mg/l

0.16

419

3774

Diseases of the myoneural junction and muscle

105

1208

0.87

0.75

1.6

1.7

4.55

3.98

mg/l

0.13

855

Respiratory tuberculosis, confirmed and not-confirmed

381

0.76

0.75

2.6

1.8

12.30

3.09

mg/l

0.57

293

Respiratory tuberculosis

381

0.76

0.75

2.6

1.8

12.30

3.09

mg/l

0.57

293

Aneurysms, operations, SAH

163

1822

0.89

0.75

1.7

3.79

3.83

mg/l

0.01

117

1309

Viral hepatitis, IBD co-morbidity

992

0.85

0.74

1.5

4.20

2.58

mg/l

1.36

596

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

1121

0.86

0.74

2.1

1.7

3.25

3.64

mg/l

0.19

785

Congenital deformities of feet

388

1.25

0.74

1.3

1.7

4.24

3.33

mg/l

0.37

263

Heart failure and antihypertensive medication

335

2393

0.92

0.74

4.1

1.4

6.94

2.94

mg/l

5.85

313

1554

Nephrotic syndrome

357

0.75

0.74

1.3

1.7

8.64

3.01

mg/l

0.55

262

Ectopic pregnancy

348

3228

1.08

0.74

1.6

1.7

2.88

3.46

mg/l

1.12

249

2266

Unspecified maternal hypertension

241

0.69

0.73

4.6

1.8

5.46

2.83

mg/l

0.37

158

Amoebiasis

1.61

0.73

1.3

2.1

6.55

3.15

mg/l

—

Assault by hanging, strangulation and suffocation

1.81

0.73

2.6

1.4

0.84

2.15

mg/l

—

Endometriosis diagnosis and infertility diagnosis occurring together

234

2136

1.10

0.73

1.5

1.6

3.69

3.54

mg/l

0.08

163

1466

Unequal limb length (acquired)

134

1.44

0.73

1.6

1.4

2.34

3.10

mg/l

—

Alzheimer’s disease, wide definition

758

0.85

0.73

1.7

1.6

2.66

2.98

mg/l

0.15

576

Cholera

434

1.23

0.72

1.8

14.58

2.49

mg/l

0.47

327

Hepatic failure, not elsewhere classified

367

0.76

0.72

2.0

1.8

4.27

4.39

mg/l

0.02

270

Redundant prepuce, phimosis and paraphimosis

285

2611

1.09

0.72

1.7

2.92

3.68

mg/l

0.95

205

1757

Noise effects on inner ear

423

0.78

0.72

1.5

1.7

2.72

4.72

mg/l

0.96

297

Other malignant neoplasms of skin (=non-melanoma skin cancer)

520

3858

1.07

0.72

1.6

1.7

2.92

3.68

mg/l

1.04

366

2796

Small fibre neuropathy

264

1.30

0.72

1.4

1.9

3.84

3.08

mg/l

0.39

198

Diastasis of muscle

126

1.46

0.72

1.4

2.0

2.40

2.76

mg/l

0.15

Inflammatory disorders of breast

1127

0.86

0.72

1.4

1.7

4.24

3.87

mg/l

0.16

763

Congenital malformations of genital organs

195

1755

1.11

0.72

1.6

1.7

3.55

3.74

mg/l

0.12

126

1190

Abnormalities of forces of labour

230

2100

1.10

0.72

1.6

1.7

2.78

3.55

mg/l

1.31

175

1478

Other and unspecified rosacea

126

1112

1.14

0.72

1.8

1.7

3.70

3.53

mg/l

0.08

104

775

Hypertensive diseases (excluding secondary)

1289

7204

1.04

0.71

1.9

1.4

5.33

3.06

mg/l

4.57

1066

4795

Ulcerative enterocolitis

488

0.79

0.71

1.5

1.7

3.84

4.37

mg/l

0.14

343

Idiopathic peripheral autonomic neuropathy

1.96

0.71

1.6

1.8

0.89

3.01

mg/l

—

Motorcycle rider injured in noncollision transport accidents

472

1.22

0.71

1.4

1.8

3.76

4.13

mg/l

0.10

322

Aortic aneurysm

155

1702

0.89

0.71

1.6

1.7

3.26

4.09

mg/l

0.57

120

1215

Benign neoplasm: Colon, unspecified

197

2173

0.90

0.71

1.6

1.7

3.62

3.79

mg/l

0.08

159

1569

Other systemic involvement of connective tissue (FG)

371

3431

1.08

0.71

1.8

1.6

4.82

3.22

mg/l

1.42

291

2314

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

205

0.67

0.71

1.1

1.8

1.82

3.39

mg/l

1.87

143

Neuralgia and neuritis, unspecified

674

1.18

0.71

2.1

1.7

3.11

4.85

mg/l

0.75

456

Benign neoplasm: Stomach

112

981

1.15

0.71

1.9

1.6

8.34

3.66

mg/l

1.21

699

Abnormal blood-pressure reading, without diagnosis

545

1.20

0.71

1.9

1.6

3.07

3.27

mg/l

0.10

365

Personal history of medical treatment

118

1.47

0.71

2.1

1.6

4.01

2.64

mg/l

0.52

Autoimmune diseases

2339

12292

0.97

0.70

1.8

1.6

4.20

3.34

mg/l

3.28

1781

8250

Cerebral palsy and other paralytic syndromes

126

1423

0.88

0.70

1.7

4.26

3.89

mg/l

0.20

103

1010

Other hearing loss

248

2233

1.09

0.70

1.6

1.7

3.26

3.56

mg/l

0.18

176

1609

Other and unspecified visual disturbances

129

1142

1.13

0.70

1.7

2.06

4.07

mg/l

2.78

805

Umbilical hernia

392

3660

1.07

0.70

1.7

5.51

3.36

mg/l

0.89

308

2584

Otosclerosis

100

870

1.15

0.70

1.5

1.7

2.54

3.93

mg/l

1.02

623

Other cataract

476

3923

0.94

0.70

1.9

1.7

6.19

3.50

mg/l

1.46

372

2781

Divergent concomitant strabismus

105

1199

0.87

0.70

2.0

1.7

5.66

3.93

mg/l

0.38

835

Urolithiasis

395

3689

1.07

0.70

1.6

1.7

4.26

3.78

mg/l

0.32

290

2613

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

797

7588

1.05

0.70

1.7

1.6

4.51

3.44

mg/l

1.94

607

5088

Hypertrophic disorders of skin

103

899

1.15

0.70

1.5

1.7

3.91

4.21

mg/l

0.08

616

Other contact dermatitis

105

1199

0.87

0.70

1.7

3.88

3.04

mg/l

0.33

839

Other disorders of Eustachian tube

353

0.76

0.70

1.4

1.7

2.36

4.51

mg/l

0.69

250

Viral meningitis

602

1.19

0.70

1.5

1.7

4.95

4.61

mg/l

0.05

414

Pain in limb

1524

10642

1.04

0.70

1.7

1.6

3.66

3.49

mg/l

0.31

1166

7179

Mumps

364

0.76

0.70

1.6

1.7

7.21

3.15

mg/l

0.31

253

Generalized skin eruption due to drugs and medicaments

464

1.22

0.69

2.8

1.7

4.59

3.28

mg/l

0.67

332

Fracture at wrist and hand level

531

5623

0.94

0.69

1.7

1.6

3.29

3.60

mg/l

0.28

379

3830

Chronic periodontitis, complicated

996

0.86

0.69

1.6

1.8

11.47

4.06

mg/l

2.12

705

Basal cell carcinoma, including avohilmo

556

4131

1.06

0.69

1.6

1.7

2.88

3.70

mg/l

1.31

400

2989

Distal bite

534

1.20

0.69

1.4

1.6

3.24

3.83

mg/l

0.29

354

Ankle and foot

117

0.59

0.69

2.0

2.1

5.91

2.95

mg/l

—

Atopic dermatitis, strict definition with reimbursement

687

6330

1.05

0.69

1.6

3.63

3.30

mg/l

0.45

482

4215

Other congenital malformations of circulatory system

341

0.76

0.69

1.2

1.7

3.03

2.95

mg/l

0.02

246

Contusion of other and unspecified parts of foot

844

0.85

0.69

1.7

3.63

4.56

mg/l

0.46

571

Endocarditis

341

0.76

0.68

2.0

1.4

6.35

3.55

mg/l

0.80

245

Anosmia

325

1.26

0.68

1.5

1.3

2.24

2.76

mg/l

0.44

205

Acute peritonitis

639

0.83

0.68

1.2

1.6

4.30

3.93

mg/l

0.09

458

Bicuspidal aortic valve syndrome

474

0.80

0.68

1.4

1.8

2.46

3.65

mg/l

1.02

338

First line medication for Crohn's disease

2418

12827

1.03

0.68

2.5

1.4

4.96

3.09

mg/l

9.20

1896

8612

Exclusion endpoint for supernumerary teeth

191

0.67

0.68

1.5

1.8

1.39

2.72

mg/l

—

122

Impetigo

681

0.83

0.68

1.4

1.7

6.25

3.64

mg/l

1.05

452

Nontoxic single thyroid nodule

105

920

1.15

0.68

1.6

1.7

3.83

3.81

mg/l

0.01

659

Respiratory tuberculosis, not confirmed

261

0.72

0.67

3.1

1.8

2.49

2.91

mg/l

0.19

206

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1642

11045

0.97

0.67

1.8

1.7

3.53

3.58

mg/l

0.06

1235

7808

Asthma-related pneumonia

392

4183

0.93

0.67

2.0

1.6

7.61

3.24

mg/l

4.97

336

2901

Family history of certain disabilities and chronic diseases leading to disablement

837

1.15

0.67

1.6

1.5

3.46

3.97

mg/l

0.23

559

Maternal care for known or suspected fetal abnormality and damage

421

3514

1.07

0.67

1.4

1.6

3.90

3.64

mg/l

0.22

281

2355

Ankylosing spondylitis

116

1311

0.88

0.67

1.9

1.7

5.00

4.09

mg/l

0.24

913

Benign neoplasm: Skin of ear and external auricular canal

373

0.77

0.67

1.6

1.7

2.30

4.79

mg/l

0.84

269

Other congenital malformations of face and neck

472

0.80

0.67

1.5

1.8

4.22

3.39

mg/l

0.24

322

Other maltreatment syndromes

516

0.81

0.67

1.4

1.8

3.39

3.98

mg/l

0.27

346

Ménière disease

981

0.86

0.66

1.7

3.06

3.64

mg/l

0.31

712

Gonarthrosis [arthrosis of knee](FG)

1328

7535

1.04

0.66

1.7

1.6

3.91

3.23

mg/l

1.36

1056

5272

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

126

1415

0.89

0.66

2.0

1.7

4.05

3.00

mg/l

0.95

101

985

Hereditary corneal dystrophies

295

1.26

0.65

2.1

1.8

1.63

4.95

mg/l

1.12

224

258

0.73

0.65

1.2

1.4

6.90

4.22

mg/l

0.41

162

Infections of genitourinary tract in pregnancy

163

1803

0.90

0.65

1.5

1.6

3.12

3.70

mg/l

0.48

117

1189

Benign lipomatous neoplasm

402

3769

1.07

0.65

1.6

1.7

3.41

3.57

mg/l

0.18

299

2679

Dorsalgia

2189

11523

1.03

0.65

1.7

1.6

3.88

3.46

mg/l

1.04

1617

7820

Abnormal findings on examination of urine, without diagnosis

504

0.81

0.65

1.7

8.50

3.04

mg/l

0.77

355

Cholesteatoma of middle ear

515

0.81

0.65

1.8

2.47

3.22

mg/l

0.76

374

Frostbite

128

0.62

0.65

1.4

1.8

3.98

4.46

mg/l

—

Struck by thrown, projected or falling objec

681

1.17

0.65

1.6

1.7

2.84

3.81

mg/l

0.92

471

Other diseases of pericardium

450

1.21

0.64

3.2

1.5

4.61

3.23

mg/l

0.39

326

Carcinoma in situ of other and unspecified genital organs

212

0.70

0.64

1.3

1.9

3.32

4.89

mg/l

—

157

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

612

0.83

0.64

1.2

1.7

2.88

4.10

mg/l

0.51

425

Cleft lip, lip and palate or palate

280

0.74

0.64

1.5

1.7

1.97

2.95

mg/l

0.70

192

Unspecified privation

151

1359

1.12

0.64

1.7

5.97

4.08

mg/l

0.74

113

940

Arthropathies

2187

10822

1.03

0.64

1.7

1.6

3.88

3.37

mg/l

1.43

1635

7215

Disorders of mineral metabolism

101

887

1.14

0.64

1.9

1.7

2.75

4.00

mg/l

0.83

609

Antenatal screening

630

3369

1.06

0.64

1.5

1.6

3.50

3.89

mg/l

0.50

419

2366

Other secondary coxarthrosis

370

0.78

0.64

1.6

1.8

8.78

4.46

mg/l

0.34

273

Tuberculosis

415

0.79

0.64

2.5

1.8

10.62

3.02

mg/l

0.56

318

Other disorders of the genitourinary system

146

1312

1.12

0.64

1.5

1.7

2.84

3.55

mg/l

0.55

109

972

Superficial injuries involving multiple body regions

369

1.23

0.64

1.5

1.6

9.69

3.20

mg/l

0.88

258

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

1019

0.87

0.63

2.1

1.7

3.41

3.72

mg/l

0.13

713

Hypoplasia of dental enamel , including avohilmo

376

0.78

0.63

1.2

1.6

3.42

3.91

mg/l

0.21

244

Other orthopaedic follow-up care

710

1.16

0.63

1.6

4.92

3.98

mg/l

0.37

490

Flatulence and related conditions

121

1.42

0.63

1.3

1.7

2.38

2.98

mg/l

—

Other disorders of ear

1497

10304

0.97

0.63

1.6

1.7

3.64

3.51

mg/l

0.17

1056

7329

Disorders of puberty, all

268

0.74

0.63

1.3

1.6

3.74

3.98

mg/l

0.08

172

Injury of nerves at wrist and hand level

544

1.18

0.63

1.9

1.7

2.14

3.66

mg/l

1.88

381

Rash and other nonspecific skin eruption

136

1219

1.12

0.63

2.1

1.6

7.68

3.64

mg/l

1.16

104

858

Medical abortion

1304

7341

0.96

0.62

1.6

3.07

3.47

mg/l

1.23

937

5075

Dermatitis due to substances taken internally

711

1.16

0.62

2.4

1.7

4.01

3.25

mg/l

0.44

501

Injury of other and unspecified intrathoracic organs

686

0.84

0.62

1.5

1.7

6.15

4.06

mg/l

0.26

482

Corns and callosities

772

0.85

0.62

1.6

6.13

4.34

mg/l

0.42

535

Hereditary angioödema type 1

0.00

0.62

0.0

1.4

—

2.94

—

Cleft palate

187

0.68

0.62

1.5

1.7

3.13

2.83

mg/l

—

119

Intentional self-harm by crashing of motor vehicle

0.00

0.62

0.0

1.9

—

1.52

—

Strabismus

398

4227

0.94

0.62

1.7

4.03

3.64

mg/l

0.26

278

2932

Foreign body on external eye

193

2111

0.91

0.62

1.8

1.7

4.00

3.64

mg/l

0.13

154

1445

Other disorders of cornea

128

1144

1.12

0.62

1.8

1.7

2.92

4.14

mg/l

0.98

815

Toxic effect of alcohol

290

0.75

0.62

1.7

1.8

5.24

4.27

mg/l

0.19

208

Acné excoriée

0.00

0.62

0.0

1.5

—

1.63

—

Complications of the puerperium, not elsewhere classified

845

0.86

0.62

1.6

1.7

3.43

4.19

mg/l

0.37

571

Exposure to other and unspecified animate mechanical forces

478

0.81

0.62

1.7

1.8

3.13

4.83

mg/l

0.54

322

Moyamoya

0.00

0.62

0.0

1.6

—

1.37

—

Hypopituitarism

102

899

1.14

0.62

1.5

1.7

4.58

4.40

mg/l

0.06

625

Noninfectious colitis NAS

168

1849

0.91

0.62

1.7

4.43

3.90

mg/l

0.35

132

1293

Obstetric embolism

0.00

0.62

0.0

2.6

—

1.36

—

Benign neoplasm of eye and adnexa

118

1050

1.13

0.61

2.1

1.6

4.66

3.73

mg/l

0.21

747

Cryoglobulinemia

0.00

0.61

0.0

1.5

—

1.39

—

Anomalies of dental arch relationship, including avohilmo

380

3202

1.07

0.61

1.5

1.6

3.62

3.83

mg/l

0.18

261

2195

Benign neoplasm: Lip

233

0.72

0.61

1.5

1.9

3.11

3.32

mg/l

—

174

Epidermolysis bullosa

0.00

0.61

0.0

1.5

—

2.57

—

Other salmonella infections

462

1.20

0.61

1.5

1.7

7.86

2.95

mg/l

1.01

321

Exposure to ignition of highly flammable material

1.60

0.61

1.9

1.7

1.89

2.99

mg/l

—

Cerebral oedema

0.00

0.61

0.0

1.9

—

3.08

—

Periodontosis

0.00

0.61

0.0

3.1

—

4.36

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

525

3814

0.95

0.61

1.6

1.7

2.88

3.65

mg/l

1.09

375

2710

Abnormal pulmonary venous return

0.00

0.61

0.0

1.2

—

1.09

—

Diseases of tongue

722

1.15

0.61

1.5

1.7

3.12

3.01

mg/l

0.07

510

Acute pharyngitis

299

2765

1.08

0.61

1.4

1.6

4.40

3.74

mg/l

0.54

219

1823

Melanoma in situ

323

0.77

0.61

1.6

1.7

2.31

3.09

mg/l

0.47

246

Benign neoplasm: Short bones of lower limb

151

0.65

0.61

1.6

2.0

1.79

3.21

mg/l

—

103

Severe mental retardation

0.00

0.61

0.0

1.5

—

4.18

—

Carcinoma in situ of lip, oral cavity and pharynx

0.00

0.61

0.0

1.5

—

2.63

—

Other viral diseases

569

5392

1.05

0.61

1.6

5.28

3.54

mg/l

1.74

414

3664

Congenital malformation of biliary tract

0.00

0.61

0.0

1.5

—

0.96

—

Pneumonia due to Streptococcus pneumoniae

510

0.82

0.61

2.1

1.7

5.50

2.52

mg/l

0.93

355

Postpartum haemorrhage due to anatomy

246

2276

1.09

0.60

1.7

1.5

3.58

3.38

mg/l

0.15

172

1475

Infections, IBD-co-morbidities

266

2090

0.92

0.60

1.8

1.5

7.05

2.50

mg/l

3.49

209

1312

Stenosis and insufficiency of lacrimal passages

112

995

1.13

0.60

1.4

1.7

3.07

3.61

mg/l

0.31

721

Scleritis and episcleritis

101

892

1.14

0.60

1.5

1.7

3.73

4.27

mg/l

0.25

624

Other disorders of gingiva or/and edentulous alveolar ridge

618

0.84

0.60

1.6

1.7

4.17

2.98

mg/l

0.43

434

Marasmic kwashiorkor

0.00

0.60

0.0

1.5

—

1.51

—

Open wound of head

707

7285

0.95

0.60

1.9

1.6

4.35

3.51

mg/l

0.90

519

5033

Other and unspecified injuries of ankle and foot

682

0.85

0.60

1.5

1.7

5.17

4.32

mg/l

0.14

463

Other specified and unspecified disorders of conjunctiva

114

1.42

0.60

2.8

2.0

2.03

2.68

mg/l

—

Systemic lupus erythematosus, unspecified

421

0.80

0.60

1.6

1.7

7.86

4.37

mg/l

0.44

294

Other infective otitis externa

780

1.15

0.60

1.6

1.7

3.60

3.85

mg/l

0.09

547

Episcleritis

771

1.15

0.59

1.4

1.7

3.72

4.58

mg/l

0.38

535

Lichen ruber planus, wide definition including periferal and oral lichen planus

272

2527

1.08

0.59

1.9

1.7

4.76

3.60

mg/l

0.71

200

1814

All dysplastic lesions of the vulva

638

0.84

0.59

1.7

1.8

3.14

4.09

mg/l

0.27

451

Relapsing polychondritis

0.00

0.59

0.0

2.3

—

2.26

—

Malignant neoplasm of oral cavity

299

0.76

0.59

1.3

1.7

2.89

2.97

mg/l

0.02

223

Meningitis

681

0.85

0.59

1.9

1.7

6.38

4.71

mg/l

0.24

478

Asthma-related pneumonia or sepsis

395

4189

0.94

0.59

2.0

1.6

7.61

3.24

mg/l

5.04

338

2905

Asthma, hospital admissions 3, pneumonia

395

4189

0.94

0.59

2.0

1.6

7.61

3.24

mg/l

5.04

338

2905

Traumatic amputation of ankle and foot

0.00

0.59

0.0

1.7

—

4.43

—

Benign neoplasm: Skin, unspecified

508

0.82

0.59

2.1

1.7

6.46

3.11

mg/l

0.48

352

Pulmonary heart disease, diseases of pulmonary circulation

291

3121

0.93

0.59

2.0

1.6

6.90

3.62

mg/l

2.36

238

2235

Carcinoma in situ of breast, other/unspecified

150

0.66

0.59

1.4

1.7

2.46

2.23

mg/l

—

109

Allergic contact dermatitis

247

2288

1.08

0.59

1.7

3.62

3.28

mg/l

0.23

192

1598

Other follicular disorders

125

1121

1.12

0.59

1.5

1.7

6.12

4.17

mg/l

1.31

106

764

Injuries to unspecified part of trunk, limb or body region

134

1206

1.11

0.59

1.8

1.7

4.37

4.13

mg/l

0.07

101

840

Glaucoma, exfoliation

541

0.83

0.58

1.4

1.6

1.75

3.68

mg/l

1.23

433

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

509

3704

0.95

0.58

1.6

1.7

2.93

3.67

mg/l

0.98

362

2639

Chronic kidney disease

214

2311

0.92

0.58

2.5

1.6

7.48

3.74

mg/l

2.32

192

1656

115

1.41

0.58

1.7

2.1

3.12

2.62

mg/l

0.19

Malignant neoplasm of breast

709

5348

0.96

0.58

1.7

2.49

3.36

mg/l

3.72

544

3845

Benign neoplasm of other and unspecified female genital organs

550

0.83

0.58

1.6

1.7

3.52

3.81

mg/l

0.08

374

Benign neoplasm: Skin of lower limb, including hip

319

1.23

0.58

1.5

1.8

9.57

2.56

mg/l

0.74

237

Benign neoplasm of other and unspecified endocrine glands

145

1600

0.90

0.57

1.5

1.7

4.18

3.90

mg/l

0.10

107

1120

Congenital malformations of great arteries

248

0.75

0.57

1.4

2.66

3.40

mg/l

—

172

Benign neoplasm: Rectum, anus and anal canal

197

1809

1.09

0.57

1.8

1.7

4.24

3.59

mg/l

0.21

154

1305

Diseases of salivary glands

271

2910

0.93

0.57

1.4

1.6

3.59

3.08

mg/l

0.67

193

2001

Carcinoma in situ of skin

521

1.17

0.57

2.8

1.7

2.62

4.04

mg/l

0.61

383

Vitreous haemorrhage

113

1009

1.12

0.57

1.6

1.7

3.44

3.91

mg/l

0.25

719

Infarction of spleen

1.69

0.57

1.8

1.5

2.98

2.29

mg/l

—

Pulmonary embolism

272

2919

0.93

0.57

2.0

1.6

5.54

3.65

mg/l

1.52

220

2090

Bacterial meningitis

451

0.82

0.57

1.9

1.8

9.04

4.66

mg/l

0.40

321

Torticollis

274

0.76

0.57

2.0

1.8

3.33

2.88

mg/l

0.22

185

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

451

0.82

0.57

1.3

1.6

2.55

4.40

mg/l

0.66

314

Superficial injury of ankle and foot

187

2036

0.92

0.56

1.6

3.43

3.97

mg/l

0.56

132

1384

Pulmonary heart disease

272

2918

0.93

0.56

2.0

1.6

5.54

3.75

mg/l

1.39

220

2091

Contusion of ankle

613

0.84

0.56

1.6

1.8

4.77

4.89

mg/l

0.04

424

Hypotension due to drugs

0.56

3.4

1.5

7.72

2.92

mg/l

—

Acute appendicitis, with complications

291

2718

1.07

0.56

1.7

3.34

3.75

mg/l

0.36

215

1896

Other skin changes

192

1764

1.09

0.56

1.5

1.7

6.06

3.84

mg/l

0.78

135

1255

Assault by bodily force

146

1325

1.11

0.56

1.9

1.7

3.77

4.00

mg/l

0.10

118

894

Fever of other and unknown origin

869

8373

0.96

0.56

1.8

1.6

5.60

3.28

mg/l

4.56

682

5644

Other metabolic disorders

213

1967

1.09

0.56

1.9

1.7

5.78

3.88

mg/l

1.01

164

1364

Benign neoplasm of other and ill-defined parts of digestive system

204

1880

1.09

0.56

1.8

1.7

5.93

3.59

mg/l

1.02

158

1351

Atrial septal defect

490

0.83

0.56

1.6

1.7

3.31

3.40

mg/l

0.03

336

Other strabismus

348

3689

0.94

0.55

1.7

1.6

4.20

3.57

mg/l

0.41

242

2546

Normotensive glaucoma

548

0.84

0.55

1.3

1.6

1.43

3.86

mg/l

1.77

429

Intracranial injury

861

8645

0.96

0.55

1.8

1.6

3.43

3.52

mg/l

0.11

636

5888

Sequelae of injuries of head

701

1.15

0.55

1.4

1.8

4.18

mg/l

0.00

499

Shigellosis

1.61

0.55

1.5

2.1

4.39

2.72

mg/l

—

Other specified/unspecified disorders of tympanic membrane

1.61

0.55

1.0

2.1

8.71

4.48

mg/l

—

Mesial bite

151

1.34

0.55

1.2

1.8

2.19

3.11

mg/l

0.73

Lesion of lateral popliteal nerve

590

0.84

0.55

1.9

1.7

3.27

4.67

mg/l

0.47

414

Postmenopausal osteoporosis with pathological fracture

362

0.80

0.55

4.1

1.7

2.44

4.07

mg/l

0.52

278

Vertical strabismus

438

0.82

0.55

1.6

1.7

3.01

2.89

mg/l

0.05

307

Polymyalgia rheumatica

890

0.87

0.55

1.6

1.7

4.42

3.53

mg/l

0.40

670

Intrahepatic Cholestasis of Pregnancy (ICP)

162

1481

1.10

0.54

1.8

1.7

3.07

3.83

mg/l

0.72

118

1007

Embedded and impacted teeth

630

5119

1.05

0.54

1.5

4.16

3.71

mg/l

0.36

415

3294

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

181

1663

1.09

0.54

1.8

1.7

2.92

3.65

mg/l

0.81

135

1149

Multiple gestation

187

2030

0.92

0.54

1.9

1.7

3.15

3.64

mg/l

0.49

140

1400

Pain in thoracic spine

252

2346

1.08

0.54

1.6

1.7

3.99

3.78

mg/l

0.08

180

1614

Paralytic strabismus

718

0.86

0.54

1.6

3.02

3.62

mg/l

0.23

508

Ganglion

392

3704

1.06

0.54

1.5

1.7

2.95

3.65

mg/l

1.47

296

2509

Contact with machinery

110

1226

0.89

0.54

1.6

1.7

4.40

3.60

mg/l

0.20

858

Oral lichen ruber planus, including avohilmo

665

1.15

0.54

2.0

1.8

2.93

3.86

mg/l

0.44

480

Left ventricular outflow tract obstruction, narrow definition

642

0.85

0.54

1.5

1.8

2.60

3.87

mg/l

1.21

452

Acute and subacute iridocyclitis

289

2705

1.07

0.53

1.6

1.7

4.45

3.72

mg/l

0.51

207

1901

Hodgkin lymphoma, hilmo

371

0.80

0.53

1.3

1.8

5.08

2.90

mg/l

1.26

252

Primary gonarthrosis, bilateral

585

4885

1.05

0.53

1.7

4.59

3.46

mg/l

1.33

481

3485

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

846

7543

1.04

0.53

2.1

1.7

5.55

3.38

mg/l

3.22

661

5336

Conjunctivitis (acute, non atopic)

476

4508

1.05

0.53

1.5

1.6

4.02

3.67

mg/l

0.35

347

3108

Hernia of abdominal wall

631

6038

1.05

0.53

1.6

1.7

5.25

3.38

mg/l

1.34

499

4265

Other immunodeficiencies

152

1.33

0.53

2.6

1.4

7.44

2.93

mg/l

0.71

106

Other specified/unspecified inflammatory spondylopathies

801

0.87

0.53

1.9

1.7

5.63

4.09

mg/l

0.26

550

Other shoulder lesions

153

1397

1.10

0.53

1.8

1.6

5.37

4.15

mg/l

0.34

118

950

Meniscus derangement

988

6523

1.04

0.53

1.7

1.6

3.78

3.38

mg/l

0.53

749

4547

Asthma/COPD (KELA code 203)

1868

13503

0.97

0.53

1.7

1.6

5.21

3.20

mg/l

5.36

1366

9249

Epileptic seizures related to drugs

1.53

0.52

1.2

1.8

7.37

2.45

mg/l

—

Other appendicitis

106

1181

0.89

0.52

1.7

2.79

3.97

mg/l

0.98

813

Conductive hearing loss, unspecified

120

1083

1.11

0.52

1.4

1.7

3.27

3.91

mg/l

0.40

760

Pedestrian injured in collision with two- or three-wheeled motor vehicle

1.52

0.52

1.7

2.0

3.33

2.16

mg/l

—

ILD, hospital admission 2, with pulmonary infections

737

0.87

0.52

2.1

1.7

35.72

3.85

mg/l

5.62

532

Benign neoplasm of meninges

1065

0.89

0.52

1.8

1.7

3.48

3.57

mg/l

0.05

768

Overjet

331

1.21

0.52

1.4

1.6

2.25

3.28

mg/l

1.03

216

Accidental poisoning by and exposure to alcohol

270

0.77

0.52

1.1

1.5

4.02

3.59

mg/l

0.07

185

Contact with other hot metals

180

0.72

0.52

1.6

1.8

3.20

3.54

mg/l

—

129

Coagulation defects, purpura and other haemorrhagic conditions

236

2534

0.93

0.52

1.7

5.22

3.77

mg/l

0.61

166

1770

Other disorders of bladder

121

1093

1.11

0.51

1.7

5.39

3.84

mg/l

0.50

760

Synovial cyst of popliteal space [Baker]

789

0.87

0.51

1.9

1.6

4.09

4.62

mg/l

0.14

550

Other specified disorders of muscle

369

0.81

0.51

1.7

7.75

6.04

mg/l

0.14

260

Other, unspecified and serous retinal detachments

281

0.78

0.51

1.3

1.9

5.21

2.93

mg/l

0.70

209

Superficial injury of thorax

204

1889

1.08

0.51

1.6

1.7

4.57

3.74

mg/l

0.31

161

1329

Lower back pain or/and sciatica

2041

13817

1.03

0.51

1.6

4.07

3.43

mg/l

1.81

1513

9533

Unspecified misadventure during surgical and medical care

621

1.15

0.51

1.6

1.7

3.39

3.92

mg/l

0.17

440

Hypertrichosis

426

1.18

0.51

1.5

1.6

4.25

3.20

mg/l

0.72

284

Other surgical follow-up care

444

1.18

0.51

1.7

1.6

7.08

4.07

mg/l

0.55

318

Neoplasms

1959

10239

1.03

0.51

1.6

3.84

3.50

mg/l

0.61

1400

6919

Dermatitis due to ingested food

512

0.84

0.51

1.4

1.5

4.63

3.61

mg/l

0.35

343

Migraine without aura, drug-induced

213

0.74

0.51

1.7

2.0

6.68

2.37

mg/l

0.70

146

Other neurotic disorders

565

1.16

0.51

2.1

1.6

4.73

4.18

mg/l

0.08

390

Residual foreign body in soft tissue

692

0.86

0.51

1.9

1.8

2.98

5.28

mg/l

1.14

470

Benign neoplasm: Ascending colon

102

1137

0.89

0.51

1.6

1.7

3.28

3.55

mg/l

0.11

804

Disorders of speech understanding and production

509

1.16

0.51

1.8

1.7

5.92

3.40

mg/l

0.52

339

Dyshidrosis [pompholyx]

252

1.24

0.50

1.5

1.8

3.84

3.54

mg/l

0.12

175

Melanocytic naevi of eyelid, including canthus

127

1.36

0.50

1.7

2.0

3.17

2.54

mg/l

0.18

Other and unspecified acne

234

1.25

0.50

1.4

1.7

5.69

3.34

mg/l

0.61

157

Long labour

594

4965

1.05

0.50

1.6

3.37

3.55

mg/l

0.26

423

3382

Special screening examination for neoplasms

426

1.18

0.50

1.3

1.7

3.66

3.98

mg/l

0.06

298

Congenital malformations of the circulatory system

192

2009

0.92

0.50

1.6

1.7

4.70

3.97

mg/l

0.28

130

1371

Otitis externa

342

3228

1.06

0.50

1.5

1.7

4.15

3.74

mg/l

0.30

261

2235

Molar incisor enamel hypoplasia

403

0.82

0.50

1.3

1.6

4.29

3.93

mg/l

0.11

261

L02BG Aromatase inhibitors

364

3443

1.06

0.50

1.7

2.73

3.15

mg/l

0.69

301

2463

Provisional assignment of new diseases of uncertain etiology

810

7806

1.04

0.49

1.8

1.6

5.32

3.40

mg/l

3.16

587

5321

Hypoglycaemia, other or unspecified

821

1.12

0.49

1.9

1.7

3.36

4.22

mg/l

0.38

573

Collagenous colitis

1071

0.89

0.49

1.5

1.7

4.96

3.79

mg/l

0.34

762

Anterior Iridocyclitis

300

2822

1.07

0.49

1.7

4.38

3.77

mg/l

0.42

213

1986

Hyperlipidaemia, other/unspecified

366

3660

0.95

0.49

1.9

1.6

4.32

3.66

mg/l

0.48

299

2584

Pneumonia due to other infectious organisms, not elsewhere classified

367

0.81

0.49

3.1

1.8

14.13

2.30

mg/l

0.92

259

Internal derangement of knee

683

6545

1.04

0.49

1.5

1.6

4.09

3.41

mg/l

0.77

507

4459

Superficial injury of neck

326

1.21

0.49

2.1

1.6

3.72

3.41

mg/l

0.07

223

In situ neoplasms

439

4401

0.95

0.49

1.7

1.6

3.10

3.38

mg/l

0.32

311

3051

Cellulitis

274

2919

0.94

0.49

1.8

1.6

4.80

3.41

mg/l

1.24

211

2042

Malignant neoplasm of breast, HER-positive

452

4242

1.05

0.49

1.7

2.43

3.22

mg/l

2.26

364

3054

Acute laryngitis and tracheitis

252

2321

1.07

0.49

1.7

1.6

3.73

3.54

mg/l

0.15

176

1495

Benign neoplasm: Parotid gland

870

0.88

0.49

1.6

1.7

4.34

4.05

mg/l

0.06

596

Injuries involving multiple body regions

521

1.16

0.49

1.5

1.8

7.58

4.62

mg/l

0.42

360

Pilonidal cyst

143

1561

0.91

0.49

1.8

1.7

4.92

3.48

mg/l

0.63

115

1043

Liver disorders in diseases classified elsewhere

1.52

0.49

7.3

1.5

2.45

2.72

mg/l

—

Nausea and vomiting

372

3465

1.06

0.48

1.7

1.6

5.01

3.44

mg/l

1.47

309

2319

Foreign body in respiratory tract

681

1.14

0.48

2.6

1.7

5.61

3.14

mg/l

0.62

474

Other acute disseminated demyelination

177

0.73

0.48

1.9

2.1

4.68

2.33

mg/l

—

120

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

335

3166

1.06

0.48

1.6

1.7

4.60

3.72

mg/l

1.14

281

2158

Amblyopia ex anopsia

560

0.85

0.48

1.4

1.7

2.98

3.40

mg/l

0.19

381

Erosion and ectropion of cervix uteri

322

0.80

0.48

2.0

1.8

1.91

3.14

mg/l

1.66

235

Monoarthritis, not elsewhere classified

592

0.86

0.48

1.4

1.7

2.30

4.12

mg/l

0.98

402

Melanocytic naevi of other and unspecified parts of face

868

0.88

0.48

2.2

1.7

2.72

3.88

mg/l

0.80

605

Benign neoplasm: Rectum

173

1597

1.09

0.48

1.8

1.7

4.43

3.56

mg/l

0.26

136

1160

Benign neoplasm: Long bones of lower limb

495

0.84

0.48

1.7

4.39

3.28

mg/l

0.38

338

Disorders of puberty

233

0.77

0.48

1.3

1.5

3.93

3.74

mg/l

0.05

143

Benign neoplasm of other and unspecified female genital organs

538

0.85

0.48

1.6

1.7

3.52

3.66

mg/l

0.03

374

Benign neoplasm: Skin of eyelid, including canthus

176

1627

1.08

0.47

1.4

1.7

3.09

3.58

mg/l

0.41

118

1179

Burns and corrosions confined to eye and internal organs

419

0.83

0.47

2.9

1.8

2.83

3.88

mg/l

0.61

288

Tooth agenesis EXCLUDE clefts and syndromes

644

0.86

0.47

1.4

1.6

6.62

3.52

mg/l

0.54

420

Other peripheral vertigo

108

976

1.11

0.47

1.6

1.7

2.82

3.59

mg/l

0.55

704

Scleritis

182

1.28

0.47

1.5

1.8

5.26

2.96

mg/l

0.93

137

Other obstructed labour

125

1370

0.91

0.47

1.4

1.7

3.40

3.72

mg/l

0.21

963

Benign neoplasm: Cranial nerves

321

0.80

0.47

1.4

1.7

1.20

2.82

mg/l

2.29

225

Dronedarone medication

244

0.77

0.47

2.8

1.4

2.48

2.89

mg/l

0.23

182

Benign neoplasm: Skin of ear and external auricular canal

354

0.82

0.47

1.6

1.7

2.30

4.53

mg/l

0.69

257

Pterygium

244

0.77

0.47

1.5

1.7

3.69

3.30

mg/l

0.09

184

Codes for special purposes

810

7817

1.04

0.47

1.8

1.6

5.32

3.40

mg/l

3.16

587

5328

Streptococcal septicaemia

814

0.88

0.47

1.7

10.78

3.92

mg/l

1.11

570

Superficial injury of wrist and hand

357

3384

1.06

0.47

1.9

1.6

4.16

3.55

mg/l

0.75

268

2281

Cluster headache, strict, including avohilmo

797

1.12

0.47

1.8

1.7

2.08

4.46

mg/l

2.06

541

Mandibular prognathia

232

0.77

0.46

1.4

1.6

1.86

3.27

mg/l

1.79

155

Other/unspecified dorsalgia

631

6032

1.04

0.46

1.7

3.76

3.50

mg/l

0.29

476

4161

Benign neoplasm: Liver

310

1.20

0.46

1.4

1.7

4.00

3.22

mg/l

0.24

211

Torsion of ovary, ovarian pedicle and fallopian tube

384

1.18

0.46

1.8

1.7

2.09

3.59

mg/l

1.73

256

Chondrocostal junction syndrome [Tietze]

477

1.16

0.46

1.5

1.7

5.33

4.41

mg/l

0.16

324

Intussusception

255

1.22

0.46

1.7

1.8

2.12

4.53

mg/l

0.57

191

Appendectomy

1324

12408

1.03

0.46

1.7

1.6

3.45

3.48

mg/l

0.05

981

8551

Major anomalies of jaw size

412

1.17

0.46

1.7

4.81

3.57

mg/l

0.26

277

Abnormal serum enzyme levels

302

2812

1.06

0.46

1.5

1.7

4.57

4.01

mg/l

0.27

227

1989

Asthma and opportunity respiratory infection

393

1.18

0.46

1.8

1.7

8.60

2.78

mg/l

1.48

292

Other disorders of adrenal gland

568

0.86

0.46

2.7

1.6

3.81

4.12

mg/l

0.09

404

Atopic dermatitis, strict definition

652

6147

1.04

0.46

1.6

3.65

3.54

mg/l

0.11

459

4129

Melanoma in situ

309

0.81

0.46

1.6

1.7

2.31

2.68

mg/l

0.19

240

Carcinoma in situ of cervix uteri, endocervix

253

0.78

0.46

1.6

1.8

2.99

2.88

mg/l

0.04

160

LeFortI or BSSRO operation

748

0.88

0.46

1.5

1.7

2.62

4.38

mg/l

1.01

511

Family history of malignant neoplasm

189

1757

1.08

0.45

1.5

2.11

3.37

mg/l

2.54

129

1217

Corneal ulcer

254

2703

0.94

0.45

1.6

1.7

3.49

3.85

mg/l

0.28

187

1882

Other symptoms and signs involving general sensations and perceptions

428

0.84

0.45

1.6

1.8

4.37

4.21

mg/l

0.03

307

Benign neoplasm: Skin of lower limb, including hip

329

1.19

0.45

1.5

1.7

9.57

4.46

mg/l

0.45

233

Labour and delivery complicated by fetal stress [distress]

669

4295

1.04

0.45

1.6

3.20

3.68

mg/l

1.10

452

2881

Right bundle-branch block

329

1.19

0.45

3.9

1.4

1.48

2.95

mg/l

2.99

245

Pedestrian injured in transport accident

894

1.11

0.45

1.4

1.7

3.58

4.26

mg/l

0.34

618

Symptoms and signs concerning food and fluid intake

129

1179

1.10

0.45

1.6

1.5

6.70

3.72

mg/l

0.61

780

Cushing syndrome

152

0.72

0.45

1.4

1.9

3.49

2.60

mg/l

0.42

108

Scar conditions and fibrosis of skin

582

1.14

0.45

1.9

1.7

7.07

4.35

mg/l

0.42

411

Maternal care for cervical incompetence

598

0.86

0.45

1.5

1.6

3.83

3.94

mg/l

0.03

406

Other and unspecified vascular occlusions

638

1.13

0.44

2.3

1.7

3.12

3.92

mg/l

0.33

471

Benign neoplasm: Larynx

302

1.20

0.44

1.8

3.82

3.18

mg/l

0.12

225

Other protozoal intestinal diseases

211

1.24

0.44

1.5

1.9

1.17

2.70

mg/l

2.16

149

Benign neoplasm of urinary organs

405

0.84

0.44

1.5

1.7

2.64

4.17

mg/l

0.50

297

Allergic purpura

437

0.84

0.44

1.7

1.8

2.90

3.75

mg/l

0.55

304

Pure hypercholesterolaemia

1056

6872

1.03

0.44

1.9

1.6

3.23

3.56

mg/l

0.52

848

4857

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

106

962

1.11

0.44

1.8

1.7

4.94

4.01

mg/l

0.42

679

Unspecified haematuria

431

3869

0.95

0.44

1.7

5.15

3.68

mg/l

1.08

315

2755

Benign neoplasm: Lip

219

0.77

0.44

1.5

1.9

3.11

3.58

mg/l

—

168

Tubulo-interstitial nephritis, not specified as acute or chronic

799

0.89

0.44

1.5

1.6

4.53

3.68

mg/l

0.24

559

Oral corticosteroids

2145

12705

1.02

0.44

2.5

1.5

5.78

3.07

mg/l

13.11

1705

8664

Urethral stricture

437

0.84

0.44

1.6

1.7

4.42

3.57

mg/l

0.19

308

Speech and linguistic disorders

159

1412

1.08

0.43

1.7

1.6

5.39

3.65

mg/l

0.97

122

915

Asthma, unspecified (mode), excluding more controls

974

7415

1.03

0.43

1.9

1.4

5.59

2.81

mg/l

4.26

774

4955

Care involving use of rehabilitation procedures

1022

9992

0.97

0.43

1.7

1.5

5.39

3.33

mg/l

3.95

740

7006

Bacterial intestinal infections, IBD co-morbidities

213

1993

1.07

0.43

1.6

1.7

5.40

3.71

mg/l

0.91

167

1413

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

404

0.84

0.43

1.7

4.58

4.29

mg/l

0.04

292

Cardiac murmurs and other cardiac sounds

125

1347

0.91

0.43

1.5

5.59

3.20

mg/l

1.03

883

Burn and corrosion confined to eye and adnexa

371

0.83

0.43

3.1

1.8

2.95

3.60

mg/l

0.33

253

Lesion of radial nerve

436

0.84

0.43

2.2

1.8

4.95

4.77

mg/l

0.03

314

Nutritional anaemias

610

5709

1.04

0.43

1.9

1.6

4.75

3.43

mg/l

1.63

470

4040

Other disorders of male genital organs

396

1.17

0.43

1.8

1.7

2.53

4.38

mg/l

0.76

276

Radial styloid tenosynovitis [de Quervain]

102

926

1.11

0.43

2.1

1.6

3.67

4.16

mg/l

0.20

610

Spondylolisthesis/Spondylolysis

258

2431

1.06

0.43

1.9

1.7

3.55

3.65

mg/l

0.07

201

1700

Iridocyclitis

338

3210

1.05

0.43

1.8

1.7

4.26

3.73

mg/l

0.40

243

2244

Diverticular disease of intestine

1033

6658

1.03

0.43

1.7

4.33

3.56

mg/l

1.28

789

4765

Other diseases of intestine

130

1194

1.09

0.42

1.9

1.6

5.80

3.51

mg/l

0.72

849

Urethritis and urethral syndrome

304

1.19

0.42

1.5

1.7

3.91

4.72

mg/l

0.14

214

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

425

1.16

0.42

2.4

1.7

3.69

3.45

mg/l

0.07

286

Other and unspecified iridocyclitis

542

0.86

0.42

2.3

1.7

3.03

4.29

mg/l

0.50

381

Other noninflammatory disorders of cervix uteri

542

0.86

0.42

1.5

1.7

1.83

3.42

mg/l

3.63

382

Foreign body entering into or through eye or natural orifice

118

1080

1.10

0.42

2.0

1.7

3.92

4.21

mg/l

0.12

751

Edwards' syndrome and Patau's syndrome

0.00

0.42

0.0

1.5

—

3.70

—

Explosion and rupture of other specified pressurized devices

0.00

0.42

0.0

1.3

—

1.38

—

Benign neoplasm: Long bones of lower limb

488

0.86

0.42

1.7

4.39

3.17

mg/l

0.43

342

Juvenile dermatomyositis

0.00

0.42

0.0

1.7

—

2.87

—

Abuse of non-dependence-producing substances

0.00

0.42

0.0

1.7

—

5.39

—

Other and unspecified hereditary haemolytic anaemias

0.00

0.42

0.0

2.1

—

1.46

—

Polyhydramnios

994

0.90

0.42

1.4

1.7

4.48

4.20

mg/l

0.08

661

Tuberculosis of nervous system

0.00

0.42

0.0

1.5

—

1.20

—

Other obstetric trauma

119

1091

1.10

0.42

1.7

3.89

4.09

mg/l

0.09

747

Diphtheria

0.00

0.42

0.0

1.8

—

1.75

—

Autonomic disorders

240

1.22

0.42

1.3

1.7

3.77

3.26

mg/l

0.10

178

Other drug-induced osteomalacia in adults

0.00

0.42

0.0

1.8

—

3.24

—

Mixed disorders of conduct and emotions

466

0.85

0.42

1.6

3.70

3.78

mg/l

0.03

292

Lens-induced iridocyclitis

0.00

0.41

0.0

1.6

—

3.15

—

Other factor of the environment

161

0.74

0.41

1.8

1.9

8.27

3.16

mg/l

—

124

Postpartum haemorrhage due to retained placenta

274

2591

1.06

0.41

1.6

3.75

3.23

mg/l

0.51

181

1751

Spondylopathies (FG)

220

2342

0.94

0.41

1.8

1.7

4.83

3.49

mg/l

0.64

169

1554

Severe bullous disorders, KELA reimbursement

0.00

0.41

0.0

2.7

—

3.11

—

Postprocedural disorders of eye and adnexa, not elsewhere classified

0.00

0.41

0.0

1.5

—

3.67

—

Spontaneous abortion

1030

6805

1.03

0.41

1.6

3.29

3.48

mg/l

0.43

703

4708

Carcinoma in situ of lip, oral cavity and pharynx

0.00

0.41

0.0

1.5

—

1.67

—

Drug-induced autoimmune haemolytic anaemia

0.00

0.41

0.0

1.6

—

1.42

—

Benign lipomatous neoplasm of intrathoracic organs

0.00

0.41

0.0

1.5

—

6.78

—

Mixed connective tissue disease

868

0.90

0.41

1.7

6.88

3.86

mg/l

0.51

606

Asthma, unspecified (mode)

976

7510

1.03

0.41

1.9

1.4

5.59

2.84

mg/l

4.19

776

5046

conjunctival scars

0.00

0.41

0.0

1.7

—

5.44

—

Female infertility, tubal origin

881

1.11

0.41

1.7

1.8

3.58

3.29

mg/l

0.22

595

Benign neoplasm: Liver/bile ducts

333

1.18

0.41

1.4

1.7

3.88

3.26

mg/l

0.19

229

Cardiomyopathy due to drugs and other external agents

0.00

0.41

0.0

1.8

—

1.76

—

Ventral hernia

288

2727

1.06

0.41

1.6

1.7

6.97

3.15

mg/l

1.32

227

1957

Benign neoplasm: Thymus

0.00

0.41

0.0

1.3

—

2.09

—

Asymmetry of jaw

260

0.80

0.41

2.4

1.8

2.35

3.40

mg/l

0.66

179

Other disorders of optic [2nd] nerve and visual pathways

773

0.89

0.41

1.9

1.7

6.65

3.34

mg/l

0.69

531

Alzheimer’s disease (undefined), excluding more controls

0.00

0.41

0.0

1.6

—

3.23

—

Other diseases of lip and oral mucosa

226

2125

1.07

0.41

1.7

1.6

3.48

2.99

mg/l

0.56

170

1477

Carcinoma in situ of breast, other/unspecified

138

0.72

0.41

1.4

1.8

2.46

1.98

mg/l

—

105

Single spontaneous delivery

727

4006

0.96

0.41

1.5

1.6

3.77

3.83

mg/l

0.02

491

2852

Hypertension, essential

1599

8913

1.02

0.41

1.8

1.6

4.59

3.19

mg/l

3.01

1320

6104

Failure in dosage during surgical and medical care

0.00

0.41

0.0

1.3

—

3.26

—

Abnormal findings on diagnostic imaging of other body structures

138

1493

0.92

0.41

1.9

1.7

3.13

3.51

mg/l

0.31

104

1074

Haemorrhage from respiratory passages

395

3499

1.05

0.41

1.6

4.42

3.27

mg/l

1.39

304

2412

Placenta praevia

971

0.90

0.40

1.9

1.7

3.20

4.09

mg/l

0.51

664

422

0.85

0.40

1.2

1.8

3.77

4.65

mg/l

0.20

291

Oesophageal obstruction

296

1.19

0.40

1.3

1.7

4.11

3.17

mg/l

0.23

217

Allergic urticaria

141

1304

1.08

0.40

1.7

1.6

3.76

3.92

mg/l

0.06

104

891

Other and unspecified thalassaemias

0.00

0.40

0.0

1.4

—

5.83

—

Other disorders of glucose regulation and pancreatic internal secretion

112

1025

1.10

0.40

1.9

1.7

3.57

4.19

mg/l

0.31

716

Rickettsioses

0.00

0.40

0.0

1.5

—

6.26

—

Superficial injury of forearm

138

1492

0.92

0.40

1.5

1.7

2.97

4.19

mg/l

1.20

1017

Traumatic amputation of lower leg

0.00

0.40

0.0

1.7

—

5.17

—

Other deformities of toe(s)

422

0.85

0.40

1.8

2.37

4.47

mg/l

0.79

297

Mandibular retrognathia

103

1124

0.91

0.40

1.7

2.62

4.37

mg/l

1.63

754

Femoral hernia

427

1.15

0.40

2.2

1.7

4.30

2.88

mg/l

0.38

317

Substance use, excluding alcohol

319

3354

0.95

0.40

1.6

1.7

5.58

3.52

mg/l

2.06

270

2270

209

0.78

0.40

1.1

1.3

8.33

4.20

mg/l

0.53

132

Medial epicondylitis

560

0.87

0.40

1.8

1.6

2.91

4.69

mg/l

0.71

380

208

2213

0.94

0.40

1.3

1.6

2.95

3.78

mg/l

1.06

146

1465

Twin gestation

183

1955

0.93

0.40

1.9

1.7

3.00

3.66

mg/l

0.74

136

1352

Benign neoplasm: Short bones of lower limb

137

0.72

0.40

1.6

2.0

1.79

2.90

mg/l

—

Other papulosquamous disorders

137

0.72

0.39

2.2

1.6

2.09

3.24

mg/l

—

Retained placenta and membranes, without haemorrhage

196

2089

0.94

0.39

1.7

3.06

3.54

mg/l

0.50

129

1473

Benign neoplasm: Skin, unspecified

485

0.86

0.39

2.1

1.7

6.46

2.96

mg/l

0.51

353

LSIL lesion of the vulva

442

0.85

0.39

2.0

1.8

3.79

2.85

mg/l

0.22

305

Other infective spondylopathies

0.00

0.39

0.0

1.5

—

0.85

—

Other specified/unspecified disorders of middle ear and mastoid

0.00

0.39

0.0

1.7

—

6.15

—

Other/unspecified disorders of vestibular function

378

0.84

0.39

1.9

1.7

5.19

2.65

mg/l

1.07

273

Malignant melanoma, excluding all cancers (controls excluding all cancers)

160

1718

0.93

0.39

1.7

2.69

3.68

mg/l

1.15

118

1217

Melanocytic naevi of eyelid, including canthus

133

1.29

0.39

1.7

1.9

3.17

3.20

mg/l

0.01

Monocytic leukaemia

0.00

0.39

0.0

1.5

—

1.27

—

Astigmatism

835

1.10

0.39

1.7

1.6

3.81

4.12

mg/l

0.11

567

Specific development disorders of speech and language

832

1.10

0.39

1.8

1.6

5.27

3.69

mg/l

0.49

548

Other and unspecified injuries of wrist and hand

551

1.13

0.39

1.3

1.8

2.68

3.34

mg/l

0.47

377

COPD/asthma related infections

2228

11370

0.98

0.39

1.8

1.6

4.33

3.09

mg/l

5.52

1643

7687

COPD/asthma/ILD related infections

2228

11370

0.98

0.39

1.8

1.6

4.33

3.09

mg/l

5.52

1643

7687

Benign neoplasm: Sigmoid colon

177

1654

1.07

0.39

1.7

6.26

3.57

mg/l

1.02

135

1202

Artrosis, including avohilmo

1654

8876

1.02

0.39

1.7

4.20

3.45

mg/l

1.07

1292

6210

Embedded teeth, including avohilmo

173

1849

0.93

0.38

1.5

1.6

4.43

4.12

mg/l

0.08

116

1212

Other/unspecified enthesopathies, not elsewhere classified

117

1077

1.09

0.38

1.8

1.7

4.91

4.20

mg/l

0.21

739

Congenital malformations of aortic and mitral valves

547

0.87

0.38

1.5

1.8

2.60

3.55

mg/l

0.85

389

Infective bursitis

317

1.17

0.38

1.6

1.8

4.63

5.72

mg/l

0.15

225

Other disorders of amniotic fluid and membranes

315

3275

0.95

0.38

1.6

3.36

3.66

mg/l

0.41

216

2212

Congenital malformations of cardiac septa

885

0.90

0.38

1.7

6.58

4.33

mg/l

0.40

609

Malignant melanoma

123

1332

0.92

0.38

1.6

1.7

2.93

3.70

mg/l

0.60

955

Carcinoma in situ of cervix uteri, endocervix

246

0.80

0.38

1.6

1.8

2.98

2.84

mg/l

0.06

162

Other benign neoplasms of connective and other soft tissue

120

1300

0.92

0.38

1.3

1.7

2.67

3.92

mg/l

1.29

900

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

102

1113

0.91

0.38

1.7

5.62

3.80

mg/l

0.56

778

Hydrocele

100

914

1.10

0.38

1.5

1.7

5.27

3.85

mg/l

0.37

634

Other otitis externa (chronic)

819

1.10

0.38

1.7

5.19

3.96

mg/l

0.37

568

Other localized connective tissue disorders

234

1.20

0.38

1.5

1.7

3.14

2.27

mg/l

0.70

173

Other congenital malformations

130

1402

0.92

0.38

1.5

1.7

5.97

4.21

mg/l

0.54

953

Carcinoma in situ of breast, intraductal

107

982

1.09

0.37

1.5

1.7

2.34

3.59

mg/l

0.99

717

Dysplastic lesion of unknown severity of the cervix uteri

191

0.78

0.37

1.1

1.8

3.21

2.48

mg/l

—

125

Late syphilis

152

1.26

0.37

2.7

2.0

2.22

3.24

mg/l

0.53

113

Benign neoplasm: Brain, supratentorial

213

0.79

0.37

1.4

1.8

2.73

3.34

mg/l

—

155

Other/unspecified soft tissue disorders related to use, overuse and pressure

421

1.15

0.37

1.8

1.6

6.13

5.09

mg/l

0.10

283

Cluster headache, wide,, including avohilmo

830

1.10

0.37

1.8

1.7

2.07

4.41

mg/l

2.13

569

Trochanteric bursitis

186

1746

1.07

0.37

1.6

4.61

3.53

mg/l

0.61

155

1207

Other specified disorders of kidney and ureter

346

1.16

0.37

1.9

1.8

3.82

4.64

mg/l

0.18

256

Use of donepezil

708

0.90

0.37

1.7

1.5

1.26

3.08

mg/l

5.27

538

Other and unspecified injuries of neck

135

0.73

0.37

2.0

1.7

3.51

3.27

mg/l

—

Septal defects

832

0.90

0.37

1.6

1.7

4.55

4.38

mg/l

0.04

572

Abnormal findings on diagnostic imaging of lung

511

4792

1.04

0.37

2.2

1.7

6.96

3.42

mg/l

3.44

412

3418

Alcohol-induced acute pancreatitis

407

0.86

0.37

1.3

1.8

10.19

4.59

mg/l

0.54

289

Nerve, nerve root and plexus disorders

1948

12471

0.98

0.36

1.8

1.6

3.92

3.47

mg/l

1.10

1471

8681

Filling of root of tooth

403

1.15

0.36

1.8

1.7

5.45

3.13

mg/l

0.43

287

Infectious mononucleosis

190

1787

1.07

0.36

1.4

1.6

4.14

3.70

mg/l

0.26

134

1177

Supervision of high-risk pregnancy

542

3159

1.04

0.36

1.7

1.6

3.59

3.91

mg/l

0.33

373

2227

Neonatal jaundice from other and unspecified causes

104

1.31

0.36

1.1

1.4

4.90

4.63

mg/l

—

Other and unspecified mononeuropathies of upper limb

417

0.86

0.36

1.6

1.8

2.65

4.16

mg/l

0.46

292

Benign neoplasm: Brain, unspecified

0.63

0.36

2.4

1.9

4.99

3.64

mg/l

—

Benign neoplasm of other and unspecified sites

385

0.85

0.36

1.3

1.7

1.97

4.51

mg/l

0.99

273

Evidence of alcohol involvement determined by level of intoxication

162

1.25

0.36

1.6

1.8

4.33

3.89

mg/l

0.08

114

Special screening examination for other diseases and disorders

127

1177

1.08

0.36

1.5

1.6

2.95

3.35

mg/l

0.24

778

Juvenile osteochondrosis

555

1.12

0.36

1.7

1.8

5.49

3.59

mg/l

0.40

371

Liposarcoma, excluding all cancers (controls excluding all cancers)

1.33

0.36

1.4

1.5

3.43

2.66

mg/l

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

0.63

0.36

3.6

1.8

1.88

4.11

mg/l

—

ILD medications: nintedanib

1.44

0.36

2.7

1.4

58.39

2.85

mg/l

—

Perichondritis of external ear

162

1.24

0.36

2.3

1.8

1.80

2.92

mg/l

0.88

119

Congenital malformations of breast

329

1.16

0.36

1.8

1.7

2.69

3.06

mg/l

0.34

219

ILD, hospital admissions 1, main diag only

109

1004

1.09

0.36

2.0

1.7

29.35

3.44

mg/l

6.54

719

Azathioprine

227

2398

0.94

0.35

6.7

1.5

8.99

3.44

mg/l

2.41

184

1634

Fall on and from stairs and steps

327

3422

0.95

0.35

1.8

1.7

3.61

3.80

mg/l

0.17

253

2403

Diseases of liver

430

4473

0.96

0.35

1.9

1.7

3.92

3.60

mg/l

0.37

357

3137

Benign neoplasm of mouth and pharynx

122

1316

0.92

0.35

1.5

1.7

2.33

4.04

mg/l

1.92

919

Non-allergic asthma (mode), excluding more controls

288

2717

1.05

0.35

1.7

1.4

6.28

2.76

mg/l

2.96

209

1788

Oesophagitis

554

0.88

0.35

1.6

3.69

3.14

mg/l

0.26

389

Orchitis and epididymitis

803

1.10

0.35

1.5

1.7

5.91

3.88

mg/l

0.46

551

Lichen planus, including avohilmo

226

2139

1.06

0.35

1.8

1.7

5.11

3.62

mg/l

0.79

165

1549

Persons encountering health services for specific procedures and health care

2137

13470

0.98

0.35

2.5

1.5

4.83

3.31

mg/l

6.06

1593

9273

Non-allergic asthma (mode)

288

2718

1.05

0.35

1.7

1.4

6.28

2.85

mg/l

2.83

209

1799

Other inflammation of vagina/vulva

680

1.11

0.35

1.4

1.7

4.75

3.88

mg/l

0.21

449

Male infertility

651

1.11

0.35

1.6

1.8

4.51

3.54

mg/l

0.22

436

Exclusions for E4_PCOS_BROAD

262

2489

1.05

0.35

1.8

1.7

3.94

3.69

mg/l

0.21

192

1741

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

182

1712

1.07

0.35

1.6

1.7

2.64

3.92

mg/l

1.81

131

1222

Other specified/unspecified systemic involvement of connective tissue

805

0.90

0.35

1.7

7.72

3.81

mg/l

0.63

564

Ulcerative proctitis

951

0.91

0.35

1.4

1.7

3.00

4.09

mg/l

0.69

659

Burns and corrosions

195

2067

0.94

0.35

2.1

1.7

3.28

3.95

mg/l

0.71

147

1423

Benign neoplasm: Kidney

330

0.84

0.35

1.6

1.7

2.79

4.67

mg/l

0.50

238

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

574

0.89

0.35

1.2

1.8

2.88

4.20

mg/l

0.54

404

Other viral diseases, not elsewhere classified

309

2943

1.05

0.34

1.7

4.92

3.68

mg/l

0.75

226

2026

Pedal cyclist injured in transport accident

334

3490

0.96

0.34

1.6

1.7

3.83

3.75

mg/l

0.04

229

2405

Chronic hepatitis, not elsewhere classified

424

1.14

0.34

1.6

1.7

4.46

4.29

mg/l

0.04

305

Delivery, wide proxy

649

3342

1.03

0.34

1.5

1.6

4.29

3.79

mg/l

0.22

438

2340

Other congenital malformations of the digestive system

549

0.88

0.34

1.7

3.27

4.42

mg/l

0.40

380

Mandibular hypoplasia

118

1.29

0.34

1.5

2.0

9.07

2.76

mg/l

—

Chorioretinal inflammation

349

1.15

0.34

1.6

1.7

11.13

4.80

mg/l

0.49

249

Cysts of oral region, not elsewhere classified

573

0.89

0.34

2.0

1.6

3.50

2.98

mg/l

0.31

409

HSIL lesion of the vagina

191

1.21

0.34

1.7

1.9

2.45

2.32

mg/l

0.05

134

Other specified/unspecified bacterial intestinal infections

729

1.10

0.34

1.7

5.06

3.83

mg/l

0.28

513

Gonarthrosis,primary

1330

8181

1.02

0.34

1.8

1.7

4.05

3.54

mg/l

0.87

1060

5858

Amyloidosis, other/unspecified

136

1.26

0.34

1.7

2.51

2.61

mg/l

0.04

101

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

454

3823

0.96

0.34

1.7

2.43

3.19

mg/l

2.05

365

2741

Acquired clawhand, clubhand, clawfoot and clubfoot

0.68

0.34

2.0

1.9

7.98

2.97

mg/l

—

Iron deficiency anaemia

522

4993

1.04

0.34

1.9

1.6

4.87

3.39

mg/l

1.66

394

3523

Exposure to smoke, fire and flames

318

0.84

0.34

1.8

3.74

3.49

mg/l

0.09

225

Seborrhoeic dermatitis

102

1105

0.92

0.33

1.8

1.7

3.39

3.38

mg/l

0.00

770

Insulin, fast-acting (human)

257

2446

1.05

0.33

1.5

1.7

3.45

3.59

mg/l

0.11

244

1626

Post-traumatic wound infection, not elsewhere classified

312

1.16

0.33

2.2

1.8

2.74

5.19

mg/l

0.68

225

ILD medications: azathioprine

227

2392

0.95

0.33

6.7

1.4

8.99

3.27

mg/l

2.53

184

1608

Specific development disorders of scholastic skills

750

1.10

0.33

1.5

1.7

5.44

3.54

mg/l

1.09

488

Pregnancy hypertension

938

8243

1.03

0.33

1.8

1.6

4.46

3.29

mg/l

1.23

693

5679

Trigger finger

215

2037

1.06

0.33

1.6

1.7

3.06

3.79

mg/l

0.84

179

1389

Haemolytic anaemias

371

0.86

0.33

2.8

1.6

5.90

3.13

mg/l

0.63

264

Fall on and from ladder

730

1.10

0.33

1.7

1.8

2.35

3.73

mg/l

1.52

531

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

373

3583

1.04

0.33

2.2

1.7

5.29

3.55

mg/l

3.43

333

2490

Maternal care for other conditions predominantly related to pregnancy

510

4864

1.04

0.33

1.7

1.6

3.56

3.40

mg/l

0.22

375

3216

Other and unspecified nail disorders

274

0.83

0.33

3.3

1.8

3.08

2.98

mg/l

0.03

199

Injury, poisoning and certain other consequences of external causes

1346

6601

1.02

0.33

1.7

1.6

4.23

3.23

mg/l

1.32

962

4341

Diseases of peritoneum

101

1093

0.92

0.33

1.4

1.7

3.96

3.77

mg/l

0.07

785

Presbycusis

548

0.89

0.33

2.0

1.6

1.68

3.59

mg/l

1.16

420

Falls/tendency to fall

2526

12451

1.02

0.33

1.6

3.98

3.38

mg/l

1.26

1847

8461

Other congenital malformations of peripheral vascular system

198

0.80

0.32

1.8

3.11

3.65

mg/l

0.14

141

Dental pulpitis 3

300

2259

0.95

0.32

1.4

4.79

3.59

mg/l

2.10

220

1365

Injuries to the elbow and forearm

1193

11018

0.98

0.32

1.7

1.6

3.46

3.50

mg/l

0.06

861

7597

Use of galantamine

231

0.82

0.32

1.9

1.4

1.13

3.15

mg/l

2.45

185

Use of amantadine

187

0.80

0.32

1.6

2.0

1.45

3.47

mg/l

—

139

Schizoid personality disorder

252

0.83

0.32

2.3

1.8

1.58

3.28

mg/l

1.68

180

Early lumbar disc prolapse, operated

207

1962

1.06

0.32

1.9

1.7

4.50

3.89

mg/l

0.19

153

1314

Metabolic disorders

1653

10461

0.98

0.32

1.9

1.6

3.78

3.52

mg/l

0.45

1327

7297

Other specified/unspecified dorsopathies

465

0.88

0.32

1.7

3.26

4.34

mg/l

0.32

338

Benign neoplasm: Liver

323

1.15

0.32

1.4

1.7

4.00

3.15

mg/l

0.27

215

Anomalies of pupillary function

316

0.85

0.32

1.7

1.8

2.63

3.00

mg/l

0.11

226

All influenza

330

3440

0.96

0.32

1.9

1.6

4.74

3.54

mg/l

0.80

243

2366

L02BA Anti-estrogens

231

2196

1.05

0.32

1.6

1.7

2.26

3.38

mg/l

2.20

177

1593

Type 1 diabetes, wide definition

369

3833

0.96

0.32

1.5

1.6

3.84

3.38

mg/l

0.56

343

2520

Adrenocortical insufficiency

433

0.87

0.32

2.9

1.7

4.28

4.27

mg/l

0.00

316

Other and unspecified injuries of lower leg

104

1122

0.92

0.32

1.8

1.7

4.52

4.35

mg/l

0.08

759

Congenital malformations of heart and great arteries

175

1795

0.94

0.32

1.5

1.6

5.64

4.14

mg/l

0.56

118

1226

Vitamin D deficiency

239

1.18

0.32

1.6

1.7

3.71

3.05

mg/l

0.19

162

Follicular cysts of skin and subcutaneous tissue

237

2489

0.95

0.31

1.6

1.7

4.92

3.66

mg/l

0.63

182

1737

Sequelae of external causes of morbidity and mortality

290

3031

0.96

0.31

1.7

1.6

5.31

3.59

mg/l

0.98

226

2142

Disorders of tooth development and eruption

863

1.09

0.31

1.7

1.6

8.25

3.43

mg/l

0.96

572

Other and unspecified corneal deformities and disorders

418

1.13

0.31

1.6

1.7

2.62

4.54

mg/l

0.66

296

Parapsoriasis

251

0.83

0.31

1.4

1.8

3.02

3.36

mg/l

0.15

190

Postprocedural endocrine and metabolic disorders, not elsewhere classified

193

1828

1.06

0.31

1.9

1.7

4.61

3.60

mg/l

0.54

147

1265

Disorders of lipoprotein metabolism and other lipidaemias

1285

7909

1.02

0.31

1.9

1.7

3.38

3.52

mg/l

0.20

1040

5561

Other diseases of gallbladder

418

1.13

0.31

1.7

6.08

2.95

mg/l

0.68

298

Other and unspecified dermatitis

823

8022

1.03

0.31

1.8

1.7

4.11

3.29

mg/l

1.40

617

5574

Burn and corrosion of trunk

379

0.87

0.31

1.8

3.32

3.89

mg/l

0.24

263

Chronic periapical parodontitis

308

2953

1.04

0.31

2.0

1.6

7.86

3.03

mg/l

4.72

266

2022

Coxarthrosis, primary, with hip surgery

412

4049

0.96

0.31

1.6

1.7

3.33

3.66

mg/l

0.33

329

2908

Other facial nerve disorders

362

1.14

0.30

1.5

1.8

2.53

4.61

mg/l

0.68

260

Family history of other specific disorders

203

1.19

0.30

1.7

1.5

5.10

2.80

mg/l

0.63

133

952

0.92

0.30

1.7

1.6

2.51

3.43

mg/l

0.67

718

Abnormal weight loss

922

0.92

0.30

1.5

1.7

8.20

3.94

mg/l

0.59

650

Other bacterial intestinal infections

210

1996

1.05

0.30

1.7

5.51

3.09

mg/l

1.57

161

1405

Trigeminal neuralgia

706

1.09

0.30

2.1

1.7

3.79

3.86

mg/l

0.02

491

Use of selegiline

325

0.86

0.30

1.4

1.6

1.91

4.58

mg/l

0.90

250

Diseases of pulp and periapical tissues

609

5916

1.03

0.30

1.9

1.6

6.08

2.97

mg/l

5.59

524

4036

Acute suppurative otitis media

590

5349

1.03

0.30

1.6

3.54

3.56

mg/l

0.03

412

3513

Polyarteritis nodosa and related conditions

163

0.79

0.30

1.0

1.7

7.09

3.77

mg/l

—

110

All dysplastic lesions of the cervix uteri, vagina or vulva

620

6336

0.97

0.30

1.7

1.6

2.97

3.43

mg/l

1.19

421

4352

Maternal care for known or suspected abnormality of pelvic organs

605

4296

0.97

0.29

1.6

1.7

3.52

3.60

mg/l

0.10

439

2933

Postpartum haemorrhage

616

5211

1.03

0.29

1.6

3.36

3.60

mg/l

0.40

411

3555

Parasetamol

1996

10023

1.02

0.29

1.8

1.5

4.39

3.09

mg/l

3.49

1546

6432

Extracorporeal dialysis

611

1.10

0.29

1.8

1.7

8.65

4.72

mg/l

1.02

437

Other blood glucose lowering drugs, excl. Insulins

152

1612

0.94

0.29

2.0

1.7

4.74

3.59

mg/l

0.65

132

1133

Gastric ulcer

138

1468

0.94

0.29

1.9

1.7

5.44

3.07

mg/l

1.13

116

1045

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

106

987

1.08

0.29

1.8

1.7

4.94

4.04

mg/l

0.40

690

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

440

0.88

0.29

1.8

1.9

3.54

3.34

mg/l

0.04

301

Injury of unspecified body region

900

1.08

0.29

1.6

1.7

4.34

3.47

mg/l

0.23

633

Uterine polyps

132

1239

1.07

0.29

1.7

1.8

3.34

3.45

mg/l

0.06

100

871

Carbimazole or st.post thyroidectomy, condition for graves disease

332

3194

1.04

0.29

2.2

1.7

3.34

3.62

mg/l

0.32

259

2238

Atypical facial pain

679

1.09

0.29

2.0

1.7

2.54

3.95

mg/l

0.84

476

Dermatophytosis

147

1385

1.06

0.29

1.7

1.8

3.78

3.90

mg/l

0.06

114

975

Congenital malformations of the nervous system

355

0.87

0.29

1.5

1.7

5.71

2.77

mg/l

0.89

233

Benign neoplasm: Skin of eyelid, including canthus

176

1668

1.06

0.29

1.4

1.7

3.09

3.75

mg/l

0.60

118

1180

Hereditary deficiency of other clotting factors

140

0.78

0.28

1.5

1.7

3.13

2.58

mg/l

—

101

Abnormality of white blood cells, not elsewhere classified

103

1.27

0.28

1.1

1.8

2.09

3.42

mg/l

—

Osteomyelitis

607

0.90

0.28

1.6

5.32

4.25

mg/l

0.19

432

Disorders of continuity of bone

142

1338

1.06

0.28

1.4

1.7

3.70

3.66

mg/l

0.02

105

929

Poisoning by medicine

420

4062

1.04

0.28

1.6

1.7

4.29

3.64

mg/l

0.91

353

2781

Examination and encounter for administrative purposes

450

1.11

0.28

1.7

2.51

2.64

mg/l

0.06

306

Other/unspecified synovitis and tenosynovitis

173

1640

1.06

0.28

1.7

4.06

3.89

mg/l

0.07

132

1122

Coeliac disease

169

1783

0.95

0.28

1.8

1.7

3.67

3.63

mg/l

0.01

125

1242

Open wound of ankle and foot

149

1407

1.06

0.28

2.5

1.7

4.31

4.10

mg/l

0.11

120

970

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

226

0.83

0.28

1.2

1.7

3.35

2.46

mg/l

0.62

148

Disorders of eyelid in diseases classified elsewhere

403

1.12

0.28

1.6

1.7

3.54

4.32

mg/l

0.18

274

Muscle strain

459

0.89

0.27

2.4

1.6

3.83

5.43

mg/l

0.45

310

Any event in hilmo or specialist outpatient

1.20

0.27

1.5

1.2

3.32

2.09

mg/l

0.41

Abscess of Bartholin gland

490

0.89

0.27

2.0

1.6

3.30

4.05

mg/l

0.22

332

Chronic iridocyclitis

647

0.91

0.27

2.5

1.7

2.63

3.93

mg/l

0.69

457

Benign neoplasm of other and unspecified endocrine glands

145

1535

0.94

0.27

1.5

1.7

4.18

3.77

mg/l

0.15

107

1090

Abrasion of teeth

425

3023

1.03

0.27

1.6

1.7

3.22

3.13

mg/l

0.07

311

2078

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

416

0.88

0.27

1.7

2.31

3.07

mg/l

0.75

267

Benign neoplasm: Liver/bile ducts

347

1.13

0.27

1.4

1.7

3.88

3.24

mg/l

0.20

235

Melanocytic naevi of other and unspecified parts of face

833

0.92

0.27

2.2

1.7

2.72

3.79

mg/l

0.70

586

Dermatographic urticaria

115

1079

1.07

0.27

1.7

1.6

2.89

4.07

mg/l

0.93

738

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

448

4343

1.03

0.27

1.7

3.69

3.57

mg/l

0.08

333

3006

Acute bronchiolitis

777

0.92

0.27

1.4

1.5

3.91

3.73

mg/l

0.09

506

Benign neoplasm: Uterine tubes and ligaments

0.70

0.26

1.2

1.8

7.90

1.78

mg/l

—

Benign neoplasm: Brain, unspecified

0.69

0.26

2.4

2.0

4.99

3.69

mg/l

—

Idiopathic gout

656

0.91

0.26

1.9

1.7

6.17

3.24

mg/l

0.88

465

Other respiratory disorders and diseases

154

1625

0.95

0.26

1.8

1.7

17.97

3.50

mg/l

6.02

132

1162

Other diseases of the respiratory system

154

1625

0.95

0.26

1.8

1.7

17.97

3.50

mg/l

6.02

132

1162

Dermatitis herpetiformis

214

0.84

0.26

1.7

2.0

1.10

2.85

mg/l

2.25

158

Benign neoplasm: Uterine tubes and ligaments

0.67

0.26

1.2

1.6

7.90

2.12

mg/l

—

Carcinoma in situ of other and unspecified digestive organs

214

0.84

0.26

1.3

1.6

6.20

5.97

mg/l

0.01

159

Herpesviral keratitis and keratoconjunctivitis

499

0.90

0.26

1.7

5.04

4.15

mg/l

0.12

360

Exposure to other specified electric current

197

1.18

0.26

1.5

1.8

3.02

4.32

mg/l

0.51

131

Sacroiliitis, not elsewhere classified

883

0.93

0.26

2.1

1.7

4.06

4.33

mg/l

0.10

595

Benign neoplasm of other and unspecified sites

373

0.88

0.26

1.3

1.8

1.97

4.43

mg/l

0.97

278

Reiter disease

0.66

0.26

1.6

1.8

3.98

5.29

mg/l

—

Direct fill therapy

199

1899

1.05

0.26

1.9

1.6

9.76

3.75

mg/l

2.99

157

1314

Carcinoma in situ of skin of trunk

141

1.21

0.26

1.5

1.7

2.72

2.52

mg/l

—

112

Other injuries of upper limb, level unspecified

132

1.22

0.26

1.6

1.7

4.11

3.14

mg/l

—

Gout, strict definition

116

1234

0.94

0.26

2.3

1.7

5.68

3.60

mg/l

1.05

107

879

Benign neoplasm: Rectosigmoid junction

310

1.13

0.26

1.5

1.8

1.73

4.42

mg/l

0.87

237

Benign neoplasm: Skin of trunk

501

1.10

0.26

1.6

1.7

2.34

4.04

mg/l

0.76

359

Malignant neoplasm of breast, HER-negative

240

2299

1.04

0.26

1.7

2.63

3.33

mg/l

1.02

169

1638

Carcinoma in situ of cervix uteri

173

1817

0.95

0.26

1.5

1.7

3.28

3.81

mg/l

0.42

112

1238

Iliotibial band syndrome

188

1.18

0.26

2.8

1.9

2.12

5.65

mg/l

0.66

143

Deforming dorsopathies

449

4357

1.03

0.26

1.8

1.6

3.42

3.61

mg/l

0.23

325

2989

Benign neoplasm of eye and adnexa

118

1110

1.07

0.26

2.1

1.7

4.66

3.70

mg/l

0.22

781

Benign neoplasm: Parotid gland

831

0.92

0.26

1.6

1.7

4.34

3.74

mg/l

0.14

586

Pyogenic arthritis

717

0.92

0.26

1.5

1.7

6.16

3.74

mg/l

0.44

493

Open wound of hip and thigh

463

1.11

0.26

1.5

1.7

4.62

3.96

mg/l

0.23

315

Benign lipomatous neoplasm

402

3894

1.03

0.26

1.6

1.7

3.41

3.55

mg/l

0.16

299

2724

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1119

6461

1.02

0.25

1.6

3.16

3.56

mg/l

1.19

750

4479

Acute nasopharyngitis (common cold)

188

1958

0.95

0.25

2.1

1.7

3.26

4.02

mg/l

0.60

133

1332

Other complications of labour and delivery, not elsewhere classified

294

2730

1.04

0.25

1.6

3.29

3.88

mg/l

0.81

198

1780

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

162

1540

1.05

0.25

2.3

1.7

4.65

3.04

mg/l

2.43

127

1053

Benign neoplasm: Scapula and long bones of upper limb

151

1.20

0.25

1.2

1.9

2.28

2.93

mg/l

0.27

115

Diabetic retinopathy

309

1879

1.04

0.25

1.8

2.1

4.26

4.87

mg/l

0.70

278

1601

Amputation of foot

181

0.83

0.25

2.4

1.7

12.88

2.48

mg/l

1.10

135

Benign neoplasm of meninges

1016

0.93

0.25

1.8

1.7

3.48

3.54

mg/l

0.03

752

Pregnancy, childbirth and the puerperium

546

2778

1.03

0.25

1.5

1.6

4.33

3.92

mg/l

0.14

367

1932

Other and unspecified follicular disorders

550

1.09

0.25

1.7

1.8

3.77

4.64

mg/l

0.29

373

Other disorders of the musculoskeletal system and connective tissue

159

1673

0.95

0.25

1.7

4.48

3.90

mg/l

0.28

122

1198

Idiopathic urticaria

340

0.88

0.25

1.4

1.7

1.82

2.85

mg/l

1.64

227

Obstructed labour due to maternal pelvic abnormality

255

2451

1.04

0.25

1.7

3.27

3.33

mg/l

0.03

172

1754

Volvulus

245

0.85

0.25

1.4

1.7

9.14

2.27

mg/l

0.55

187

Covid-19 confirmed case

414

4014

1.03

0.25

1.9

1.6

6.50

3.55

mg/l

2.57

309

2768

Viral pneumonia

153

1611

0.95

0.25

1.5

1.7

6.13

3.49

mg/l

1.14

114

1113

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1015

8709

1.02

0.25

1.8

1.6

4.42

3.29

mg/l

1.32

753

6009

Other and unspecified drugs and medicaments

1046

0.93

0.25

1.7

6.15

3.94

mg/l

0.99

733

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

148

0.81

0.25

1.8

2.0

0.76

2.59

mg/l

—

108

Alopecia areata

413

0.89

0.25

1.9

1.94

4.52

mg/l

1.05

277

Correction of physiology of bite - demanding therapy visit

124

1171

1.06

0.25

1.5

1.7

4.51

3.76

mg/l

0.21

814

Misadventures to patients during surgical and medical care

166

1743

0.95

0.24

2.1

1.6

3.50

3.61

mg/l

0.06

124

1230

Constipation

1410

9932

1.02

0.24

1.6

1.7

3.44

3.57

mg/l

0.21

1053

7032

Mental and behavioural disorders due to opioids

673

0.92

0.24

1.7

6.10

3.65

mg/l

1.28

449

Rheumatic fever incl heart disease

255

0.86

0.24

1.6

1.7

6.26

3.25

mg/l

0.43

192

Nail disorders

118

1113

1.06

0.24

2.4

1.7

2.60

4.06

mg/l

1.31

780

Carcinoma in situ of cervix uteri

173

1813

0.95

0.24

1.5

1.7

3.28

3.69

mg/l

0.31

112

1215

Benign neoplasm of other and ill-defined parts of digestive system

204

1953

1.05

0.24

1.8

1.7

5.93

3.76

mg/l

0.92

158

1382

Missing teeth due to accident, extraction or parodontitis

133

1404

0.95

0.24

2.0

1.6

5.44

3.03

mg/l

1.47

111

985

Benign lipomatous neoplasm of other sites/unspecified

890

0.93

0.24

1.4

1.7

4.35

3.91

mg/l

0.15

627

Other nutritional anaemias

0.72

0.24

2.0

1.5

1.85

2.24

mg/l

—

Superficial injury of shoulder and upper arm

143

1506

0.95

0.24

1.7

3.36

4.27

mg/l

0.73

107

1047

Use of disulfiram, acamprosate or naltrexone

120

1270

0.94

0.24

1.6

1.8

4.59

4.18

mg/l

0.14

106

894

Nonspecific lymphadenitis

103

968

1.07

0.24

1.4

1.8

4.72

3.99

mg/l

0.13

686

Postpartum hemorraghe, all women as controls

616

5988

1.03

0.24

1.6

3.36

3.44

mg/l

0.12

411

4072

Sixth [abducent] nerve palsy

307

0.88

0.24

1.7

2.49

2.96

mg/l

0.25

233

Donors of organs and tissues

222

0.85

0.24

1.1

1.6

3.89

2.69

mg/l

0.37

157

Dislocation, sprain and strain of joints and ligaments of thorax

443

0.90

0.23

1.9

1.7

4.08

4.31

mg/l

0.05

311

Burns and corrosions of external body surface, specified by site

148

1556

0.95

0.23

2.1

1.7

3.36

4.08

mg/l

0.58

109

1074

Familial hypercholesterolemia, with ischemic heart disease

641

0.92

0.23

1.7

1.6

5.45

3.75

mg/l

0.23

468

Benign neoplasm: Short bones of upper limb

243

0.86

0.23

1.1

1.8

2.83

3.18

mg/l

0.14

172

Social disorders starting during childhood or adolecense, excluding more controls

106

1.24

0.23

1.3

1.8

6.07

2.55

mg/l

—

Toxic effect of other noxious substances eaten as food

1.33

0.23

1.0

1.6

4.79

3.16

mg/l

—

Adhesive capsulitis of shoulder

230

2211

1.04

0.23

1.5

1.7

2.79

3.65

mg/l

1.38

185

1522

Liveborn infants according to place of birth

115

1.21

0.23

1.7

1.4

1.50

4.02

mg/l

—

Disorders of gallbladder, biliary tract and pancreas

1712

11186

0.99

0.23

1.7

4.64

3.38

mg/l

2.73

1375

7836

Intentional self-harm by jumping from a high place

0.76

0.23

1.3

1.7

14.10

3.34

mg/l

—

Other inflammatory liver diseases

815

0.93

0.23

2.0

1.7

4.71

4.16

mg/l

0.11

566

Retinal haemorrhage

200

0.85

0.23

1.6

1.44

3.00

mg/l

1.40

147

Hereditary retinal dystrophy

181

1.17

0.23

1.8

1.9

2.09

3.42

mg/l

0.74

131

Femoral hernia, unilateral

266

1.13

0.23

2.7

1.7

5.13

3.00

mg/l

0.33

204

Inguinal hernia, unilateral

266

1.13

0.23

2.7

1.7

5.13

3.00

mg/l

0.33

204

Inguinal of femoral hernia, unilateral

266

1.13

0.23

2.7

1.7

5.13

3.00

mg/l

0.33

204

Car occupant injured in noncollision transport accident

556

0.91

0.22

1.4

1.8

4.41

3.90

mg/l

0.19

384

Inflammation of lacrimal passages (acute and unspecified)

200

1.16

0.22

1.7

1.9

3.95

2.81

mg/l

0.37

150

Other congenital malformations of ear

238

1.14

0.22

1.3

1.7

2.84

3.58

mg/l

0.29

151

Assault by unspecified chemical or noxious substance

0.00

0.22

0.0

1.3

—

1.77

—

Other disorders of breast and lactation associated with childbirth

391

1.11

0.22

1.9

1.6

2.23

3.17

mg/l

1.08

257

Turner's syndrome

1.23

0.22

1.2

1.9

1.25

2.58

mg/l

—

Other benign neoplasms of connective and other soft tissue

120

1266

0.95

0.22

1.3

1.7

2.67

3.70

mg/l

0.97

883

Other specific arthropathies, wide

305

0.88

0.22

2.1

1.7

4.91

5.17

mg/l

0.04

214

Other female pelvic inflammatory diseases

257

2480

1.04

0.22

1.5

1.7

3.47

3.33

mg/l

0.13

193

1718

Use of rivastigmine

495

1.09

0.22

1.4

1.5

2.88

3.08

mg/l

0.07

386

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

147

1401

1.05

0.22

1.6

3.81

3.58

mg/l

0.12

104

926

Neuromuscular dysfunction of bladder

1009

0.94

0.22

1.7

4.55

3.62

mg/l

0.31

714

Other melanin hyperpigmentation

191

1.16

0.22

1.6

1.73

2.45

mg/l

0.65

147

Benign neoplasm: Larynx

324

1.11

0.22

1.8

3.82

3.10

mg/l

0.13

234

Pregnancy with abortive outcome

1443

7433

1.02

0.22

1.6

3.25

3.47

mg/l

0.54

1004

5134

Ischaemic infarction of muscle

0.00

0.22

0.0

1.4

—

1.74

—

Epiphyseal arrest

0.00

0.22

0.0

1.6

—

3.30

—

Concussion

987

8392

1.02

0.22

1.8

1.6

3.43

3.26

mg/l

0.25

730

5478

Drug-induced hypopituitarism

0.00

0.22

0.0

1.7

—

3.16

—

Type 1 diabetes, strict definition, subgroup 1

165

1575

1.05

0.21

1.7

1.6

3.24

3.80

mg/l

0.46

149

965

Benign neoplasm: Urethra

0.00

0.21

0.0

1.6

—

2.66

—

Scissor bite

345

0.89

0.21

1.4

1.7

4.91

4.08

mg/l

0.11

225

Papilloedema, unspecified

315

1.12

0.21

1.8

1.7

8.58

2.88

mg/l

0.63

222

Disorders of muscle tone of newborn

0.00

0.21

0.0

1.4

—

5.65

—

Haemophilus septicemia

0.00

0.21

0.0

1.7

—

2.13

—

Other and unspecified disorders of globe

0.00

0.21

0.0

1.6

—

1.47

—

Lumbar disc prolapse

1168

9133

1.02

0.21

1.7

3.88

3.50

mg/l

0.52

859

6352

Tularaemia

156

0.83

0.21

1.4

1.6

5.67

3.19

mg/l

—

112

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

689

0.93

0.21

1.9

1.7

8.66

3.74

mg/l

1.91

492

Leiomyoma of uterus

1147

6416

1.02

0.21

1.7

3.16

3.33

mg/l

0.29

820

4622

Patellar tendinitis

304

0.88

0.21

1.4

1.9

1.98

3.57

mg/l

1.07

208

Environmental-pollution-related condition

0.00

0.21

0.0

1.8

—

2.20

—

Secondary polycythaemia

241

0.87

0.21

1.6

2.52

3.29

mg/l

0.33

176

Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

0.00

0.21

0.0

1.7

—

4.88

—

Fracture of rib(s), sternum and thoracic spine

317

3270

0.97

0.21

1.6

1.7

5.58

3.69

mg/l

1.03

242

2315

Benign lipomatous neoplasm of intrathoracic organs

0.00

0.21

0.0

1.6

—

0.99

—

Cramp and spasm

604

1.08

0.21

1.3

1.7

3.54

4.13

mg/l

0.19

422

Open wound of thorax

209

0.86

0.21

1.4

1.7

4.83

3.59

mg/l

0.23

150

Benign neoplasm: Caecum

874

0.94

0.21

1.7

1.6

3.50

3.91

mg/l

0.09

626

Occupational exposure to risk-factors

398

0.90

0.21

1.7

1.8

3.09

3.19

mg/l

0.05

286

Other disorders of kidney and ureter

121

1274

0.95

0.21

2.0

1.7

4.99

3.97

mg/l

0.40

904

Disorders of muscles

143

1364

1.05

0.21

2.1

1.7

6.50

4.00

mg/l

0.73

107

934

Defect, injury or illness of skull

0.00

0.21

0.0

1.5

—

3.40

—

Forearm

0.00

0.21

0.0

1.6

—

1.35

—

Suicide or other Intentional self-harm

458

4466

1.03

0.21

1.6

1.7

4.64

3.59

mg/l

1.82

384

3076

Noonan syndrome

0.00

0.21

0.0

1.5

—

1.35

—

Bacterial meningoencephalitis and meningomyelitis

0.00

0.21

0.0

1.5

—

3.11

—

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

0.00

0.21

0.0

1.6

—

1.29

—

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

0.00

0.21

0.0

1.8

—

2.22

—

Carcinoma in situ of oropharynx, excluding all cancers

0.00

0.21

0.0

1.5

—

2.16

—

Myasthenia gravis, drug-induced

0.00

0.21

0.0

3.0

—

2.24

—

Loose body in joint

314

0.89

0.21

1.4

1.7

1.88

5.10

mg/l

1.00

219

Knuckle pads

0.00

0.21

0.0

2.1

—

3.34

—

Excessive vomiting in pregnancy

156

1630

0.96

0.21

1.5

1.6

3.11

3.79

mg/l

0.60

115

1090

Monocytic leukaemia

0.00

0.21

0.0

1.5

—

4.59

—

Maternal care for known or suspected malpresentation of fetus

466

3561

0.97

0.21

1.6

3.31

3.79

mg/l

0.70

318

2385

Malignant neoplasm of breast, HER2-negative

692

5189

0.98

0.21

1.7

2.49

3.33

mg/l

3.39

533

3734

Visual impairment including blindness (binocular or monocular)

605

0.92

0.21

1.8

1.7

5.52

3.84

mg/l

0.44

438

Dental pulpitis 3, only avohilmo

278

2097

0.97

0.20

1.4

4.85

3.63

mg/l

1.93

202

1263

Suppurative and unspecified otitis media

781

6793

1.02

0.20

1.6

3.53

3.55

mg/l

0.02

556

4472

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

282

0.88

0.20

1.1

1.7

2.44

3.25

mg/l

0.53

203

Type1 diabetes, definitions combined, early onset

129

1348

0.95

0.20

1.6

1.7

3.19

3.78

mg/l

0.69

119

862

Other disorders of pigmentation

470

1.09

0.20

1.9

1.6

2.89

4.15

mg/l

0.42

336

Temporal arteritis

261

0.88

0.20

1.3

1.7

5.59

4.39

mg/l

0.18

199

Anorexia

221

1.14

0.20

1.4

1.8

3.10

2.71

mg/l

0.12

152

Diabetic nephropathy, excluding more controls

146

1164

1.05

0.20

1.7

1.9

5.04

4.47

mg/l

0.21

138

994

Bronchitis, not specified as acute or chronic

104

1097

0.95

0.20

2.0

1.7

5.84

3.55

mg/l

0.96

758

Erythema intertrigo

229

0.87

0.20

1.8

5.25

2.80

mg/l

0.56

174

Glomerular diseases

217

2093

1.04

0.20

1.8

1.7

5.28

3.72

mg/l

0.81

183

1463

Other and unspecified disease of Bartholin gland

365

0.90

0.20

1.4

1.7

1.76

4.03

mg/l

0.80

255

Glaucoma suspect

362

3720

0.97

0.20

1.8

1.7

3.83

3.48

mg/l

0.29

270

2677

Pedestrian injured in collision with pedal cycle

413

1.09

0.20

1.3

1.8

3.19

4.61

mg/l

0.44

297

Other and unspecified mononeuropathies of lower limb

317

1.11

0.20

2.1

1.7

3.05

4.66

mg/l

0.40

237

Congenital malformations of ovaries, fallopian tubes and broad ligaments

115

1094

1.05

0.20

1.5

1.7

3.23

3.91

mg/l

0.39

752

Fracture of shoulder and upper arm

454

4647

0.98

0.20

1.4

1.7

3.27

3.58

mg/l

0.35

328

3207

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

747

0.93

0.19

1.7

4.94

4.57

mg/l

0.07

502

Herpesviral [herpes simplex] infections

170

1633

1.04

0.19

1.9

1.7

4.06

3.58

mg/l

0.20

123

1146

Toxic liver disease

186

0.86

0.19

1.3

1.9

1.75

2.77

mg/l

0.95

133

Allergic colitis

317

1.11

0.19

1.1

1.6

4.20

3.77

mg/l

0.14

203

143

1324

0.96

0.19

1.7

1.6

2.54

3.46

mg/l

0.94

116

981

Other erythematous conditions

385

0.91

0.19

1.6

1.8

2.89

4.73

mg/l

0.57

286

Hypermetropia

931

0.94

0.19

1.4

1.7

3.72

4.07

mg/l

0.14

633

Benign neoplasm: Ascending colon

102

1075

0.95

0.19

1.6

1.7

3.28

3.48

mg/l

0.08

767

Third [oculomotor] nerve palsy

165

1.16

0.19

1.7

1.8

3.79

3.05

mg/l

0.14

123

Other bursopathies

162

1555

1.04

0.19

1.7

3.83

3.96

mg/l

0.05

132

1060

Shoulder region

154

0.84

0.19

1.3

1.9

8.85

3.45

mg/l

—

114

Syncope and collapse

602

5443

0.98

0.19

2.2

1.6

3.81

3.34

mg/l

0.56

455

3709

Benign neoplasm: Cranial nerves

291

0.89

0.19

1.4

1.7

1.20

2.93

mg/l

2.35

213

Hydatidiform mole

270

1.12

0.19

2.3

1.7

3.16

5.53

mg/l

0.50

190

Palmar fascial fibromatosis [Dupuytren]

132

1261

1.05

0.19

1.5

1.6

3.47

4.24

mg/l

0.25

101

876

Benign neoplasm: Brain, supratentorial

196

0.86

0.19

1.4

1.8

2.73

3.55

mg/l

—

145

Injuries to the wrist and hand

1976

14161

1.01

0.18

1.6

3.80

3.48

mg/l

0.44

1438

9746

Congenital malformations of uterus and cervix

415

1.09

0.18

1.4

1.6

4.47

3.10

mg/l

0.49

278

Puerperal sepsis

197

2041

0.96

0.18

1.8

1.7

4.22

3.39

mg/l

0.48

144

1439

Blood alcohol or alcohol intoxication level

363

0.91

0.18

1.6

1.7

5.21

4.12

mg/l

0.25

249

Benign neoplasm: Skin of scalp and neck

290

0.89

0.18

2.0

1.8

1.82

3.22

mg/l

1.31

205

Asthma mixed form (mode), excluding more controls

724

0.94

0.18

1.5

1.4

3.28

2.57

mg/l

0.40

484

Idiopathic thrombocytopenic purpura

342

0.90

0.18

2.5

1.7

3.14

2.94

mg/l

0.09

245

Childhood allergy (age < 16)

348

2941

0.97

0.18

1.4

3.91

3.57

mg/l

0.35

216

1796

Mixed disorders of conduct and emotions, excluding more controls

367

1.09

0.18

1.6

3.70

3.10

mg/l

0.26

200

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

166

1.15

0.18

1.5

1.9

4.01

2.79

mg/l

0.51

116

Personal history of other diseases and conditions

210

2021

1.04

0.18

1.7

1.5

4.59

3.62

mg/l

0.59

156

1359

Contact with nonpowered hand tool

580

1.07

0.18

2.0

1.7

2.30

3.59

mg/l

1.43

412

Contusion of toe(s) with damage to nail

153

0.84

0.18

1.5

1.6

4.21

2.84

mg/l

—

111

Panniculitis affecting regions of neck and back

528

0.93

0.18

1.6

4.70

4.01

mg/l

0.14

374

Degeneration of macula and posterior pole

355

3003

0.97

0.18

1.6

3.11

3.57

mg/l

0.45

275

2170

Type 1 diabetes, wide definition, subgroup 1

361

3697

0.97

0.18

1.5

1.6

3.86

3.41

mg/l

0.51

335

2409

Benign neoplasm: Colon

558

5356

1.02

0.18

1.6

1.7

4.09

3.60

mg/l

0.39

432

3844

Benign neoplasm: Cerebral meninges

959

0.95

0.18

1.8

1.7

3.53

3.64

mg/l

0.05

697

Scabies

651

0.93

0.18

1.5

1.8

4.03

3.63

mg/l

0.18

448

Benign neoplasm of major salivary glands

101

1061

0.95

0.17

1.8

1.7

3.97

3.98

mg/l

0.00

738

Assault

229

2363

0.97

0.17

1.8

1.7

3.73

3.80

mg/l

0.04

183

1596

Corneal scars and opacities

281

1.11

0.17

1.5

1.8

3.24

3.37

mg/l

0.04

204

Recurrent dislocation of patella

113

1079

1.05

0.17

1.6

3.78

4.15

mg/l

0.18

704

Benign neoplasm: other/unspecified salivary gland

243

1.11

0.17

2.1

1.8

2.60

2.78

mg/l

0.08

191

0.76

0.17

2.4

1.9

2.12

2.98

mg/l

—

Localized skin eruption due to drugs and medicaments

148

1.16

0.17

1.5

2.17

3.13

mg/l

—

104

Sequelae of tuberculosis

0.73

0.17

1.6

1.7

34.95

1.80

mg/l

—

Rheumatic valve diseases

152

0.85

0.17

1.7

1.6

4.06

2.94

mg/l

—

112

Ehlers-Danlos syndrome

196

1.13

0.17

2.2

1.8

3.78

2.90

mg/l

0.31

134

Short stature, not elsewhere classified

260

0.90

0.17

1.1

1.6

2.31

3.82

mg/l

1.31

167

Galactorrhea

196

1.13

0.16

1.6

1.8

3.01

2.60

mg/l

0.22

136

Other congenital malformations of female genitalia

177

1.14

0.16

1.9

1.6

5.77

3.51

mg/l

0.42

116

Pneumothorax

680

0.94

0.16

2.9

1.7

12.49

2.91

mg/l

1.65

478

Chronic Coagulation defects

381

0.92

0.16

1.5

1.7

4.88

4.75

mg/l

0.02

266

Tongue abnormality

641

1.06

0.16

1.6

1.7

3.13

3.91

mg/l

0.32

462

Autoimmune thyroiditis

298

0.90

0.16

1.8

3.35

4.45

mg/l

0.22

207

Lifestyle-related condition

141

0.85

0.16

1.8

1.9

8.27

3.19

mg/l

—

110

Meralgia paraesthetica

437

1.08

0.16

2.2

1.7

6.19

3.24

mg/l

0.55

307

Other and unspecified nerve root and plexus disorders, also in other diseases

279

2716

1.03

0.16

1.7

5.43

3.75

mg/l

0.80

190

1878

Fracture of forearm

857

8144

0.98

0.16

1.6

3.41

3.46

mg/l

0.07

615

5637

Graves ophthalmopathy

329

0.91

0.16

1.7

2.50

4.58

mg/l

0.58

232

Disorders of lacrimal system and orbit in diseases classified elsewhere

329

0.91

0.16

1.7

2.50

4.66

mg/l

0.61

230

Immunodeficiencies

622

1.06

0.16

2.1

1.6

4.67

4.06

mg/l

0.16

435

Fibroblastic disorders

275

2677

1.03

0.16

1.7

3.25

3.61

mg/l

0.23

216

1850

Oral lichen ruber planus

273

1.10

0.16

2.8

1.8

3.19

4.61

mg/l

0.30

211

Asthma mixed form (mode)

720

0.94

0.16

1.5

1.4

3.28

2.60

mg/l

0.38

484

Other CVD

141

1356

1.04

0.16

2.2

1.7

3.60

3.99

mg/l

0.18

110

969

Unspecified lump in breast

214

2206

0.97

0.16

1.5

1.7

2.76

3.42

mg/l

0.74

150

1546

Transient synovitis

130

0.84

0.16

1.1

1.6

2.48

2.63

mg/l

—

Pleural plaque

447

1.07

0.16

1.9

1.6

11.69

2.55

mg/l

1.62

323

Chronic suppurative otitis media

847

1.05

0.16

1.9

1.7

3.71

4.26

mg/l

0.18

590

Haemorrhage in early pregnancy

582

5779

0.98

0.16

1.8

1.6

3.41

3.35

mg/l

0.05

406

3907

Acne

218

2115

1.03

0.16

1.5

4.00

3.77

mg/l

0.17

135

1365

Benign neoplasm: Orbit, unspecified

0.77

0.16

6.0

1.9

1.35

3.81

mg/l

—

Other disorders of teeth and supporting structures

295

3025

0.97

0.16

2.1

1.6

5.78

3.11

mg/l

2.78

241

2077

Gestational [pregnancy-induced] hypertension

554

5627

0.98

0.16

1.8

1.6

4.79

3.23

mg/l

0.85

395

3824

Dislocation, sprain and strain of joints and ligaments of elbow

995

0.95

0.16

1.6

1.7

3.56

4.37

mg/l

0.44

680

Cyst of Bartholin Gland

633

1.06

0.15

1.4

1.7

2.95

4.22

mg/l

0.61

433

Perineal laceration during delivery

418

3649

1.02

0.15

1.6

3.17

3.67

mg/l

0.90

277

2424

LSIL lesion of the cervix uteri, vagina or vulva

271

2781

0.97

0.15

1.7

1.6

2.88

3.48

mg/l

0.85

185

1922

Intestinal adhesions without obstruction

801

0.95

0.15

1.5

1.7

5.28

3.40

mg/l

0.48

577

Injury of eye and orbit

213

2194

0.97

0.15

1.8

1.7

3.73

3.67

mg/l

0.03

157

1473

Cervicobrachial syndrome

363

3550

1.02

0.15

1.8

1.7

2.57

3.55

mg/l

2.74

262

2480

Brain meningioma, excluding all cancers (controls excluding all cancers)

524

0.93

0.15

1.6

1.7

4.49

4.33

mg/l

0.04

374

Lesion of ulnar nerve

179

1849

0.97

0.15

2.2

1.7

3.63

3.99

mg/l

0.21

133

1296

Hordeolum and other deep inflammation of eyelid

780

0.95

0.15

1.4

1.7

2.35

4.32

mg/l

1.53

541

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

276

0.90

0.15

1.1

1.8

2.44

3.35

mg/l

0.62

208

Alzheimer’s disease (Late onset)

590

0.94

0.15

1.7

1.4

1.80

2.90

mg/l

1.29

455

Intermittent heterotropia

943

0.95

0.15

1.5

1.6

5.47

3.59

mg/l

1.13

632

Somnolence, stupor and coma

497

1.07

0.15

2.8

1.7

3.26

4.14

mg/l

0.30

358

Symptoms and signs involving the urinary system

1147

8757

1.01

0.15

1.7

4.33

3.51

mg/l

1.30

841

6161

Diffuse brain injury

472

0.93

0.15

1.9

1.8

2.64

3.58

mg/l

0.51

313

Injury of muscle and tendon at forearm level

265

0.90

0.15

1.8

3.26

3.37

mg/l

0.05

188

Congenital deformities of hip

284

1.09

0.15

1.4

1.8

4.77

3.48

mg/l

0.47

193

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

244

0.90

0.15

1.4

1.8

4.12

3.22

mg/l

0.22

159

Arthrosis

1354

7360

1.01

0.15

1.7

3.92

3.38

mg/l

0.91

1058

5120

Abnormal involuntary movements

169

1636

1.03

0.15

1.4

1.7

3.86

3.95

mg/l

0.04

131

1154

Tooth eruption problems

293

2970

0.98

0.15

1.4

1.5

4.25

3.98

mg/l

0.12

192

1915

Cerebral cysts

791

1.05

0.15

1.9

1.7

5.07

4.15

mg/l

0.34

541

Caught, crushed, jammed or pinched in or between objects

707

0.95

0.15

2.3

1.7

3.32

4.01

mg/l

0.33

480

Graves disease, strict definition

156

1613

0.97

0.15

2.0

1.7

3.00

3.79

mg/l

0.83

123

1130

Injury of cranial nerves

0.78

0.14

1.6

2.0

2.85

2.21

mg/l

—

Dislocation, sprain and strain of joints and ligaments of head

664

1.06

0.14

1.4

1.7

2.71

4.31

mg/l

0.82

455

Brain meningioma

502

0.93

0.14

1.6

1.7

3.87

4.19

mg/l

0.09

361

Nonsuppurative otitis media

479

4064

1.02

0.14

1.5

5.02

3.57

mg/l

1.35

313

2592

Thyrotoxicosis with toxic multinodular goitre

553

0.94

0.14

1.5

1.7

3.44

3.88

mg/l

0.13

403

Other diseases of arteries and capillaries

919

1.05

0.14

1.7

3.38

3.68

mg/l

0.12

648

Carcinoma in situ of other and unspecified digestive organs

202

0.89

0.14

1.3

1.7

6.20

3.15

mg/l

0.27

155

Bilateral sagittal split ramus osteotomy operation

614

0.94

0.14

1.5

1.7

2.64

4.47

mg/l

0.84

418

Monoplegia

181

0.88

0.14

2.7

1.7

3.48

3.42

mg/l

0.01

132

Benign neoplasm: Skin of scalp and neck

285

0.91

0.14

2.0

1.8

1.82

3.30

mg/l

1.38

204

Use of antiglaucoma preparations and miotics

522

0.94

0.14

1.5

1.7

5.72

3.84

mg/l

0.38

411

Leisure time condition

234

2402

0.97

0.14

1.6

3.63

3.75

mg/l

0.07

171

1660

Covid-19 suspected case

381

3887

0.98

0.14

1.7

1.6

4.24

3.54

mg/l

0.77

275

2645

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS